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“Photoreceptors sit on a knife edge separating function and survival 
from dysfunction and death, and almost any defect seems capable of 
tipping them towards cell death.” 
 
- Alan F. Wright et al., “Photoreceptor degeneration: genetic and 
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Diseases of the retina, the layer of the human eye which is responsible for detecting 
light and relaying that signal to the brain, are a leading cause of blindness, especially 
in younger ages. One such disease, called “Retinitis pigmentosa” (RP), is 
characterised by the death of the light-detecting cells, the photoreceptors. The cause 
of RP is exclusively genetic, meaning that it is caused by DNA alterations that run in 
families and not environmental or external factors. One subtype of RP (type 2) is 
known to be caused by alterations in the DNA region which contains instructions for 
the production of a protein molecule called RP2. Currently, there is no therapy for 
RP; it is, therefore, important to understand why the function of RP2 in the retina is 
so crucial that photoreceptors die when it is lost, as this will lead to the identification 
of more effective treatments. The present thesis reports novel information on how 
RP2 interacts with other protein molecules in cells and how its activity might be 
regulated. In particular, molecular biology techniques have been used to show that 
RP2 forms a complex with other proteins that participate in fundamental cellular 
processes like cell movement and repair of DNA damage. Moreover, this project has 
led to the identification of two sites on RP2 where a phosphate group might be added 
to control the protein’s activity. Finally, a major goal in disease research is finding 
animal models which can be used to screen and test potential therapies, as it is not 
possible to perform these procedures directly on human patients. To this end, a novel 
genome manipulation technique has been used to generate zebrafish with targeted 
DNA alterations in the region responsible for producing the zebrafish version of 
RP2. The presence of retinal degeneration has been shown by histological 
examination in one of these fish lines that lack RP2 function. Overall, this thesis 
provides new data that expand the knowledge on the molecular mechanisms that 




The term “Retinitis pigmentosa” (RP) represents a group of inherited, late-onset 
diseases characterised by progressive retinal degeneration due to photoreceptor 
death. Mutations in the RP2 gene are found in 7-18% of patients with X-linked RP, 
one of the most severe forms. The RP2 gene product is a membrane-associated 
protein which encompasses two distinct domains. The N-terminal domain is well 
characterised as possessing GTPase-activating protein (GAP) activity towards the 
small GTPase ARL3 and thus regulate the transport of lipid-modified proteins within 
the photoreceptor cell. However, it is not known if the loss of this particular function 
of RP2 is the sole reason that causes the disease, while the role of the protein’s C-
terminus remains unknown. This thesis focuses on the characterisation of two novel 
protein-protein interactions of RP2 with the aim to investigate novel roles of the 
protein. Firstly, evidence is provided that a highly-conserved cluster of RP2 residues 
that span both the N- and C-terminus participate in direct interaction with Osteoclast-
stimulating factor 1 (OSTF1). Two hypotheses are explored about the potential role 
of the complex in SRC-mediated RP2 phosphorylation and the regulation of cell 
motility. Secondly, the catalytic subunit of DNA-dependent protein kinase (DNA 
PK) is identified as a novel interaction partner of RP2 in cultured cells. The two 
proteins are shown to co-localise in the nuclear and membrane compartments of a 
retinal-derived cell line and might engage in a kinase-substrate relationship. So far, 
no evidence was found that RP2 participates in the canonical function of DNA PK 
which is the regulation of DNA double-stranded breaks. Finally, the CRISPR/Cas9 
genome editing method was applied on zebrafish embryos to generate a novel 
vertebrate animal model for the loss of RP2 function. One out of three different 
zebrafish lines with rp2 mutations was shown by histology to have mild late-onset 
thinning of the photoreceptor outer segments. The present thesis reports previously 
unexplored aspects of RP2’s function and will, therefore, contribute to understanding 
the molecular mechanisms that underlie RP. Moreover, this thesis will contribute to 
the discussion about the usefulness of zebrafish as an RP model.  
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Chapter 1. Introduction 
Inherited retinal degenerations (IRDs) today affect more than 2 million people 
worldwide (Sahel, Marazova and Audo 2014). IRDs may be constricted to the 
macula or affect the entire retina, ultimately leading to severe visual impairment and 
constituting a substantial burden on patients’ everyday lives and the whole of 
society. Although these diseases remain untreatable, significant progress has been 
made regarding both the research for therapeutic strategies and the development of 
technological aids and substitutes. These advances go hand-in-hand with the rise of 
new sequencing technologies which has led to an explosion in the identification of 
genetic causes for these highly heterogeneous diseases and basic research which 
sheds light to the molecular pathways leading to disease.  
In the following chapter, I will first provide a brief overview of the principles 
concerning retinal structure in general and photoreceptor biology in particular. I will 
then describe some of the main types of IRDs and Retinitis pigmentosa (RP), a form 
of IRD which stems from photoreceptor degeneration. This disease is the focus of the 
present thesis, which presents research on the molecular mechanisms underlying a 
specific subtype of X-linked RP caused by mutations in the RP2 gene. Subsequently, 
I will summarise all current bibliography concerning the function of protein RP2, 
and, finally, I will lay out the aims of my PhD research.  
 
1.1 General principles of photoreceptor structure and function 
The vertebrate retina is laminated in an orderly manner. It consists of an outer 
monolayer of polarised epithelial cells, the retinal pigment epithelium (RPE), and the 
inner neural retina, a laminated network of neurons and their connections. The 
photoreceptor layer, consisting of highly differentiated neurons which generate 
electrical responses after light stimulation, is found at the outer part of the retina 
adjacent to the RPE layer. This arrangement means that light must first pass through 
the inner layers of the retina before reaching the light-sensitive outer segment (Sung 
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and Chuang 2010) (Figure 1.1A). Rod photoreceptors (rods) are specialised for high-
sensitivity photon detection in low-light conditions, while cone photoreceptors 
(cones) are adapted to high-resolution colour vision. While this basic organisation is 
common among vertebrates, the distribution of rods and cones across the retina 
differs among species. For example, humans and other primates have specialised 
cone-dense areas in the central retina responsible for high-acuity vision, the macula 
and the fovea (Hendrickson 2005). Because rodents commonly used in retinal 
research are nocturnal animals, they have a rod-dominant retina and poor colour 
vision. Zebrafish, another useful small-animal model for the study of retinal diseases, 
have four different types of cones and, as a result, possess the ability for 
tetrachromatic colour vision (Malicki et al. 2016, Gregory-Evans 2012). The 
zebrafish retina is also considered cone-dominant, at least during early larval stages 
when vision is exclusively dependent on cones (Bilotta, Saszik and Sutherland 
2001). However, there are other physiological differences between the zebrafish and 
the human retina (Lieschke and Currie 2007). These differences in photoreceptor 
distribution must be considered when interpreting results from animal model studies.   
The photoreceptors have a very tight relationship with the adjacent RPE layer which 
performs many functions essential for photoreceptor viability. For example, the 
regeneration of the chromophore 11-cis retinal which is exhausted during 
phototransduction [a reaction known as the visual cycle (Lamb and Pugh 2004, Jin et 
al. 2005)] takes place in the RPE. Moreover, the RPE cells prevent and repair retinal 
photooxidative damage, caused by the production of reactive oxygen species due to 
high levels of light exposure, via their capacity for light filtration and their high 
antioxidant content (Newsome et al. 1994, Dun et al. 2013). Other functions of the 
RPE layer include the transport of nutrients and ions between the retina and the 
choriocapillaris (Adijanto et al. 2009), the secretion of neurotrophic factors , and the 
secretion of proteoglycans which make up the interphotoreceptor matrix (Tawara, 
Varner and Hollyfield 1989). Most importantly, the RPE cells are active phagocytes 
which daily “consume” shed photoreceptor OS (~10% of OS discs in the rat) and 
assist in their renewal (Kevany and Palczewski 2010, Young and Bok 1969).  
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Photoreceptors are highly compartmentalised cells divided into the outer segment 
(OS), a system of tightly-packed membrane stacks where phototransduction takes 
place, the inner segment (IS) where all biosynthetic reactions take place, the nucleus 
and the synapse (Pearring et al. 2013) (Figure 1.1B). Phototransduction begins with 
photon absorption by the visual pigment molecules (rhodopsin or cone opsins), G 
protein-coupled receptors covalently conjugated to a chromophore. This event 
initiates a signalling cascade involving the activation of G protein transducin and 
cGMP phosphodiesterase (PDE) which ultimately leads to the decrease in 
intracellular cGMP concentration (Arshavsky and Wensel 2013).  
The OS is, in fact, the continuation of a modified primary cilium embedded within 
the photoreceptor cell, called the connecting cilium (CC). The CC functions as a 
bridge connecting the IS and the OS and permits protein transport between the two 
compartments in a highly regulated and efficient manner (Figure 1.1B). It has been 
estimated that ~80 molecules of rhodopsin, the visual pigment of rod photoreceptors, 
have to be synthesised and delivered to the OS every second in mouse 
photoreceptors (Williams 2002). The delivery of OS proteins from their site of 
synthesis to the base of the cilium is regulated by sophisticated mechanisms 
involving RAB, ARF and ARL GTPases, of which the most mechanistically 
dissected is the mechanism governing transport of rhodopsin (Deretic and Wang 
2012, Deretic et al. 1995, Mazelova et al. 2009). In general, transmembrane or 
membrane-associated OS proteins are delivered either as transport vesicles 
assembled at the Golgi apparatus or with the help of trafficking chaperones which 
recognise lipid-modified cargo (Pearring et al. 2013). Once in the ciliary apparatus, 
the transport of proteins up and down the microtubule-based structure, the ciliary 
axoneme, is carried out by molecular motors and the intraflagellar transport (IFT) 
protein complexes. This has been shown in primary cilia and is most likely 
applicable to photoreceptor CC as well (Pearring et al. 2013). Anterograde transport 
(towards the ciliary tip) is carried out by the IFT-B complex and molecular motors of 
the kinesin-2 family, while retrograde transport (from the tip to the base of the 
cilium) is carried out mainly by cytoplasmic dynein-2 and the IFT-A complex. The 
role of the components mentioned above in ciliary transport has been supported by a 
multitude of mouse and zebrafish studies showing that mutations in motor proteins or 
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IFT proteins lead to mislocalisation phenotypes and defective photoreceptor 
development (Pazour et al. 2002, Marszalek et al. 2000, Zhao et al. 2012, Krock, 
Mills-Henry and Perkins 2009, Tsujikawa and Malicki 2004b).  
A disruption in ciliary trafficking is bound to affect all outer segment functions, from 
phototransduction to phagocytosis by the RPE, and therefore compromise 
photoreceptor function and viability. The strict requirement for efficient protein 
transport through the CC is only one of the reasons that the photoreceptors are so 
vulnerable to the slightest compromise of their functional state. Another factor that 
contributes to the vulnerability of photoreceptors and stems from their unique 
cellular organisation is the susceptibility to light-induced damage and lipid oxidation 
(Wright et al. 2010, Hollyfield et al. 2008). The combination of photoexcitation of 
molecules, such as retinoids, and high oxygen content in the retina can readily lead to 
the generation of reactive oxygen species and oxidative damage in biomolecules, 
especially if genetic mutations lead to increased accumulation of by-products of the 
visual cycle (Sun and Nathans 2001). Besides, the susceptibility of photoreceptors to 
oxidative damage is multiplied by their very high lipid content, especially regarding 
long-chain polyunsaturated fatty acids, readily oxidised to highly reactive 
compounds which can initiate free radical chain reactions. Indeed, the potential of so 
many stressors to tip the balance towards cell death is reflected in the fact that 
photoreceptor degeneration is considered one of the most genetically heterogeneous 
disorders in humans (Wright et al. 2010).  
 
1.2 Retinitis pigmentosa and other forms of inherited retinal 
degeneration 
Several types IRDs exist which stem from photoreceptor degeneration but differ 
from each other by the kind of photoreceptors involved, the age of onset and the 
clinical characteristics. Some examples are: 
• Leber congenital amaurosis (LCA) [reviewed in (den Hollander et al. 
2008)] is the most severe non-syndromic retinal dystrophy, characterised by 
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early (infantile onset) visual loss and non-detectable electroretinogram (ERG) 
responses. Mutations in more than 20 genes can cause the disease (Retinal 
Information Network, RetNet) and can manifest as cone-rod or rod-cone 
degeneration, depending on which photoreceptor type is primarily affected.  
• Cone-rod dystrophies [reviewed in (Michaelides et al. 2006)] are 
types of retinal dystrophies characterised by cone degeneration preceding rod 
degeneration. Early manifestations include loss of visual acuity, photophobia, 
and the appearance of macular pigment deposits, while late stages are 
characterised by arteriolar attenuation and optic disc pallor. More than 30 
genes have been identified today to cause the various forms of the disease 
(RetNet), such as ABCA4 (autosomal recessive form), UNC119 (autosomal 
dominant form) and even RPGR, one of the major causative genes for X-
linked RP.  
• X-linked retinoschisis [reviewed in (Molday, Kellner and Weber 
2012)] stems from the splitting of the inner layers of the neurosensory retina, 
leading to foveal “schisis” (breaking) and vision loss. It is diagnosed in 
infancy or early childhood and usually follows a mild disease progression 
course. It is caused by mutations in the RS1 gene. 
• Stargardt disease [reviewed in (Tanna et al. 2017)] is bilateral macular 
atrophy accompanied by subretinal deposition of lipofuscin-like material. It is 
juvenile-onset and usually diagnosed as impaired central and detailed vision 
and decreased visual acuity. Typical Stargardt disease is associated with 
mutations in the ABCA4 gene.  
• Retinitis pigmentosa (RP) is a clinically and genetically 
heterogeneous group of IRDs, characterised by progressive bilateral 
dysfunction of predominantly rod photoreceptors followed by secondary 
degeneration of cone photoreceptors (therefore, a rod-cone degeneration) and 
the RPE. The disease in its typical form initially manifests with problems in 
night vision (nyctalopia) and progressive restriction of the peripheral vision 
field (tunnel vision), characteristic of rod photoreceptor loss. The central 
retina (the macula) is usually preserved until the latest stages of the disease. 
However, the patients are often already considered legally blind due to 
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severely constricted visual fields. In late stages, RP is characterised by a 
classic clinical triad of changes in fundus appearance: retinal blood vessel 
attenuation, retinal pigmentary changes (often hyperpigmentation in the form 
of bone spicule deposits), waxy pallor of the optic nerve head (Sahel et al. 
2014) (Figure 1.1C). Other symptoms/ocular manifestations of the disease 
include fatigue and decline in contrast sensitivity, scotomas in the mid-
periphery, early development of cataracts, refractive errors including myopia 
and astigmatism, cells in the vitreous as well as cystoid macular oedemas 
(Hartong, Berson and Dryja 2006). RP is an exclusively genetically 
determined form of retinal degeneration, meaning that there are no known 
risk factors other than genetic predisposition. The age of onset is very 
variable among the different types, ranging from early childhood to mid-30s 




Figure 1.1 Basic organisation of the human retina and hallmarks of disease (A-
C). Crystal structure of human RP2 (D). 
A) Transverse section of the human retina visualised with H&E staining which 
makes its laminated layers visible, reproduced from (Sung and Chuang 2010). The 
OS, IS, ONL layers represent different parts of the photoreceptor cells. The INL and 
GCL layers contain the nuclei of the second-order neurons that process the light 
signals generated by the photoreceptors and transmit them through the optic nerve to 
the brain. The OPL and IPL layers are formed by neuronal synaptic terminals and 
processes. B) A schematic representation of rod and cone photoreceptors reproduced 
from (Veleri et al. 2015). Photoreceptors are highly compartmentalised neurons, 
consisting of the photosynthetic OS with its membranous discs containing 
phototransduction components, the IS which contains the biosynthetic machinery, 
the nucleus and the presynaptic region where docking of synaptic vesicles takes 
place. C) Picture of the internal surface of the eye (fundus) from a Retinitis 
pigmentosa patient (left) compared to a healthy person (right). The characteristic 
clinical manifestations of RP are marked on the picture, namely the bone spicule 
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pigment deposits (white arrows), retinal vessel attenuation (star) and waxy pallor of 
the optic disc head (black arrow). The picture is taken from the National Eye 
Institute website. D) Crystal structure of human RP2 (Kuhnel et al. 2006). The N-
terminal has homology to Tubulin cofactor C (TBCC) and the C-terminal domain is 
homologous to Nucleoside diphosphate kinases (NDK). 
RPE: retinal pigment epithelium, OS: outer segment, IS: inner segment, ONL: outer 
nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL: inner 
plexiform layer. GCL: Ganglion cell layer. 
 
1.2.1 Molecular genetics and pathways leading to photoreceptor death 
in RP 
The average worldwide prevalence of RP ranges from 1:3000-1:7000, an estimation 
which differs between populations but argues for the labelling of this disease as a 
leading cause of inherited blindness worldwide (Sahel et al. 2014). About 20-30% of 
RP patients suffer from the syndromic or systemic form of the disease, meaning that 
retinal degeneration co-exists with other manifestations affecting multiple organs or 
with system-wide pathological features. For example, RP constitutes the ocular 
manifestation of ciliopathy syndromes such as Usher syndrome (RP and hearing 
impairment), Bardet-Biedl syndrome (RP associated with polydactyly, obesity, 
diabetes type 2, hypogonadism, cognitive impairment and renal abnormalities) or 
Joubert syndrome (RP associated with hypotonia progressing to ataxia, global 
developmental delay, breathing dysregulation, renal and liver abnormalities). Non-
syndromic RP can be inherited as autosomal dominant (20-25% of non-syndromic, 
non-systemic cases), autosomal recessive (15-20%) or X-linked trait (10-15%) 
(Ferrari et al. 2011). In addition, rare cases of digenic and mitochondrial inheritance 
have been reported (Kajiwara, Berson and Dryja 1994), while a significant 
percentage of patients are referred to as isolated or simplex cases, meaning that an 
inheritance pattern is not immediately recognisable (Bravo-Gil et al. 2017).  
The enormous genetic complexity of RP is highlighted by the fact that to date, 
mutations in more than 60 genes have been found to account for the non-syndromic 
forms of the disease only (Retinal information network, RetNet). Moreover, 
genotype-phenotype correlations are not always possible, as many distinct genes are 
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linked to the same phenotype, while mutations in the same gene can cause different 
diseases. As a striking example, mutations in the RPGR gene which account for the 
majority of recessive and dominant X-linked RP cases (depending on whether female 
carriers are affected) have also been blamed for X-linked recessive atrophic macular 
degeneration, cone-rod degeneration and extra-ocular ciliopathies like recurrent 
respiratory infections, deafness, and primary ciliary dyskinesia, in different patients 
(Sharon et al. 2003, Pelletier et al. 2007).  
Disruptions in various molecular pathways and functions can cause RP. However, 
common stressors and photoreceptor death pathways, as well as secondary responses 
of the retina to photoreceptor degeneration, seem to be remarkably similar regardless 
of the mutant gene (Bramall et al. 2010). For example, one of the main factors that 
seem to contribute to photoreceptor cell death in a large group of RP forms is 
elevated oxygen levels in the retina, probably due to energy-demanding procedures, 
such as phototransduction, and the inability of the choroidal blood vessels for 
autoregulation in response to external oxygen levels (Bramall et al. 2010). Several 
rodent models of retinal degeneration display abnormal increases in oxygen 
concentration in the outer retina (Yu et al. 2004). Moreover, light exposure is a 
common stressor which can be translated to oxidative stress in mutant retinae 
displaying accumulation of all-trans-retinal and toxic bis-retinoid byproducts of the 
visual cycle, which are easily oxidised (Organisciak and Vaughan 2010). Mutations 
that disturb outer segment phagocytosis or disc turnover fall into this category.  
Below are some examples of the most common RP causative genes:  
• Mutations in the gene encoding for rhodopsin (RHO), the visual 
pigment of rod photoreceptors and a G protein-coupled receptor, are found in 
26.5% patients with autosomal dominant RP, while they also account for 
autosomal recessive RP and congenital stationary night blindness when they 
lead to constitutively active protein (Ferrari et al. 2011). Rhodopsin forms 
over 90% of the total protein in the rod OS (Basinger, Bok and Hall 1976, 
Ferrari et al. 2011). Mutations in this protein, known to impair binding of 11-
cis retinal, cellular trafficking, or the ability for G protein coupling and 
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activation, lead to impairment of the phototransduction cascade which is 
essential for normal vision (Malanson and Lem 2009). Another big class of 
rhodopsin mutations lead to impaired protein folding, resulting in rhodopsin 
being trapped in the endoplasmic reticulum (ER) (Kunte et al. 2012). Because 
rhodopsin is very abundant in rod photoreceptors, the accumulation of 
misfolded proteins in the ER leads to ER stress and the activation of the 
unfolded protein response (UPR).  
• Mutations in other proteins of the phototransduction cascade are also 
common, such as PDE6A, PDE6B or PDE6G, the subunits of the tetrameric 
phosphodiesterase complex which regulates intracellular cGMP levels by 
hydrolysing cGMP in response to light activation of G protein-coupled 
receptors (Tsang et al. 2008). Responsible for more than 8% of cases, 
mutations in PDE6A and PDE6B are the second most identifiable cause of 
autosomal recessive RP (Ferrari et al. 2011).  
• Notable examples of how disruption in the visual cycle can lead to RP 
are mutations in the RPE65 gene, responsible for ~2% of autosomal recessive 
RP as well as 16% of LCA (Ferrari et al. 2011). RPE65 encodes for an 
isomerohydrolase expressed in the RPE layer which catalyses regeneration of 
11-cis retinal (Moiseyev et al. 2005). Mouse models of RPE65 knockout have 
no 11-cis retinal and no detectable rhodopsin in their retinae; instead, they 
display an accumulation of retinoid intermediates of the visual cycle in their 
RPE layer (Samardzija et al. 2008). Due to the abundance of naturally 
occurring and genetically engineered animal models, the effects of lack of 
RPE65 have been extensively studied, and patients have participated in gene 
therapy clinical trials which have so far positive results in terms of visual 
reactions but did not slow down retinal degeneration (Cideciyan 2010, 
Cideciyan et al. 2013). Importantly, this example highlights the stringent 
functional cooperation of the photoreceptors and the RPE layer which is 
required for retinal viability. Mutations in other genes that are exclusively 
expressed in the RPE are also responsible for RP and other forms of retinal 
degeneration (among others, ABCA4 and MERTK).  
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• Molecular pathways required for retinal viability are not restricted to 
the visual cycle but are very diverse. Some causative genes participate in 
maintaining photoreceptors’ structure. For example, the PRPH2 gene which 
is found mutated in 5-10% of patients with autosomal dominant RP (Ferrari 
et al. 2011), encodes for an integral membrane glycoprotein, Peripherin-2, 
located in the outer segment discs of rods and cones. This protein forms 
homomeric and heteromeric complexes with ROM1 which are important for 
disc morphogenesis and stabilisation (Loewen, Moritz and Molday 2001).  
• On the other hand, RP can also be caused by metabolic stress due, for 
example, to defects in protein synthesis. PRPF31 encodes for one out of three 
pre-mRNA splicing factors which are found mutated in RP and accounts for 
up to 8% of autosomal dominant RP in various cohorts (Audo et al. 2010). 
Interestingly, the proteins encoded by these genes are essential for splicing in 
all cell types; it is, therefore, unknown why rod photoreceptors are 
exclusively affected by their mutations.  
• Finally, an important group of genes whose mutations are often 
connected to retinal degenerations are genes encoding for structural or 
functional components of the CC. Because of this, and the fact that RP 
constitutes the ocular manifestation of several syndromic ciliopathies, non-
syndromic RP is also characterised as a ciliopathy. A notable example is 
RPGR, the causative gene for the majority (70-90%) of X-linked RP cases 
(Pelletier et al. 2007, Prokisch et al. 2007). Two of the protein isoforms 
encoded by this gene, a constitutive (RPGREx1-19) and a retinal-enriched 
(RPGRORF15) one, localise to the base of the photoreceptor connecting cilium, 
where they have been attributed roles in the regulation of protein trafficking 
to the connecting cilium and cytoskeletal regulation (Lyraki, Megaw and 
Hurd 2016).  
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1.2.2 X-linked RP 
X-linked inheritance pattern characterises about 10-20% of families with RP. X-
linked RP (XLRP) cases are among the most severe due to early onset leading to 
significant visual loss before the fourth decade (Pelletier et al. 2007). Linkage 
analyses indicate at least five XLRP loci, but only three genes have been identified to 
date. Mutations in RPGR (Roepman et al. 1996) and RP2 (Schwahn et al. 1998) 
genes together account for the vast majority of all XLRP [over 80%, as estimated in 
(Sharon et al. 2003)], but have also been identified in patients previously 
characterised as simplex cases (Branham et al. 2012). Different studies have 
estimated that the percentage of patients with RP2 mutations in XLRP cohorts ranges 
from 7 to 18%, while RPGR mutations have been identified in 70-90% of the cases 
(Sharon et al. 2003, Pelletier et al. 2007, Jayasundera et al. 2010). A hypomorphic 
intronic variant in OFD1, the causative gene for severe syndromes such as Joubert 
and orofaciodigital syndrome-1, which is male lethal, has been identified in one 
XLRP family (locus RP23); this report is an example of how reduced expression of a 
syndromic ciliopathy gene can lead to RP (Webb et al. 2012).  
The present thesis focuses on the molecular mechanisms that result in disease in 
response to RP2 mutations. More than 70 pathogenic mutations in RP2 have been 
identified to date (Retinal information network, RetNet). These include variable 
changes like premature stop codons leading to truncated proteins, splice site changes, 
small in-frame deletions and missense mutations. According to an estimation based 
on a French cohort of 127 families, the majority of identified RP2 mutations were 
expected to result in null alleles or highly truncated proteins (Pelletier et al. 2007). 
Nonetheless, even mutations that are not initially predicted to be deleterious, like 
small in-frame deletions, have been proved to severely affect protein expression 
when assessed from a structural point of view. For example, a recent in vitro and in 
silico study of the expression levels of different mutated forms of RP2 found that 
more than half of the missense mutations or small in-frame deletions lead to 
misfolded or destabilised proteins (Liu et al. 2017a). On the other hand, there is a 
smaller subset of missense mutations that are not predicted to affect the folding of 
the protein and are expressed at wild-type levels. These mainly affect solvent-
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exposed residues which are very likely mediators of protein-protein interactions: 
E138, R211, R118, T87 (Liu et al. 2017a). Non-destabilising missense mutations are 
very informative from a research point of view and will be discussed in more depth 
in Chapter 3. Finally, another category of non-destabilising missense RP2 mutations, 
affecting residues of the extreme N-terminal, are known to impair protein targeting 
to the plasma membrane (Chapple et al. 2000). Overall, these are the main effects of 
pathogenic mutations on RP2 protein which are known so far: 1) Nonsense mutations 
early in the gene lead to mRNA degradation by nonsense-mediated decay (NMD) 
[e.g., The R120* mutation (Mears et al. 1999, Schwarz et al. 2015)] 2) Destabilising 
mutations result in protein misfolding and degradation through the proteasome 
pathway [e.g., C67Y (Breuer et al. 2002), pLys323fs (Neidhardt et al. 2008)] 3) Non-
destabilising missense mutations affect protein-protein interactions or catalytic 
functions [e.g., E138G (Miano et al. 2001), R211L (Villaverde-Montero et al. 2007), 
R118H (Breuer et al. 2002)] 4) Mutations of the extreme N-terminus lead to loss of 
membrane association [e.g., ΔS6, G2A, C3S (Jayasundera et al. 2010)].  
RP2 mutations generally lead to a distinct and recognisable phenotype characterised 
by early manifestations of cone degeneration in the form of macular atrophy and 
declining visual acuity. In one study (Jayasundera et al. 2010), the majority of male 
patients had early-onset (before 12 years of age) of macular atrophy and low visual 
acuity combined with high myopia. This characteristic is in contrast with typical 
forms of RP, where cone degeneration is only secondary to rod degeneration and, 
therefore, the macula is spared until very late in the disease course. Macular atrophy 
was not associated with a particular type of mutation but rather manifested in 
patients with different kinds of RP2 changes [deletion leading to protein instability, 
frameshift, splice site change and missense mutation (R118C)]. ERG data confirmed 
the conclusion of cone degeneration in the early stages. Despite the unusually early 
involvement of cone degeneration, it should be noted that RP2 disease is still labelled 
as a rod-cone degeneration because rods are affected first in most patients (only one 
case was described with clear cone-rod dysfunction). Interestingly, another study 
(Dandekar et al. 2004) has also associated a small deleterious deletion with an 
atypical phenotype of macular and peripapillary retinal atrophy.  
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Other atypical phenotypes have been reported, adding to the complexity of RP2 
disease. These mainly include RPE and choroid involvement in the form of RPE and 
choroidal atrophy and depigmentation reminiscent of typical choroideremia 
(Jayasundera et al. 2010). Mutations associated with a choroideremia-like phenotype 
fall in the N-terminal β-helix domain and include both deleterious mutations (e.g. 
R120*, W150* nonsense mutations) and missense mutations (e.g. R118C).  
In general, it has been reported that RP2 mutations lead to one of the most severe 
forms of RP. Apart from the early onset of macular atrophy, all patients under 16 
presented with severe constriction of visual fields (Jayasundera et al. 2010). In 
another study, patients with RP2 mutations had on average significantly lower visual 
acuity than patients with RPGR mutations for the same age and across all ages 
(Sharon et al. 2003).  
Predictable genotype-phenotype correlations are not possible when studying RP type 
2, because even RP2 mutations that are not predicted to be deleterious sometimes 
lead to severe phenotypes. In general, most mutations are thought to lead to severe 
phenotypes such as declining visual acuity from an early age (a sign of macular 
dysfunction) (Jayasundera et al. 2010). This category includes all premature 
truncations as well as some missense mutations that are predicted to be non-
destabilising (Liu et al. 2017a) such as R118H and R211H. Only three mutations 
have so far been associated with a less severe phenotype, characterised by relatively 
older age at onset of macular dysfunction: C3S, S6del and T87I (Jayasundera et al. 
2010). C3S and ΔS6 affect the protein’s localisation to the plasma membrane, while 
T87I is a missense mutation which is not predicted to destabilise the protein structure 
and is thought to affect yet unknown protein-protein interactions of RP2 (Liu et al. 
2017a).  
Overall, mutations in the RP2 gene result in severe retinal disease whose spectrum 
reaches beyond typical RP and involves both rod and cone degeneration.  
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1.3 Functional significance of RP2 in the retina 
1.3.1 The RP2 protein 
The RP2 gene, which was first identified as an XLRP gene in 1998 by linkage 
analysis (Schwahn et al. 1998), encodes for a protein product of 350 residues. At the 
RNA level, RP2 expression was detected at several human fetal and mouse tissues 
including the brain, the kidney and the liver (Schwahn et al. 1998). At the human 
retina, RP2 was detected at the intracellular face of the plasma membrane of both rod 
and cone photoreceptors, the RPE and other cell types (Grayson et al. 2002). 
Numerous other studies in cultured cells and mouse models have also reported pools 
of RP2 in the Golgi apparatus, the primary cilium axoneme (where it is transported 
via an Importin β2-mediated mechanism) and the basal body of the photoreceptor’s 
CC (Evans et al. 2010, Hurd et al. 2010, Hurd, Fan and Margolis 2011). The N-
terminus of RP2 undergoes lipid modifications in the form of myristoylation of G2 
and palmitoylation of C3 which are necessary for plasma membrane localisation and 
cilia targeting and are pathologically relevant (Chapple et al. 2000, Chapple et al. 
2002). 
Crystallography revealed that RP2 consists of two domains that appear not only 
structurally but also functionally distinct (Kuhnel et al. 2006) (Figure 1.1 D). The N-
terminal domain (residues 1-228) consists of a β-helix with a tightly packed and 
mainly hydrophobic domain. This part of the protein is homologous (~30% sequence 
identity) to Tubulin Cofactor C (TBCC), a chaperone in the α/β tubulin heterodimer 
assembly. TBCC has GTPase activating protein (GAP) activity towards β tubulin, 
stimulating GTP hydrolysis which causes the release of native tubulin heterodimers 
from the cofactor complex (Tian et al. 1997). Despite the fact that critical residues of 
the TBCC catalytic core, such as the catalytic arginine finger R118 and E138, are 
conserved on RP2, it was shown early that RP2 cannot substitute for TBCC in 
tubulin folding reactions in vitro (Bartolini et al. 2002). While both RP2 and TBCC 
can partially complement for the loss of their distant yeast holomog CIN2 in 
restoring hypersensitivity to microtubule poisons (Bartolini et al. 2002), it is believed 
today that RP2 and TBCC have developed distinct functions in mammals. In 
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particular, it is now established that the small GTPase Arf-like 3 (ARL3) is a 
substrate for the GAP activity of RP2. This interaction is highly specific and very 
efficient: RP2 accelerates the intrinsic GTP hydrolysis rate of ARL3 more than 1000 
fold, while it only shows a minor activity towards the closely related ARL2 GTPase 
(Veltel et al. 2008). The RP2-ARL3 interaction has been the subject of intense 
research, and its function will be analysed in the next section in further detail.  
On the other hand, the C-terminal domain of RP2 (residues 229-350) has a 
ferredoxin-like fold. It has been described as a three-layered α/β sandwich with an 
antiparallel β sheet (Kuhnel et al. 2006). This domain is characterised by sequence 
similarity with Nucleoside diphosphate kinases (~22% identity with the D. 
discoideum NDK). However, because there is no evidence of ADP binding on RP2 
and the overall protein structure does not support an NDK-like phosphotransferase 
activity, it is unlikely that RP2 shares NDK’s canonical function (Kuhnel et al. 
2006). This RP2 domain is not necessary for GTP hydrolysis (Veltel et al. 2008), and 
its function has been so far understudied. Only one study has looked 
comprehensively at this domain, showing that it participates in exonuclease activity 
against single-stranded DNA in vitro (Yoon et al. 2006). One of the aims of the 
present thesis is to investigate a novel potential role for the C-terminal domain of 
RP2 (Chapter 3).  
 
1.3.2 Suggested roles of the RP2-ARL3 complex in protein trafficking 
within the photoreceptors 
The small GTPase ARL3 belongs to the ADP ribosylation factor (ARF) family of the 
Ras superfamily of small GTPases, which includes ARF, ARL and SAR1 proteins. 
Members of the ARF family participate in membrane traffic and organelle structure 
(Donaldson and Jackson 2011). Members of the ARL subfamily, in particular, are 
known to be important for transport of ciliary proteins and cilia maintenance and are 
associated with human ciliopathies, like Bardet-Biedl syndrome (ARL6) (Chiang et 
al. 2004) and Joubert’s syndrome (ARL13B) (Cantagrel et al. 2008). ARL3 itself is 
considered a microtubule-associated protein (MAP) and linked to several 
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microtubule-related processes such as unloading of cargo from dynein motors (Jin et 
al. 2014), cell morphology and cytokinesis (Zhou et al. 2006), and flagellum 
biogenesis (Cuvillier et al. 2000). Mouse models of absent or aberrant ARL3 
function have established a role of this small GTPase in ciliary processes. For 
example, an Arl3 knockout mouse model suffers from abnormal development of 
renal, hepatic and pancreatic epithelial tube structures reminiscent of human 
polycystic kidney disease (PKD), alongside severe retinal degeneration post-natally 
characterised by abnormal OS discs (Schrick et al. 2006). The combination of these 
defects is reminiscent of human ciliopathies because mechanosensory primary cilia 
have a central role in regulating renal epithelial cells’ proliferation and 
differentiation, whereas retinal degeneration is often attributed to defective protein 
transport through the photoreceptor’s modified cilium.  
Most hypotheses about the function of the RP2-ARL3 complex revolve around 
protein trafficking within ciliated cells in general and more specifically through the 
CC to the photoreceptor OS (Figure 1.2). Some studies claim RP2 participates in 
global vesicle trafficking between the Golgi and the cilium and is essential for Golgi 
cohesion (Evans et al. 2010, Schwarz et al. 2015). Other studies have suggested that 
RP2 participates in the subcellular targeting of specific lipid-modified protein cargo. 
Structural approaches have uncovered an allosteric mechanism by which GTP-bound 
ARL3 displaces lipid-modified cargo from chaperones UNC119 and its homolog 
PDE6δ, which solubilise and assist the cargo mentioned above in its transport 
through the cytosol (Ismail et al. 2011, Ismail et al. 2012). UNC119 regulates the 
ciliary targeting of acylated proteins, while PDE6δ binds prenylated cargo; known 
cargoes of specific interest to phototransduction that need to be delivered to the OS 
through the CC are myristoylated Tα transducin subunit, and prenylated cGMP 
phosphodiesterase PDE6 and rhodopsin kinase GRK1 (Zhang et al. 2011, Zhang et 
al. 2012). The role of RP2 in this process would be to keep ARL3 in an inactive, 
GDP-bound state by stimulating GTP hydrolysis, and therefore to render it unable to 
displace cargo from UNC119 and PDE6δ. It is also possible that RP2 is more 
directly involved in trafficking of phototransduction proteins by interacting with the 
protein cargo. Specifically, RP2 has been found to interact with Gβ transducin and 
facilitate its trafficking to the membrane compartment (Schwarz et al. 2012). 
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Besides, RP2 interacts with ciliary kinesins KIF17 and KIF7 and regulates their 
trafficking to the ciliary tip of cultured immortalised RPE cells (Schwarz et al. 2017).  
The exact location in the cell where RP2 and ARL3 interact remains a mystery, 
although (Gotthardt et al. 2015) recently suggested an intriguing hypothesis by 
identifying ARL13B as having guanine exchange factor (GEF) activity towards 
ARL3, meaning it can exchange GDP for GTP and activate the protein. Because 
ARL13B is almost exclusively localised within the ciliary axoneme, this study 
suggested that ARL3 exists in an active state (which is capable of releasing lipid-
modified cargo) only within the ciliary axoneme, while it is inactive outside the 
cilium due to the action of RP2 on the basal body and other cellular locations (Figure 
1.2). However, this hypothesis is counteracted by other studies which have detected 
RP2 within the ciliary axoneme in cultured cells (Schwarz et al. 2017, Hurd et al. 
2010).    
 
1.3.3 Mouse models of RP type 2 
Genetically engineered mouse lines have been generated to test some of the 
hypotheses mentioned above in vivo. At first, a mouse model for the absence of Rp2 
expression was generated by exon 2 deletion and was found to suffer late-onset, 
slowly progressive photoreceptor degeneration which affected both types of 
photoreceptors with the effect on cones being more prominent (Li et al. 2013a). One 
of the most important phenotypes of these mice was mislocalisation of cone M-opsin 
from the OS, where it is normally localised, to the inner nuclear layer (INL) and 
synaptic layer. Interestingly, no mislocalisation of other cargoes that are proposed to 
undergo RP2-mediated transport, such as transducin subunits, was observed. Later 
studies have also reported reduced cone PDE6 expression (Mookherjee et al. 2015) 
and abnormal elongation of the axoneme and membrane of the cone CC (Li et al. 
2015).  
A second mouse model for the complete absence of Rp2 expression was later 
generated by a gene trap strategy. Contrary to the first study, the phenotype of these 
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mice corroborates the hypothesis that RP2 participates in the targeting of lipid-
modified proteins cone and rod PDE6 and GRK1, as these proteins are mislocalised 
from the OS to the synaptic region1 (Zhang et al. 2015). However, no mislocalisation 
of cone opsins or transducin subunits was observed in retinal sections from these 
mice. The differences between the two mouse models could be attributed to the 
different knockout strategies or could simply reflect the phenotypic variation which 
is characteristic of the disease and is often observed in human RP2 patients. On the 
other hand, the possibility that the mislocalisation phenotypes are secondary 
manifestations of a more fundamental defect that is yet unknown, must not be 
excluded. Finally, it is important to stress the common points of both studies, as both 
mouse models present with late-onset, slowly progressive retinal degeneration that 
affects the cone function more prominently.  
Apart from the genomic ARL3 null model (Schrick et al. 2006), other mouse models 
have been generated to analyse the function of ARL3 in the retina further. These 
have been genetically manipulated to model rod- specific and retina-specific lack of 
ARL3 expression (Hanke-Gogokhia et al. 2016), or to mimic accumulation of 
activated ARL3 (Wright et al. 2016). The conclusions drawn from these studies 
generally corroborate a role for the RP2-ARL3 complex in the trafficking of lipid-
modified phototransduction proteins in mammals; however, lack of ARL3 produces 
a more severe phenotype than lack of RP2. For example, the absence of ARL3 
expression leads to developmental phenotypes (like improper basal body formation) 
and mistrafficking of transducin subunits, which is not observed in the Rp2 null 
mouse models. This discrepancy means that the complete lack of ARL3 does not 
cause the same effects as the accumulation of the active form, which occurs in the 
absence of the GAP (RP2). Also, it might mean that there is another GAP protein for 
ARL3 in addition to RP2.  
                                               
1 It is important to note that contrary to the earlier study, Zhang et al (2015) report 
mislocalisation of PDE6 rather than reduced expression, as was confirmed by 
western blotting of whole retinal lysates. However, this technique could potentially 
mask a cone-specific reduction in PDE6 expression. 
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1.3.4 Alternative roles of RP2 
Although the function of RP2 in the photoreceptor CC is often almost exclusively 
focused upon, alternative roles have been proposed for RP2 and ARL3 in different 
tissues and different cellular contexts. For example, RP2 expression has been 
detected in the ciliary axoneme and other cellular locations in mouse kidney tubules, 
where it is proposed to regulate retrograde transport of the ciliary PKD protein, 
polycystin 2 (PC2) (Hurd et al. 2010). In addition, several studies using zebrafish 
embryos have reported a role of rp2 in early vertebrate development, not only 
because it is a maternally provided transcript which is present throughout early 
embryo development, but also because knockdown leads to developmental 
malformations (curved tail, microphthalmia (small eyes), and laterality defects-situs 
inversus) (Hurd et al. 2010, Shu et al. 2011, Desvignes et al. 2015). The role of 
protein Rp2 in zebrafish will be discussed in a detailed fashion in Chapter 5.  
Finally, roles for RP2 in the nucleus, such as in DNA processing and the regulation 
of transcription, have emerged. The authors of an earlier study (Yoon et al. 2006) 
have biochemically characterised RP2 as a DNA-binding protein with 3’-5’ 
exonuclease activity against single-stranded DNA. Furthermore, a recent study has 
implicated ARL3 in STAT (signal transducer and activator of transcription) 
signalling. ARL3-GTP is a direct interaction partner of STAT3 transcription factor 
and is involved in its activation by tyrosine phosphorylation and nuclear 
translocation which allows the regulation of gene expression (Togi et al. 2016). The 
presumed role of RP2 in this pathway would be to shut down STAT3 activation by 
ARL3-GTP through GTP hydrolysis. Interestingly, a recent study has established 
STAT3 as a cell-autonomous neuroprotective factor in mouse models of retinal 





Figure 1.2. A schematic summary of the suggested roles of RP2 and ARL3 in the 
cell (numbers 1-4) and their localisation. 
While many of the suggested roles of RP2 and ARL3 have been based on studies 
using cultured cells forming primary cilia, they are likely applicable to the 
photoreceptors as well. Pools of RP2 have been detected at the periciliary ridge and 
the basal body of the primary and the connecting cilium (CC), the Golgi complex 
(Evans et al. 2010) and the plasma membrane (Grayson et al. 2002) (anchored thanks 
to dual lipid modification) of vertebrate photoreceptors and other cell types. In 
cultured cells, RP2 has also been detected in the nucleus (Yoon et al. 2006) and the 
axoneme of the primary cilium (Hurd et al. 2010, Schwarz et al. 2017). RP2 interacts 
with Importin-β2 which assists trafficking to the cilium (Hurd et al. 2011) and 
potentially to the nucleus as well. 1) ARL3-GTP displaces lipid-modified cargo 
(such as prenylated GRK1, PDE6, or acylated Tα) from retinal chaperones UNC119 
and PDE6δ within the ciliary axoneme. RP2 activity at the basal body and possibly 
other cellular locations prevents ARL3 from acting as a displacement factor in the 
wrong locations (Zhang et al. 2015, Gotthardt et al. 2015). 2) RP2 interacts with the 
molecular motor KIF17 (and KIF7, not shown in this figure) and regulates its 
localisation to the ciliary tip (Schwarz et al. 2017). RP2 and KIF17 have both been 
found at the basal body of photoreceptors, but the exact location of the interaction is 
not established yet. 3) RP2 is localised to the Golgi and is essential for Golgi 
cohesion as well as Golgi-to-cilium vesicle transport of proteins such as IFT20 
(Evans et al. 2010). 4) ARL3-GTP directly interacts with transcription factor STAT3 
and regulates its activation and nuclear translocation (Togi et al. 2016). The exact 
location of the interaction is not known.  
 
 
1.4 Questions and aims of the thesis 
The function of RP2 in protein transport pathways to and within the ciliary apparatus 
is established and well characterised, although the discrepancies among animal 
studies regarding the identity of the transported cargo mean that the relationship 
between protein mislocalisation and disease is still obscure. Similarly, the 
importance of the RP2-ARL3 complex in RP is well established, not only because 
pathogenic RP2 mutations exist which specifically destabilise the interaction 
(Kuhnel et al. 2006) but also since ARL3 itself has been identified as a retinal 
degeneration gene (Strom et al. 2016). 
On the contrary, much fewer studies have focused on other roles that RP2 might 
have outside the cilium. For example, RP2 displays a uniform plasma membrane 
localisation and has been reported to localise to the nucleus, but its role in these 
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compartments is not clear. Moreover, it is not known if the RP2-ARL3 interaction is 
exclusively relevant for the disease, or if other RP2 interactions also play a role. A 
whole domain on RP2 protein (the C-terminal domain) is still devoid of functional 
significance, although studies have often speculated that it forms the interface for 
unknown protein-protein interactions (Liu et al. 2017a). Lastly, modes of RP2 
regulation, such as post-translational modifications, have not yet been investigated, 
except for the well-known lipid modifications of the N-terminus. Answering these 
questions will undoubtedly contribute to the development of a safe and efficient 
therapeutic option for patients with RP type 2. Another hallmark that would 
potentially contribute to the development of a –pharmacological- treatment option 
would be the generation of a whole-organism platform that can be used for screening 
chemical compounds to identify modifiers of phenotypes caused by the lack of RP2.  
My PhD had two main aims.  
1. To identify novel functions and modes of regulation for RP2 via the 
characterisation of novel protein-protein interactions. In Chapters 3 and 4 of the 
present thesis, I describe the work conducted in order to achieve this aim. 
Chapter 3 refers to the characterisation of the novel interaction between RP2 and 
Osteoclast stimulating factor 1 (OSTF1), via mapping the interaction interface 
on the surface of RP2 and investigating the potential function of the complex in 
regulating tyrosine phosphorylation of RP2 and cell motility. Chapter 4 refers to 
the proteomic analysis of RP2 complexes in cultured cells and the verification of 
the DNA-dependent protein kinase (DNA PKcs) as a novel RP2 interaction 
partner. The interaction is then characterised by examining co-localisation in 
cultured cells, its potential effect on serine/threonine phosphorylation of RP2 
and the involvement of RP2 in the cell’s response to DNA double-stranded 
breaks. 
2. To generate a genomic rp2 null zebrafish (Danio rerio) model and examine if 
it presents with a retinal degeneration phenotype. The use of CRISPR 
(Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 for 
genome editing in zebrafish and the examination of retinal lamination in adult 
fish is described in Chapter 5. 
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Chapter 2: Materials and methods 
2.1 DNA methods 
2.1.1 Agarose gel electrophoresis 
Nucleic acids were separated according to molecular weight by agarose gel 
electrophoresis. The gel was made by dissolving agarose (Ultrapure agarose, 
Invitrogen) in the appropriate buffer: 1% agarose in Tris-acetate-EDTA (TAE) buffer 
(40 mM Tris base, 20 mM acetic acid, 1 mM EDTA) was used for standard 
applications, while 2-3% agarose in Tris-borate-EDTA (TBE) buffer (89 mM Tris-
base, 89 mM boric acid, 2 mM EDTA) was used for the separation of small DNA 
fragments (<100 bp). Agarose was fully dissolved in the buffer by heating in a 
microwave oven and then left to set in a cast with combs for the formation of wells, 
after mixing with 10% v/v SYBR Safe DNA gel stain for the visualization of DNA 
(ThermoFisher Scientific). DNA samples were mixed with blue gel loading dye 
(New England Biolabs), and loaded in the wells of the agarose gel. DNA ladders 
were loaded on the gel alongside DNA samples (according to the expected molecular 
weight of the DNA fragments, 1 kb, 100 bp or low molecular weight DNA ladders 
were used, from New England Biolabs). Voltage of 90-100 V was applied to 
mobilise the nucleic acids towards the positive electrode in an electrophoresis gel 
tank. Separated nucleic acids fragments were visualized and pictures were taken 
using a UV transilluminator (Biorad).  
 
2.1.2 PCR 
DNA amplification was conducted by polymerase chain reaction (PCR) using the 
Phusion High Fidelity PCR Mastermix (New England Biolabs). The reaction mix 
contained Phusion DNA Polymerase, deoxynucleotides and reaction buffer including 
MgCl2 (all included in the Phusion Mastermix), 0.5 µM primers and DNA template 
(whose quantity varied according to the application), in a 20-50 µl total reaction 
volume. PCR reactions were carried out in a BioRad C1000 Touch thermal cycler. A 
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typical protocol is the following, although parameters like the annealing temperature 
and extension time were often changed to serve the specific application:  
 
• Initial denaturation 3 minutes 98 oC 
• Denaturation 10 seconds 98 oC 
• Annealing 15 seconds 65 oC 
• Extension 10 seconds 72 oC 
• Final extension 5 minutes 72 oC 
• Hold 4 oC 
 
2.1.3 Plasmid isolation from bacterial cultures 
Isolation of plasmids from bacterial cultures was conducted using the mini-preps (for 
low-yield extraction) and midi-preps (for higher-yield extraction of plasmid to use in 
cell culture transfections) kits from Qiagen, following the manufacturer’s 
instructions. Briefly, the outline of the procedure was the following: bacterial cells 
were lysed and the lysates were cleared by centrifugation. The lysates were loaded 
onto anion-exchange resin columns, where plasmid DNA selectively binds under 
appropriate low-salt and pH conditions. The next step involved washes with a 
medium-salt buffer to remove impurities (RNA, proteins etc). Finally, plasmid DNA 
was eluted from the columns with a high-salt buffer. During midi-preps, plasmid 
DNA was further concentrated and de-salted by isopropanol precipitation and 
washed in 70% ethanol. The DNA pellet was resuspended in TE buffer (10 mM Tris-
HCl, 1 mM EDTA •Na2) or DNase/RNase-free water and kept at 4oC for immediate 
use or -20oC for long term storage.  
X 30 
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2.1.4 Genomic DNA isolation from zebrafish embryos and adult fish 
Genomic DNA was isolated from pooled embryos or adult fish fin clips using the 
DNA Releasy reagent (Nippon Genetics). Fin clips or 10-20 embryos were placed in 
micro-tubes and covered with 10-20 µl of DNA Releasy. The tubes were placed in a 
thermal cycler and the following protocol was applied: 20 minutes at 65oC, 2 minutes 
at 96oC, 4 minutes at 65oC, 1 minute at 96oC, 1 minute at 65oC, 30 seconds at 96oC, 
20oC hold. The supernatant contained the genomic DNA, which was kept at -20oC 
until use.  
 
2.1.5 DNA sequencing 
Sanger sequencing was conducted by the Institute of Genetics and Molecular 
Medicine (IGMM) core technical services using a 3730 genetic analyser (Applied 
Biosystems). Primers used for sequencing were either provided by the technical 
services (generic primers like T7 or M13) or designed and provided by me (listed in 
Table 2.1). Chromatograms were then analysed using SnapGene Viewer software 
(version 3.2.1, GSL Biotech).  
 
2.1.6 Site-directional mutagenesis  
Point mutations were introduced in the human RP2 coding sequence using 
QuikChange II Site-Directed Mutagenesis kit following the manufacturer’s 
instructions. Briefly, pENTR/D-TOPO entry vector (Invitrogen) containing the wild-
type human RP2 coding sequence was used as a template in PCR reaction using the 
high-fidelity PfuUltra DNA polymerase and primers specific for each mutation 
(primer sequences are found in Table 2.2). After the amplification reaction, the 
template containing WT RP2 was digested by Dpn I endonuclease which only 
cleaves methylated and hemi-methylated DNA. Finally, the mutated plasmids were 
transformed into competent DH5a competent E. coli cells by heat shock at 42oC and 
isolated using the Qiagen midi-preps plasmid isolation kit after propagation by the 
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bacteria. The existence of the correct insert was confirmed by Sanger sequencing.  
To achieve expression of the constructs in mammalian cells, RP2 coding sequences 
were transferred into the destination vector pCDNA-DEST40 (Invitrogen), which 
added a C-terminal V5 tag to the construct, by recombination reaction using LR 
Clonase II (part of the Invitrogen Gateway cloning system).  
 
2.1.7 Insertion of constructs into expression vectors by recombination 
Recombination was used to flip mutated RP2 coding sequences from pENTR/D-
TOPO (Invitrogen) into mammalian expression vector pCDNA-DEST40-V5 
(Invitrogen) and WT RP2 sequence from pENTR/D-TOPO into bacterial expression 
vector pGEX6P1-Dest-HIS (a gift from Dr Martin Reijns). 70 ng of expression 
vector were mixed with equal amount of the insert-containing entry vector and LR 
Clonase II (mix of proteins to catalyse recombination, isolated from λ bacteriophage 
and E.coli, from the Invitrogen Gateway system) in TE buffer (0.5 mM EDTA, 0.3 
M NaCl, 50 mM Tris pH 7.5). After incubation for 1 hour at room temperature, 
Proteinase K (Invitrogen Gateway system) was added to digest the recombinases via 
incubation for 10 minutes at 37oC. The flip reaction was used to transform DH5a 
competent E. coli cells by heat shock at 42oC. The new plasmids were isolated using 
the Qiagen midi-preps plasmid isolation kit after being propagated by the bacteria. 
Plasmids were kept in TE buffer or purified water at -20oC for long term storage or 
4oC for short-term storage and regular use.  
 
2.1.8 Other cloning strategies 
Cloning guide RNA sequences into guide RNA expression vector 
For the CRISPR/Cas9 strategy to target zebrafish rp2 (Chapter 5), guide RNA 
(gRNA) sequences needed to be in vitro transcribed from a gRNA expression vector. 
Specific gRNA expression vectors were built by cloning a pair of annealed 
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oligonucleotides (each 26 nucleotides in length and specifically designed for ligation 
with sticky ends created by BsaI digestion) into a pDR274 vector (Addgene) that has 
been digested by BsaI endonuclease (New England Biolabs). Oligonucleotides 
corresponding to the 3 different gRNA sequences were ordered from Sigma-Aldrich 
(sequences can be found in Table 2.1). 100 µM of top and bottom strand 
oligonucleotides were annealed together by heating at 95oC for 5 minutes in the 
appropriate annealing buffer (0.01 M Tris-HCl pH 7.5, 0.05 M NaCl, 1mM EDTA) 
and then slowly cooling down to room temperature. The vector was digested by BsaI 
in CutSmart buffer (New England Biolabs) for 1 hour at 37oC. After digestion, BsaI 
needed to be heat inactivated for 30 minutes at 65oC, in order to be released from the 
DNA. After dephosphorylation by Antarctic phosphatase (New England Biolabs) for 
15 minutes at 37oC to prevent the vector from self-annealing, the linearized vector 
was purified using the Qiagen PCR column purification kit. 10 nM of annealed 
oligonucleotides were annealed with ~50 ng of linearized and purified pDR274 
vector by incubating with 1 µl of Quick ligase (New England Biolabs) for 15 minutes 
at room temperature. DH5a competent E. coli cells were transformed with the 
ligation mix by heat shock at 42oC. The presence of the correct insert was tested in 
plasmid DNA isolated from individual transformed colonies by Sanger sequencing 
using the M13 forward primer. Chosen colonies containing the correct insert were 
then propagated further, and high- quality plasmid DNA was isolated from them 
using the midi-preps plasmid isolation kit from Qiagen. These plasmids were further 
used as templates for the in vitro transcription of the gRNA sequences using a T7 
promoter.  
Cloning PCR products in pGEM-T to identify individual mutations in chimaeric 
animals 
Founder fish, the animals that have been injected with CRISPR/Cas9 component 
RNAs targeting the rp2 gene, are expected to be chimeric, i.e. different populations 
of cells will have different mutations or no mutations at all. To identify individual 
mutations by Sanger sequencing, the targeting site on the rp2 gene was amplified 
from founder fish genomic DNA using Phusion High fidelity polymerase-based PCR 
(New England Biolabs). The PCR product was purified using the Qiagen PCR 
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column purification kit and poly(A) tailed by incubating with GoTaq Flexi 
polymerase (Promega) and dATP nucleotides for 30 minutes at 72oC. The addition of 
3’A tail fragments to the PCR products aids ligation of one only insert into the vector 
compared to blunt-ended PCR products which can lead to multiple insertions. 
Subsequently, the PCR product was ligated into pGEM-T vector (Promega), via 
incubation with a T4 DNA ligase overnight at 4oC. The ligation reaction was used to 
transform OneShot TOP10 chemically competent E. coli cells (Invitrogen) by heat 
shock at 42oC. This strain of cells allows for blue/white screening of recombinant 
clones because of the lacz deletion mutant (laczΔΜ15) gene, by α- complementation 
assay. For this reason, 40 µg X-gal were plated on the agar plates before plating the 
transformed cells. Plasmid DNA was isolated from individual white colonies (=have 
internalised pGEM-T vector containing the insert of interest) and used as a template 
for Sanger sequencing using the T7 primer.  
 
2.2 RNA methods 
2.2.1 Isolation of total RNA from human cells  
Total RNA was isolated from hTERT-RPE1 cells grown to confluency in 6-well 
plates, using the RNeasy Plus Mini kit (Qiagen). This kit preferentially isolates RNA 
molecules longer than 200 nucleotides, so the resulting sample is enriched in mRNA 
compared to smaller RNA species. To prepare the cell lysate, cells were harvested 
from their plate using trypsin. Cell pellet was lysed in RLT buffer with the addition 
of 40 mM DTT and applied through a Qiashredder column, which reduces viscosity 
and removes insoluble material (Qiagen), to homogenise. After centrifugation for 2 
minutes at 13000 rpm, the flow through was applied on a gDNA eliminator column 
to remove genomic DNA, and centrifuged for 30 seconds at 10000 rpm. The lysate 
was then used for RNA isolation according to manufacturer’s instructions. Briefly, it 
was mixed with equal volume of ACS-grade 70% ethanol to ensure appropriate 
binding conditions and applied on an RNeasy column where RNA molecules are 
selectively bound on silica-based membranes. After a series of washes to remove 
contaminants, RNA was eluted in RNase-free water in an RNase-free tube. After 
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concentration and purity of the generated RNA was estimated, it was aliquoted and 
stored at 80oC, until use. Freeze-thaw cycles were avoided as they could compromise 
the integrity of the RNA.  
 
2.2.2 Isolation of total RNA from zebrafish embryos 
Total RNA was isolated from 30-40 embryos that were 3 days (post-fertilisation) old, 
using the RNeasy Plus Mini kit (Qiagen). To prepare the tissue lysate, embryos were 
released from the chorion manually, anaesthetised in Tricaine and then washed in 
distilled water. All liquid was removed. Subsequently, embryos were lysed in RLT 
buffer (Qiagen) with the addition of 40 mM DTT and the tissues were disrupted 
using pestle and mixer. The lysate was then applied to a Qiashredder homogeniser 
column, which reduces viscosity and removes insoluble material (Qiagen), and 
centrifuged for 2 minutes at 13000 rpm. To remove genomic DNA, the flow-through 
was applied to a gDNA eliminator column (Qiagen) and centrifuged for 30 seconds 
at 10000 rpm. The lysate was then mixed with 70% ethanol and RNA isolation 
proceeded as described above.  
 
2.2.3 Quantification of nucleic acid concentration and estimation of 
quality 
The yield and purity of nucleic acids were estimated by measuring optical density at 
260 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies). 
260/280 and 260/230 absorbance ratios indicate the presence of contaminants and 
were used to assess the purity level of nucleic acids.  
 
2.2.4 cDNA synthesis 
Total RNA isolated from RPE1 cells or zebrafish embryos was used as template to 
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synthesise cDNA using the Superscript First-strand synthesis system for RT-PCR 
(Invitrogen). At first, ~0.8-1 µg total RNA was annealed with oligo-dT primers. The 
mix was incubated with the reverse transcriptase, 5 mM MgCl2, 10 mM DTT and 40 
units RNase OUT (Invitrogen) for 50 minutes at 42oC followed by 15 minutes at 
70oC to terminate the reaction. The mix was finally incubated with RNase H for 20 
minutes at 37oC, to digest the RNA template. Negative controls were processed 
alongside the samples: a control without any reverse transcriptase and one without 
any RNA template. cDNA was stored at -20oC for future use or used in downstream 
applications (RT-qPCR).  
 
2.2.5 Reverse transcription quantitative real-time PCR (RT-qPCR) 
Primers specific to zebrafish rp2 and to zebrafish actb (β-actin, reference gene) were 
designed so that assays were intron-spanning, to identify any amplification resulting 
from genomic DNA contamination in the samples. Primer sequences are found in 
Table 2.3. 1 µl of cDNA was used in a 20- µl reaction containing 0.2 µM primer mix 
and 10 µl SYBR Select Green Mastermix (ThermoFisher Scientific) in 
RNase/DNase- free water. SYBR Select mastermix contains Green ER dye, a 
fluorescence dye that binds to all double-stranded DNA molecules generated during 
PCR reaction. Assays were conducted in 96-well plates with opaque walls and each 
reaction was run in triplicates. The negative controls generated during the cDNA 
synthesis reaction (without RNA/ without reverse transcriptase) were also ran in 
qPCR reactions alongside the samples, and served to identify any contamination 
resulting in unspecific amplification. All qPCR experiments were run on a 
LightCycler 480 Instrument II (Roche) using the replicate methodology below for 





• Denaturation 2 minutes 95 oC 
• Denaturation 15 seconds 95 oC 
• Annealing/extension 15 seconds 56 oC 
• Extension 15 seconds 72 oC 
Amplification data were analysed using the LightCycler software (Roche). Only 
high-quality runs were chosen for further analysis based on the absence of any 
significant amplification in the negative controls and the amount of variation 
between the three replicates which is an indication of pipetting errors. Ct values (the 
number of cycles required to reach threshold fluorescence value upon amplification) 
were used to approximate the abundance of specific mRNA molecules in the samples 
and were normalized to the Ct values corresponding to the reference gene for the 
same cDNA template. Wild-type values were set arbitrarily to one and fold-change 
was calculated for the mutant samples based on the assumption that transcripts are 
doubled after each cycle. Melting curve analysis and agarose electrophoresis 
confirmed that the reactions produced single amplification products.  
 
2.2.6 In vitro transcription  
In vitro transcription of guide RNAs 
gRNA sequences were first amplified from the gRNA expression vector in a PCR 
reaction using Phusion high fidelity DNA polymerase (New England Biolabs), mix 
of forward and reverse primers whose sequences are found in Table 2.1, and the 
gRNA expression vector as template. [60 annealing temp, 10 sec extension, x30 
repeats] After a fraction of the PCR product was tested by electrophoresis on 3% 
agarose in TBE buffer gel, it was purified using the PCR column purification kit 
(Qiagen) and eluted in DNase/RNase-free water.  
~1 µg of the PCR product was used as a template for in vitro transcription using the 
45X 
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Ambion MAXIscript T7 kit (Thermo Fisher Scientific). T7 phage RNA polymerase 
is used to catalyse the transcription step, which was conducted at room temperature 
for two hours. Subsequently, incubation with Turbo DNase at 37oC for 15 minutes 
served to digest the template DNA. The gRNAs were then purified using the 
SigmaSpin sequencing reaction cleanup kit (Sigma Aldrich). They were aliquoted 
and kept in RNase-free micro-tubes, at -80oC, until use.  
In vitro transcription of nCas9 mRNA 
For the CRISPR/Cas9 experiment targeting zebrafish rp2, Cas9 mRNA was 
synthesized from the pCS2-nCas9n vector (Addgene), which contains the coding 
sequence for a codon-optimised version of Cas9 nuclease that is more appropriate for 
genome editing in zebrafish (Jao, Wente and Chen 2013) and an SP6 promoter for in 
vitro transcription. First, the vector needed to be linearised in order to be used as 
template for the transcription reaction. Restriction digestion was conducted using the 
NotI-HF endonuclease (New England Biolabs), for 1.5 hours at 37oC in CutSmart 
buffer, followed by purification of the linear vector using the PCR column 
purification kit (Qiagen). The linearized vector (~370 ng) was used as a template to 
synthesize the nCas9 mRNA using the SP6 mMESSAGE mMACHINE kit (Thermo 
Fisher Scientific), following manufacturer’s instructions. This method serves to 
produce mRNA molecules that mimic most eukaryotic mRNAs in vivo thanks to the 
presence of a 7-methyl guanosine cap structure at the 5’ end. After the transcription 
reaction and addition of the cap analog, the mRNA was purified using the RNAeasy 
kit (Qiagen), following the manufacturer’s “RNA cleanup” protocol. Subsequently, 
E-PAP enzyme (E. coli Poly(A) polymerase) from the T7 mMESSAGE 
mMACHINE Ultra kit (Thermo Fisher Scientific) was used to add a poly(A) tail to 
the mRNA molecules. After poly(A) tailing, the mRNA molecules were purified 
again as above using the RNAeasy kit (Qiagen) and eluted in RNase-free water. To 
test the poly(A) tailing reaction efficiency, fractions of the mRNA product pre-tailing 
and post-tailing were analysed by DNA electrophoresis in 1% agarose in TAE buffer 
gel (the poly(A)-tailed mRNA runs as a smear rather than one distinct band). Both 
the 5’ cap analog and the poly(A) tail served to enhance stability of the mRNA 
molecules in the zebrafish zygote and boost translation efficiency, as they favour 
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correct initiation of protein synthesis. Synthesised nCas9 mRNA was aliquoted and 
stored in RNase-free micro-tubes at -80oC. 
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Table 2.1. List of primers and oligonucleotides used for the generation of an rp2 
null zebrafish model by CRISPR/Cas9 (Chapter 5). 
 The sequence of all primers and oligonucleotides used for PCR-based applications 
or cloning purposes are listed here, together with their specific application and the 
company that they were ordered from. 
NAME APPLICATION SEQUENCE (5’-3’) COMPANY 






































































Table 2.2. List of primers used in the RP2 site-directed mutagenesis experiments 
(Chapters 3 and 4).  
The sequence of all primers used for the PCR-based generation of RP2 constructs 
with missense mutations are listed here, together with their specific application and 
the company that they were ordered from.   























































































































































































Table 2.3. List of primers used in real-time qPCR experiments (Chapters 3 and 
5).  
The sequence of all primers used in real-time qPCR are listed here, together with 
their specific application and the company of origin.   
NAME APPLICATION SEQUENCE (5’-3’) COMPANY 










RT QPCR 3F Zebrafish rp2 




RT QPCR 3R Zebrafish rp2 
primers exons 4-5 
TGGCAAAGGATCGACACG IDT 
RT QPCR 1F Zebrafish rp2 




RT QPCR 1R Zebrafish rp2 




zebRP2qpcrF Zebrafish rp2 




zebRP2qpcrR Zebrafish rp2 




hRP2qpcrF Human RP2 primers  GCAAATGCCAGAAAACTA
ATTGATG 
IDT 







2.3 Protein and Proteomics methods 
2.3.1 Protein isolation from human cells, zebrafish and mouse tissues 
Cell pellets, fresh or snap frozen tissues or zebrafish embryos were lysed for 20 
minutes in appropriate volumes of a lysis buffer on ice (see Table 2.4 for the 
compositions). 1 mM PMSF, Protease and phosphatase inhibitor cocktails (Sigma-
Aldrich) were added to all lysis buffers just prior to use; tyrosine phosphatase 
inhibitor sodium orthovanadate (Na3VO4 1 mM, Alfa Aesar) was also added when 
examining tyrosine phosphorylation of RP2. Homogenisation using mixer and 
pestles was employed to aid lysis of tissues. Low-power sonication (3 times for 30 
seconds) was used when lysing zebrafish eyeballs. Subsequently, lysates were 
clarified by centrifugation at 13,000 rpm for 10 minutes at 4oC. The clarification step 
was repeated twice for mouse tissues. The supernatant was then moved to a new tube 
and was used immediately or transferred to -80oC for future use.  
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Table 2.4. List of buffers that were used for protein isolation.  
The composition of different lysis buffers used for total protein isolation from cells 
and tissues. Isolated proteins were then used in downstream applications such as 
pulldown assays, immunoprecipitations (IPs) and western blotting.  
LYSIS BUFFER COMPOSITION APPLICATIONS 
RIPA 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1% NP40, 
0.1% SDS, 0.5% sodium 
deoxycholate 
• Lysis of zebrafish 
eyeballs for western blot 
• Lysis of HEK293T cells 
for RP2-V5 IP designed 
to detect tyrosine or 
serine/threonine 
phosphorylation 
• Lysis of RPE1 cells to 
detect RP2 expression 
levels after X-ray 
treatment 
Triton lysis buffer 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1% Triton x100 
• Lysis of mouse brain 
tissues for western blot 
• Lysis of HEK293T and 
RPE1 cells for RP2-
V5/RP2-FLAG and 
DNA PKcs co-IPs 
• Lysis of HEK293T cells 
for RP2-V5 IPs for mass 
spectrometry 
• Lysis of HEK293T cells 




IP lysis buffer 25 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1% NP40, 
5% glycerol 
• Lysis of HEK293T cells 
for OSTF1/ARL3 Q71L 
–GST pulldowns 
Co-IP lysis buffer 50 mM Tris-HCl pH 7.5, 150mM 
NaCl, 0.1 mM EGTA, 2 mM 
MgCl2, 1% Triton X-100, 10% 
glycerol 
• Lysis of RPE1 cells for 
ARL3 Q71L-FLAG and 
RP2, DNA PKcs co-IPs 
 
2.3.2 Quantification of protein concentration 
Protein concentration of lysates was determined using the Biorad DC assay, as per 
manufacturers’ instructions. Dc is a colorimetric assay based on the reaction of the 
proteins with an alkaline copper tartrate solution and Folin reagent which leads to 
color development. 20 µl of reagent S were mixed with 1 ml of reagent A to produce 
A’ solution. 125 µl of A’ was then mixed with 2 µl of protein sample in a cuvette. 
Finally, 1 ml of reagent B was added. After mixing well and incubating for 5 minutes 
at room temperature, colorimetric readings were recorded by measuring absorbance 
at 750 nm using the BioMate 3 Spectrophotometer (ThermoFisher Scientific). A 
BSA (bovine serum albumin) reference curve that was always made on the day was 
used to estimate protein concentration based on the colorimetric readings.  
 
2.3.3 Protein separation by SDS-PAGE 
Proteins were separated by their molecular weight by SDS-polyacrylamide gel 
electrophoresis (PAGE) on 4-12% Bis-tris (for standard molecular weight proteins) 
or 3-8% Tris-acetate (for high molecular weight proteins) pre-cast acrylamide gels 
(NuPage Novex, Life Technologies), which were inserted in an XCell SureLock 
electrophoresis chamber (Life Technologies). Before loading on the gel, protein 
samples were reduced and denatured by the addition of 0.25 volume of NuPage LDS 
buffer and 0.05 M DTT, and subsequent heating at 70oC for 10 minutes. As a 
molecular weight marker, 5 µl of Broad Range Color Protein Standard were loaded 
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alongside the protein samples (New England Biolabs). The protein-loaded gels were 
run in MOPS (for 4-12% gels) or Tris-acetate buffer (for 3-8% gels) supplied with 
antioxidant (Life Technologies), by applying 150V for 60-70 minutes until 
satisfactory electrophoretic separation was achieved.  
 
2.3.4 Western blotting  
Proteins that were separated by SDS-PAGE were then transferred onto 
polyvinylidene fluoride (PVDF) or nitrocellulose membranes (0.45 µm pores, 
Amersham GE Healthcare) by semi-dry transfer (for standard molecular weight 
proteins) or wet transfer methods (for very high molecular weight proteins). In both 
cases, transfer was carried out in Towbin transfer buffer (0.25 M Tris base, 1.92 M 
glycine, 20% methanol, pH was fixed to 8.1-8.5). For semi-dry transfer, the gel 
containing the resolved proteins was “sandwiched” with the activated and 
equilibrated wet membrane between two stacks of three pieces of wet paper each, 
and inserted into the BioRad Trans-Blot Turbo Transfer system where voltage of 25 
V was applied for 30 minutes. For wet transfer, the gel containing the resolved 
proteins was “sandwiched” with the activated and equilibrated wet membrane 
between two stacks of three pieces of wet paper each and two sponges and inserted 
into a cassette that kept the sandwich firmly together. The cassette was then inserted 
into an electrophoresis chamber filled with transfer buffer and 100 V were applied 
for 90 minutes in the cold room. An ice pack was also inserted in the chamber to 
prevent overheating. After transfer was over, transfer success as well as equal 
loading in all lanes were confirmed by staining the membrane with Ponceau S 
(Sigma-Aldrich). After removing Ponceau S by TBS washes, the membrane was 
ready for the blocking stage which was carried out on an orbital shaker at room 
temperature for 1 hour or overnight in the cold room, in TBS- 0.05%Tween20- 5% 
dried skimmed milk or in Superblock (ThermoFisher Scientific) if the primary 
antibody ought to recognize phosphorylated proteins. Primary antibody incubation 
was similarly carried out on an orbital shaker at room temperature for 1 hour or 
overnight in the cold room, in blocking buffer. A list of the antibodies used and their 
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respective dilutions can be found in Table 2.5. This was followed by extensive 
washes and incubation with horseradish peroxidase (HRP)-conjugated secondary 
antibodies or Clean Blot reagent for 1 hour at room temperature in blocking buffer. 
After extensive washes in TBS- 0.05%Tween20 and one last wash in TBS to remove 
the detergent, protein band detection was achieved by incubating the membrane in 
Pierce ECL chemiluminescent substrate (Thermo Fisher Scientific) or Pierce ECL 
Plus for detection of low-abundance signal. The membrane was then inserted in a 
dark-room cassette and exposed onto a photographic film (Amersham Hyperfilm 
ECL by GE Healthcare) which was then developed in a medical film processor (SRX 
101A, Konica) to visualize the bands.  
When needed, the intensity of the protein bands was estimated by densitometry 
measurements using the “plot gel lanes” feature of Fiji software. Measurements for 
the protein of interest were normalized to the corresponding measurements for the 
loading controls (β-actin blots or Ponceau stains for the Glutathione-S-transferase 
(GST)-tagged proteins that were used as baits for pulldowns). The result was 
expressed as fold-change compared to the value of one of the samples that was set to 
1.  This quantification was used as a proxy to estimate protein abundance between 
the samples. The amount of variation between the samples was expressed as the 
standard error of the mean (SEM) and t-tests were carried out to estimate 
significance based on three independent biological repeats of the experiment.  
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Table 2.5. List of antibodies or antibody-conjugated resins.  
The antibodies used during the present thesis for western blotting (WB), 
immunofluorescence (IF) and immunoprecipitation (IP) purposes are listed below, 
together with the specific dilutions in blocking buffer or the amount used per mg of 















1 in 5000 1 in 1000  
Monoclonal anti-
phosphotyrosine 
clone 4G10  
(05-321) 
Mouse Millipore 1 in1000   
Polyclonal anti-
SRC (#2108) 










Rabbit Cell Signaling 1 in 1000   
Polyclonal anti-RP2 
(HPA000234) 
Rabbit Sigma Aldrich 1 in 1000   
Monoclonal anti-
DNA PK, clone 
Y393 (ab32566) 


























1 in 10000   
Monoclonal anti-β 
actin, clone AC-74 
(A2228) 
Mouse Sigma-Aldrich 1 in 5000 
(zebrafish) 





histone H3 (10779) 




Rabbit GeneTex 1 in 2000   
Monoclonal anti-

















1 in 500 to 
1000 
  




Rabbit Millipore 1 in 500   
Monoclonal anti-
FLAG (#14793) 
Rabbit Cell Signaling 1 in 2000   
EZ View red anti-
































 1 in 2000  
 
2.3.5 Stripping membranes  
In order to re-probe PVDF membranes for a loading control (V5 or β-actin), primary 
and secondary antibodies were removed by incubating the membrane in a mild 
stripping buffer (0.2 Μ glycine, 0.1% SDS, 0.1% Tween20, pH adjusted to 2.2), 
twice for 5-10 minutes. The membrane was then washed rigorously several times 
with PBS and TBS-T before proceeding to the blocking stage.  
 
2.3.6 Production and purification of recombinant proteins 
For the generation of GST-ARL3 Q71L, GST-OSTF1 and RP2-His recombinant 
proteins, competent BL21 DE3 E. coli cells (Agilent technologies) were transformed 
by heat shock at 42oC with pGEX4T3 vectors (GE Healthcare) containing the 
OSTF1 and ARL3 Q71L cDNAs or a modified pGEX6P1vector containing human 
RP2 cDNA. The pGEX4T3 added an N-terminal GST tag sequence to the constructs. 
The destination vector for the RP2 construct was a gift from Dr Martin Reijns who 
modified the pGEX6P1vector to add a C-terminal His tag to the construct, in 
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addition to the pre-existing N-terminal GST tag. Individual transformed colonies 
were grown in a shacking incubator at 37oC in liquid broth (LB) supplemented with 
50 µg/ml ampicillin, overnight. On the next day, 10 ml of the culture were 
transferred into fresh LB with 25 µg/ml ampicillin and incubated at 37oC until the 
optical density of the culture at 600 nm (OD600) reached appropriate levels. 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added for 4 hours to induce 
expression of the recombinant protein. After the induction, bacteria were separated 
from the medium by centrifugation and cell lysis was conducted by incubation with 4 
mM DTT, 1 mg/ml chicken lysozyme (Sigma Aldrich), 0.2% NP40 and the addition 
of PMSF protease inhibitor. Genomic DNA was fragmented by passing the mixture 
through a small needle several times. Desired recombinant proteins were found at the 
supernatant after centrifugation at 20,000 g for 20 minutes at 4oC.  
GST-tagged recombinant proteins were purified by immobilisation on glutathione-
sepharose bead slurry (GE Healthcare).  
The presence of the recombinant proteins in the lysates was confirmed by analyzing 
samples from different steps of the procedure by SDS-PAGE on 4-12% NuPage gels 
(Life Technologies), alongside BSA standard for roughly estimating protein 
concentration. The gel was then stained with Coomassie Brilliant Blue.  
While GST-tagged OSTF1 and ARL3 remained bound on the bead slurry for the 
pulldown assays, RP2-His needed to be released from the beads to be used in the 
kinase assays. To achieve this, the GST tag was cleaved off the protein by incubation 
with Prescission Protease (Sigma Aldrich) for 4 hrs at 4oC. Beads were pelleted 
down and protein remained at the supernatant, while incubation with fresh beads was 
employed to remove the protease and any residual GST. Buffer exchange and 
concentration of the recombinant RP2-His protein was conducted using Cornig Spin-
X UF concentrator columns.  
Recombinant proteins were aliquoted and stored in PBS with 10% glycerol and 1 
mM DTT at -80oC.  
 50 
2.3.7 Kinase assays 
RP2-SRC kinase assay 
Recombinant His-tagged human RP2 (0.8 µg) was mixed with different quantities of 
recombinant GST-tagged human SRC (Precisio kinase Sigma-Aldrich) (100, 200, 
400 ng corresponding to 11, 22 and 44 u) and 2 mM ATP (Thermo Scientific) in the 
appropriate kinase buffer (25 mM MOPS pH 7.2, 12.5 mM glycerol-2-phosphate, 20 
mM MgCl2, 12.5 mM MnCl2, 5 mM EGTA, 2 mM EDTA, 0.25 mM DTT added just 
prior to use) and incubated for 15 minutes at 30oC. SRC was diluted in the reaction 
buffer supplemented with 0.04 mg/ml BSA. The reaction was stopped by the 
addition of LDS sample buffer (NuPage, Life Technologies) / DTT and the mixture 
was heated at 70oC for 10 minutes to prepare for SDS-PAGE.  
RP2-DNA PKcs kinase assay 
The Promega DNA PK kinase enzyme system was used which contained the reaction 
buffer, activation buffer and DNA PK. 100 u of human DNA PK purified from HeLa 
cells and diluted in 0.1 mg/ml BSA and reaction buffer was mixed with 1 µg of 
recombinant human RP2-His, 2 mM ATP, Activation buffer (100 µg/ml calf thymus 
DNA), 1 mM PMSF, phosphatase inhibitor cocktail and 2 mM ATP (Thermo 
Scientific) in the appropriate reaction buffer (50 mM HEPES pH 7.5, 100 mM KCl, 
10 mM MgCl2, 0.2 mM EGTA, 0.1 mM EDTA, 1 mM DTT). The mix was 
incubated for 60 minutes at 30oC. The reaction was either stopped by the addition of 
LDS sample buffer and DTT, followed by incubation at 70oC for 10 minutes to 




Immunoprecipitations (IPs) were performed using cell lysates. V5 IPs with the aim 
to isolate RP2-V5 and assess phosphorylation were conducted in 
radioimmunoprecipitation assay (RIPA) buffer cell lysates. 10 µl V5 beads (Sigma-
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Aldrich) were incubated with 2-3 mg of total lysate protein for 1 hr on a rotator at 
4oC. V5 and FLAG IPs aiming to co-IP RP2-V5 and DNA PKcs and other 
interaction partners were conducted in Triton lysis buffer lysates. Endogenous DNA 
PKcs-RP2 co-IPs were conducted in Triton lysis buffer lysates. 2 µg of mouse anti-
DNA PKcs antibody (Thermo Scientific, clone 25-4) per 2 mg total lysate protein 
was incubated with the cell lysate overnight on a rotator at 4oC. A mouse-derived, 
isotype-matched (IgG2a) antibody was used at equal amounts for IP as the negative 
control. On the next day, 20 µl protein A-sepharose beads (Abcam) were added for 1 
hour at 4oC to collect the antibody-protein complexes. ARL3 Q71L-FLAG IPs 
aiming to co-precipitate RP2 and DNA PKcs were conducted in Co-IP lysis buffer. 5 
µl of EZ View red anti-FLAG M2 agarose affinity gel beads (Sigma-Aldrich) were 
incubated with ~1 mg of total lysate protein for 2 hours on a rotator at 4oC. After 
incubation with the antibodies, extensive washes followed in all cases in the 
respective lysis buffer in order to minimize non-specific protein binding. After 
washing, the beads were collected at the bottom of the tube by brief centrifugation, 
immunocomplexes were eluted off the beads by the addition of LDS buffer (NuPage, 
Life Technologies) / DTT and resolved by SDS-PAGE. Resolved protein mixes were 
then subjected to western blotting. 
 
2.3.9 Pulldown assays 
Fresh HEK293T cell lysates in IP lysis buffer supplemented with 1 mM PMSF, 
phosphatase and protease inhibitor cocktails were used for the GST pulldown assays, 
after keeping 10-20% of total protein separately as inputs. GST pulldown assays 
were conducted in IP lysis buffer by incubating 0.7-1 mg of total cell lysate protein 
with ~10 µg of GST-tagged protein bound on glutathione-sepharose beads (GST-
OSTF1, GST-ARL3 Q71L or RP2-GST) for 2 hours at 4oC under continuous 
rotation. After the end of the incubation, 10 µl of washed unbound glutathione-
sepharose beads (GE Healthcare) were added to the mix to make the bead pellet 
visible. The bead-bound GST protein complexes were washed at least three times in 
lysis buffer to remove non-specifically bound proteins. In the end, beads were 
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collected at the bottom of the tube by brief centrifugation and the GST complexes 
were eluted off the beads by the addition of LDS buffer (NuPage, Life Technologies) 
/ DTT and resolved by SDS-PAGE. Resolved protein mixes were then subjected to 
western blotting.  
 
2.3.10 Mass spectrometry 
Immunocomplexes concentrated on agarose beads or kinase assay mixes were 
processed to generate tryptic peptides for mass spectrometry (MS) analysis in the 
IGMM MS facility, where all subsequent workflow was conducted by Dr Jimi Wills-
Bukowski and Dr Alex von Kriegsheim. Resulting peptides were processed for 
HPLC and tandem MS in a Thermo Scientific 3000 RSLC Nano liquid 
chromatography system coupled to QExactive Plus mass spectrometer. All samples 
were analysed in two technical repeats; RP2-V5 interactome analysis was also 
analysed in three biological repeats. Data were processed in MaxQuant software 
version 1.5.3.17 (Cox and Mann 2008), searching against Uniprot human reference 
proteome (UP000005640_9606, release 2015_12) using Andromeda search engine 
(version 1.5.6.0). False discovery rate was set to 0.05 for peptides/post-translational 
modifications and 0.01 for protein identification. Normalized label-free 
quantification (LFQ) values were generated with match-between-runs enabled, and 
used in downstream analysis as described in chapter 4. Initial analysis and quality 
control was performed with R version 3.2.3 (2015-12-10). The above workflow 
corresponds to the RP2-DNA PK kinase assay experiment and the proteomic 
analysis of RP2-V5 IPs (Chapter 4: Figure 4.2, Figure 4.7).  
For the identification of RP2 Y27 phosphorylation (Chapter 3: Figure 3.5), data were 
processed in Peaks software version 7.0.1 (Bioinformatics solutions Inc.), searching 
against the current Uniprot human proteome dataset (08/2013 version) using Mascot 
(2.4.0) and X!Tandem (2010.12.01.1) search engines. Scaffold software (version 
4.3.4, Proteome Software Inc., Portland, OR) was used to validate MS/MS based 
peptide and protein identifications with a false discovery rate of 0.05 for peptides and 
0.01 for proteins.  
 53 
2.3.11 Fractionations 
A detergent-based cell fractionation kit (#9038, Cell Signaling Technology) was 
used to separate proteins from RPE1 cells according to 3 subcellular fractions 
(cytoplasmic, membrane/organelle and nuclear/cytoskeletal), following 
manufacturer’s instructions. Protease inhibitor cocktail and 1 mM PMSF were added 
to the buffers just before use. Confluent hTERT-RPE1 (roughly 2.5 x106 cells per 
sample) were trypsinised to detach from the flask, and growth medium was added to 
deactivate trypsin. After isolating 100 µl of cell suspension to prepare the whole cell 
lysate (crudely lysing the cells by applying LDS sample buffer and DTT and 
sonicating), the rest of the cell pellet was resuspended in 250 µl of cytoplasmic 
isolation buffer (CIB) and incubated for 5 minutes on ice (like all steps from this 
point on were performed on ice). After centrifugation for 5 minute at 500 g, the 
supernatant was kept as the cytoplasmic fraction. Subsequently, the pellet was 
resuspended in 250 µl of membrane isolation buffer (MIB) and incubated for 5 
minutes on ice. After centrifugation for 5 minute at 8000 g, the supernatant was kept 
as the membrane and organelle fraction. Finally, the pellet was resuspended in 125 µl 
of cytoskeleton/nucleus isolation buffer (CyNIB) and sonicated 3 times for 5 seconds 
at low power. This represented the cytoskeletal/nuclear fraction. LDS sample buffer 
and DTT were added to the samples which were subsequently heated at 70 oC for 5 
minutes, to reduce and denature the proteins and prepare the samples for SDS-PAGE 
and western blotting.  
A second method of fractionation was also employed based on (Holden and Horton 
2009). Protease inhibitor cocktail was added to the buffers just before use. Confluent 
hTERT-RPE1 cells were scraped off their plates in isotonic buffer (150 mM NaCl, 
25 mM HEPES buffer pH 7.5, 1 mM β-mercaptoethanol, 0.2 mM CaCl2, 0.5 mM 
MgCl2) and transferred to Eppendorf tubes. Cell suspensions were then incubated 
with 20 µg digitonin for 30 minutes at 4 oC. This concentration of digitonin is 
expected to fully extract the cytosol by forming pores on the plasma membrane, 
without permeabilising intracellular membranes. After centrifugation for 1 minute at 
13000 rpm, the supernatant was kept as the cytosolic fraction. Subsequently, the 
remaining pellet was washed with PBS and then resuspended again in isotonic 
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buffer. After adding NP-40 to 0.5% final concentration, the suspension was vortexed 
and centrifuged for 1 minute at 13000 rpm. The supernatant was kept as the 
membrane fraction, as NP-40 solubilises intracellular membranes. Finally, after 
washing the pellet in PBS, it was resuspended in RIPA buffer, which solubilizes the 
nuclear membrane and extracts nuclear residing proteins. After vortexing and 
centrifuging for 10 minutes at 13000 rpm, the supernatant was kept as the nuclear 
fraction. The pellet which contained RIPA-insoluble proteins and cell debris was 
discarded. LDS sample buffer and DTT were added to the samples which were 
subsequently heated at 70 oC for 5 minutes, to reduce and denature the proteins and 
prepare the samples for SDS-PAGE and western blotting.  
 
2.4 Mammalian tissue culture 
2.4.1 Cell culture 
HEK293T and hTERT-RPE1 cells were obtained from the ATCC (American type 
culture collection) and maintained as adherent cultures at 37 oC and 5% CO2. 
HEK293T were grown in Dulbecco’s modified Eagle medium (DMEM) with 4.5g/l 
L/D glucose and preferably (+) pyruvate (Gibco, Life Technologies), with the 
addition of 10% v/v fetal serum (bovine or calf) and penicillin/streptomycin cocktail 
at 1 mg/ml final concentration. hTERT-RPE1 were grown in DME-F12 medium 
(Hyclone, Thermo Fisher Scientific) with the addition of 10% v/v fetal serum 
(bovine or calf), penicillin/streptomycin cocktail at 1 mg/ml final concentration and 
hygromycin (10 µg/ml final concentration). The RPE1 cell lines that were stably 
expressing ARL3-FLAG or the corresponding empty vectors additionally required 
the presence of puromycin (2.5 µg/ml) and G418 (250 µg/ml) in the medium, as 
selection antibiotics. Cells were split regularly using TrypLE trypsin substitute 
(ThermoFisher Scientific).  
Cell aliquots were frozen in regular medium with the addition of 10% dimethyl 
sulfoxide (DMSO) to prevent formation of water crystals. Freezing took place slowly 
in cryovials placed in ethanol baths at -80oC. For long term storage, frozen aliquots 
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were transferred to liquid nitrogen.  
Treatments 
All reagents were filtered with 0.22 µm filter before treating the cells, unless they 
were sterile. HEK293T cells have been subjected to the following treatments: sodium 
orthovanadate tyrosine phosphatase inhibitor, 100 µM in the pre-existing medium for 
30 minutes before cell lysis, when investigating tyrosine phosphorylation of RP2-V5 
(Chapter 3). SRC inhibitor treatment (eCF560), 100 and 200 nM in fresh medium for 
1.5 hours before lysis (Chapter 3). hTERT-RPE1 cells were subjected to the 
following treatments to induce DNA damage (Chapter 4): 2,5,10 Gy of X-rays using 
Faxitron at 1 Gy/min and 130 peak kilovoltage. Cells were incubated for at least 1 
hour at normal conditions before lysis or fixation. 50 µM DMSO-dissolved etoposide 
or respective quantity of DMSO alone, for 4 hours in fresh medium before lysis or 
fixation.  
 
2.4.2 Transient transfections 
HEK29T and hTERT-RPE1 cells were transiently transfected with approximately 0.5 
µg purified plasmid DNA containing the relevant constructs per 0.2x106 cells. The 
nonliposomal transfection reagent Fugene HD (Promega) was used to deliver the 
plasmids into the cells.  
 
2.4.3 Growth curves 
To produce a growth curve of RPE1 cells, they were plated in 6-well plates at 
11.2x104 cells per well. Every day, cells from 3 biological replicates-wells were split 
and counted using the Cellometer Auto T4 cell counter (Nexcelom).  
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2.4.4 Cell motility experiments 
Cell motility of RPE1 cells was assessed via two different in vitro assays: random 
migration assay and scratch wound (wound healing) assay. 
For the random migration assay, cells were very sparsely plated (1000 cells per well 
in a 96-well plate) and left overnight in the incubator to adhere to the substrate. 6 
technical replicates (wells) were plated for each cell type. On the next day, the plate 
was transferred to the Incucyte ZOOM live-cell imaging system (Essen Bioscience) 
where cells were maintained at optimal physiological conditions inside an incubator 
for 24 hours, during which the plate was imaged every 30 minutes. Wild-type RPE1 
cells appear to be very motile when sparsely plated, moving continuously around in 
response to local gradients of growth factors in the growth medium. The distance 
covered by individual cells during a specific 10-hour time-frame was analysed 
blindly using the Manual cell tracking feature in Fiji.  
For the scratch wound assay, RPE1 cells were plated on specialized 96-well plates 
(Essen Bioscience), including 6 technical replicates (wells) for each cell type, and 
allowed to reach complete confluency. A scratch wound was then introduced in the 
middle of each well using the 96-well WoundMaker Tool (Essen Bioscience). After 
carefully washing the wells to remove floating cells, the plate was transferred in the 
Incucyte ZOOM live cell imaging system (Essen Bioscience), where the cells were 
maintained at optimal physiological conditions while imaging every 30 minutes for 
24 hours. Cells at the edge of the wound moved in a directed manner towards the 
center of the cell-free zone until the formation of new cell-cell contacts inhibited 
migration. After 24 hours, the wounds were completely closed. Cell migration was 
then measured by quantifying cell density as the cells migrated into the cell-free 
zone. The Incucyte cell migration software module automatically generated a mask 
of the initial versus later wound width and calculated the relative wound density.  
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2.4.5 Immunofluorescence  
hTERT-RPE1 were grown on sterile coverslips previously treated with HCl to create 
a rough surface for the adherent cells (12 hours at 55 oC). Cells used in the γH2AX 
staining experiment were fixed in 4% paraformaldehyde (PFA) in PBS for 10 
minutes at room temperature, washed extensively in PBS to remove PFA and then 
permeabilised in 0.1% Triton X100 in PBS for 10 minutes. Cells used in the DNA 
PKcs-RP2-V5 staining experiment were instead treated with ice-cold methanol for 5 
minutes at 4 oC, and then extensively washed in PBS to remove methanol. Cells were 
blocked in goat serum diluted 1:10 in PBS for 1 hour at room temperature or 
overnight at 4 oC, on an orbital shaker. Primary antibody incubations were performed 
in the dilutions indicated in table for 1 hour at room temperature in blocking buffer. 
After washing 3 times in blocking buffer, secondary antibody incubation followed at 
the indicated dilutions for 1 hour at room temperature. From this stage on the stained 
cells were protected from light. Before mounting, cells were stained with 4’,6-
diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) diluted 1:10000 in PBS to show 
the nuclei, for 5 minutes at room temperature. Finally, stained cells were mounted on 
Superfrost slides using Prolong Gold mounting medium (Invitrogen), and imaged on 
a Zeiss upright epifluorescent microscope operating with the Micro-manager open 
source imaging software (https://micro-manager.org/) (γH2AX staining), or with an 
A1+ Nikon confocal microscope operating with the NIS Elements software (DNA 
PKcs-RP2-V5 co-staining).  
Image analysis was conducted using the NIS Elements viewer software (for images 
obtained on the Nikon confocal) or Image J/FIJI open source software.  
 
2.5 Animal methods 
2.5.1 Fish husbandry 
Zebrafish used during this study were maintained in the MRC Human Genetics Unit 
(HGU) core fish facility, in a recirculating closed water system (Aquatic Habitats, 
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UK) at pH 7.4 and 28oC temperature. Light cycle followed a stable 14-hour day/10-
hour night pattern. All lines were derived from matings between wild-type AB adults 
from within the facility. Embryos destined to grow to adulthood were bleached on 
the first day post-fertilisation (dpf) in alternating 5-minute washes of bleach solution 
and MilliQ distilled water. Bleached embryos were grown up to 5 dpf in a petri dish 
with fresh E3 medium, in a 28oC incubator. After five days, the larvae were 
transferred to static tanks at room temperature and grown until 20-30 dpf. During this 
period, their diet consisted of paramecium and ZM000 dry food (ZM Systems, UK). 
Subsequently, the larvae were transferred into the main system and fed a 
combination of dry food (ZM Systems) and brine shrimp.  
All experimental procedures described in the present study were approved by the UK 
Home Office and complied with the UK Animals (Scientific Procedures) Act 1986. 
Permission to carry out the experiments was granted to Personal Project Licence 
(PPL) number  60/4418 and Personal Individual Licence (PIL) number 15CF674A1.  
 
2.5.2 Generation of zebrafish mutant lines by CRISPR/Cas9 
The Target Finder tool from Feng Zhang’s lab (http://crispr.mit.edu/) was used to 
identify possible gRNA target sequences on zebrafish rp2 and check for potential 
off-target binding. To generate rp2 null zebrafish, 600 ng/µl nCas9 mRNA [codon-
optimised for zebrafish genome editing, (Jao et al. 2013)] were mixed 1:1 with the 
respective gRNA (~80 ng/µl) and micro-injected directly into the cell of 1-cell stage 
AB zebrafish embryos. Injections were conducted by me and Witold Rybski. On the 
3rd day post fertilisation, 5-10 embryos were pooled and genomic DNA was isolated 
from them, in order to determine Cas9 targeting efficiency by Sanger sequencing. All 
sequencing experiments began with a single PCR reaction using appropriate primers 
flanking the targeted site on zebrafish rp2 (termed “rp2 sequencing PCR” from now 
on) and Phusion High fidelity DNA polymerase (New England Biolabs) (Table 2.1). 
When the template was expected to consist of heterogeneous DNA fragments, as in 
this case of pooled zebrafish embryos, the PCR products were subcloned into 
pGEM-T vectors and subsequently used to transform E.coli competent cells (see full 
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procedure above). Plasmid DNA from individual transformed colonies was 
submitted for Sanger sequencing using a T7 primer.  
When targeting efficiency was high (as in gRNA1- guided targeting), the rest of the 
embryos were allowed to grow to ~3 months and total genomic DNA was isolated 
from their fin clips. Because of the quick developmental rate of zebrafish embryos, it 
was expected that these fish are chimaeras, meaning that different populations of 
cells are expected to carry different mutations, if any. For this reason, sequencing to 
separate the different mutations and determine the degree of chimaerism necessarily 
included a pGEM-T subcloning step, as described above. When rp2 mutations were 
found among the colonies, the fish was considered a potential founder (F0), and was 
isolated. Because founders were all female, they were crossed with AB males to 
determine if they could pass rp2 mutations to their progeny. Total genomic DNA 
was isolated from pooled embryos produced by the AB x F0 cross, and the rp2 
sequencing PCR product was submitted for Sanger sequencing using both the 
forward and reverse primers that were used for PCR (“Sequencing primers”, see 
Table 2.1). Mutations in the heterozygous embryos were identified using the 
PolyPeak Parser software (Hill et al. 2014). When rp2 mutations were identified in 
the pooled embryo sample, the rest of the progeny were allowed to grow to ~3 
months, when the fish that were heterozygous for rp2 mutations were identified by 
rp2 sequencing PCR and Sanger sequencing (F1). F1xF1 crosses between fish with 
identical rp2 mutations were conducted and the progeny were screened by rp2 
sequencing PCR and Sanger sequencing to identify putative rp2-null homozygous 
fish (F2). Wild-type and heterozygous fish from these crosses were also kept and 
used in the histology experiments.  
 
2.5.3 Histology of retinal sections 
Paraffin sectioning 
Eyeballs were freshly dissected from adult animals, washed in PBS and then 
immediately immersed into Davidson’s fix buffer [22% v/v 10% neutral formalin in 
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phosphate buffer (100 ml/l 40% PFA, 900 ml/L distilled water, 18.6 g/l NaH2PO4, 
42.2 g/l NaOH), 33% v/v 95% ethanol, 11% v/v acetic acid in distilled water]. 
Fixation took place overnight at 4 oC. Subsequently, the eyeballs underwent a couple 
of washes in 70% ethanol and remained in 70% ethanol for another night before the 
next step. Dehydration of the tissues and embedding in paraffin took place in the 
Tissue Tek Tissue VIP5 Jr. embedding console system (Sakura). The procedure 
included the following steps, each one lasting for 40 minutes: 
1. 70% ethanol  
2. 70% ethanol 
3. 85% ethanol 
4. 95% ethanol 
5. 100% ethanol               
6. 100% ethanol 






13. Paraffin         
14. Paraffin 
 
After embedding in molten paraffin, the eyeballs were transferred into casts where 
they were orientated according to the plane of sectioning required. Paraffin was then 
allowed to set completely around the specimen and form a block. All samples that 
would be compared (e.g. age-matched rp2 null and wild-type siblings) were 
processed and stained simultaneously using the same settings.  
A Leica RM2235 microtome was used to obtain 7 µm-thick sections of the eyes. 
Sections were obtained orthogonally to the vertical meridian of the eye. Sections 




Superfrost microscopy slides (Menzer-Gläser, Thermo Fisher Scientific). They were 
subsequently air-dried overnight. 
Haematoxylin and eosin (H&E) staining 
To prepare for staining, eye sections were first de-waxed in xylene. Next, they 
underwent stepwise rehydration, passing through a reverse series of graded ethanol 
washes. Sections were subsequently dipped in haematoxylin for 4 minutes, washed 
in running tap water, differentiated in 1% HCl in 70% alcohol, washed well in 
running tap water. Next, the sections were dipped in saturated Lithium carbonate 
solution for a few seconds, washed well in tap water, stained in eosin for 4 minutes, 
rinsed in water and finally rinsed in 100% ethanol. After staining, the sections were 
dehydrated again through several 100% ethanol washes. After passing through 3 
xylene washes for 5 minutes each, the sections were ready to be mounted with DPX 
medium (Cell Path). Mounted sections were left to cure overnight.  
Imaging and analysis 
Brightfield microscopy with a Zeiss upright microscope and the Micro-manager open 
source imaging software (https://micro-manager.org/) was used to take pictures of 
the stained retinal sections. Fiji software was used to measure the thickness of 
different layers, which were made visible thanks to the H&E stain, along the length 
of the retina. The mean values from 3 different fish of the same genotype were then 
plotted on graphs, and GraphPad prism software was used for the statistical analysis.   
 
2.6 Databases, online resources, 3D protein analysis and statistics 
Online databases and resources used in this thesis include the Ensembl genome 
browser (http://www.ensembl.org/index.html), National centre for biotechnology 
information (NCBI) (https://www.ncbi.nlm.nih.gov/), Uniprot protein 
knowledgebase (http://www.uniprot.org/), Phosphosite Plus database for post-
translational modifications (http://www.phosphosite.org/homeAction.action), and the 
Retinal Information Network (https://sph.uth.edu/retnet/).  
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RP2 3D structure cartoons shown in [Chapter 3: Figure 3.6 and Chapter 4: Figures 
4.6,4.7] were made using Pymol software. A publicly available Pymol script 
(https://pymolwiki.org/index.php/FindSurfaceResidues) was employed to show 
surface exposed residues. The default cut-off value was used (2.5 Ang2).  
Phosphorylation site prediction for RP2 shown in Chapter 3 was conducted using the 
freely available Group-based prediction system (GPS) 3.0 software 
(http://gps.biocuckoo.org/) using medium threshold settings (9% FPR-false positive 
rate) which is appropriate for small scale experiments.  
Dr Dinesh Soares conducted calculations of RP2 stability upon mutagenesis (Chapter 
3: Table 3.1, Figure 3.2, Chapter 4: Figure 4.6) using FoldX software tool 
(Schymkowitz et al. 2005, Rakoczy et al. 2011). He also conducted sequence 
conservation analysis on the surface of RP2 (Chapter 3: Figure 3.2) using ConSurf 
software tool (Ashkenazy et al. 2016) and multiple-sequence alignment of vertebrate 
RP2 orthologues using MUSCLE (EMBL-EBI tool) (Edgar 2004) (Chapter 3: Figure 
3.5, Chapter 4: Figure 4.7).  
Statistical analysis was conducted using Graphpad Prism software, except for the 
analysis of the IP/MS experiment, which was analysed based on an R script provided 
by Dr Jimi Bukowski-Wills using RStudio version 0.99.903.  
During the CRISPR/Cas9 experiment (Chapter 5), the Target Finder tool from Feng 
Zhang’s lab (http://crispr.mit.edu/) was used to identify possible gRNA target 
sequences on zebrafish rp2 and check for potential off-target binding. EMBL-EBI’s 
tool Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) was used for multiple 
sequence alignments to identify rp2 mutations in Sanger-sequenced samples. 
PolyPeak Parser software served to separate Sanger sequencing chromatograms with 




Chapter 3: Characterisation of the interaction 
between RP2 and OSTF1 
3.1 Introduction 
Osteoclast stimulating factor 1 (OSTF1) was identified in our group previously as a 
direct interaction partner of RP2 by a yeast two-hybrid screen approach, and the 
interaction was subsequently confirmed using Glutathione-S-Transferase (GST) 
pulldown assays from bovine retinal extracts (Dr Toby Hurd, Figure 3.1B). This 
interaction was later identified in HEK293T cells by a large-scale study of the human 
interactome based on mass spectrometry, providing further validation of this 
interaction (Huttlin et al. 2015). OSTF1 has never been linked to photoreceptor 
degeneration before, instead it was initially identified as an intracellular polypeptide 
that indirectly stimulates formation of osteoclast-like multinucleated cells in human 
bone marrow culture and bone resorption when overexpressed (Reddy et al. 1998).  
OSTF1 is 214 residues-long and its main protein domains are a SRC-homology 3 
(SH3) domain (which shares 63% sequence homology with Fyn kinase), an N-
terminal proline-rich region (which functions as an SH3-binding domain), four 
ankyrin repeats and a well-conserved cluster of amino acids at the C-terminus 
(Figure 3.1A). Expression of OSTF1 at mRNA level has been detected in several 
human tissues including heart, brain, placenta, lung, liver, skeletal muscle, kidney, 
pancreas and differentiated osteoclasts (Reddy et al. 1998). OSTF1 has twice been 
reported to form a complex with c-SRC kinase, either directly (Reddy et al. 1998) or 
indirectly via dimers of c-Cbl (Szymkiewicz et al. 2004). In addition, it co-localises 
with c-Cbl at podosomes in differentiated osteoclasts and is known to associate with 
filamentous actin (Szymkiewicz et al. 2004). Hence, it has been considered an 
adaptor for c-SRC’s functions in the actin cytoskeleton. Other interactions that 
OSTF1 has been implicated in, via its SH3 domain, include the spinal muscular 
atrophy-determining gene product SMN (Kurihara et al. 2001) and Fas ligand (Voss, 
Lettau and Janssen 2009). Further, OSTF1 has been independently identified during 
a screen for molecules that regulate cell motility in HeLa cells. Following up this 
discovery revealed that OSTF1 is a negative regulator of cell motility under direct 
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control of the  extracellular signal-regulated kinase (ERK)1/2 pathway and that this 
property is linked to its interaction with Myosin 1E (Tanimura et al. 2016, Tanimura 
et al. 2011). Finally, OSTF1 is one of the four genes and two open reading frames 
that are included in a rare 9q21 microdeletion which causes a syndrome of 
intellectual disability, epilepsy and mild facial dysmorphy. However, loss of OSTF1 
is not the most likely cause of these defects (Boudry-Labis et al. 2013).  
What makes this novel interaction of RP2 interesting is the fact that it is absent in 
patients with a particular missense RP2 mutation, according to previous data from 
our group (Dr Toby Hurd, Figure 3.1C). Several pathogenic missense mutations have 
been found on RP2 which are not predicted to destabilise the overall folding of the 
protein or affect its expression (biophysical calculations of structural stability based 
on the free energy difference upon mutagenesis were conducted by Dr Dinesh 
Soares, Table 3.1), and are therefore expected to be highly informative about specific 
interactions/modifications that are important for the disease. Most pathogenic 
missense mutations are segregated on the interaction interface with small GTPase 
ARL3 and are experimentally proven to affect the binding (Kuhnel et al. 2006), 
highlighting the importance of this interaction for the viability of photoreceptors. On 
the contrary, the RP2-OSTF1 binding is affected by the R211L mutation which lies 
away from the ARL3 interaction interface on the opposite face of the GAP domain 
and is not predicted to destabilise the structure of RP2 or the RP2-ARL3 interaction 
(Table 3.1). These preliminary results suggested that studying the RP2-OSTF1 
interaction promises to shed light on a novel function or mode of regulation of RP2 
and led to the hypothesis that the opposite face of the GAP domain together with the 
poorly studied NDK-like C-terminal domain form the binding interface for OSTF1.  
In the following chapter, I will describe the steps I took to characterise the RP2-
OSTF1 interaction. Firstly, I will map the interaction interface on a strictly conserved 
(among vertebrates) area on RP2 which spans both the N-terminal and the C-terminal 
domains. Secondly, I will attempt to identify the function of the complex based on 
the two prominent hypotheses about the molecular pathways that OSTF1 participates 
in. In particular, I will test if OSTF1 acts as an adaptor protein to mediate the 
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phosphorylation of RP2 by c-SRC and I will examine if RP2 is a regulator of cell 
motility, similar to OSTF1.   
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Table 3.1. Several missense RP2 mutations found in patients do not affect the 
stability of the protein or the RP2/ARL3 interaction.  
Stability calculations of the energy difference between wild-type and mutant RP2 
both for the unbound protein and the RP2-ARL3 complex. The result is shown as 
ΔΔG free energy expressed in kcal/mol. When ΔΔG <1.6 kcal/mol, no effect on 
structural stability is predicted upon mutation, whereas if ΔΔG>1.6 kcal/mol (shown 
in red), the mutation is predicted to destabilise the structure [data generated by Dr 
Dinesh Soares using the FoldX software (Liu et al. 2017a)]. 
 
Missense pathogenic 
mutations on RP2 
Stability energy calculation 
on human RP2 crystal 
structure (PDB ID: 2BX6) 
(mean ΔΔG in kcal/mol) 
Stability energy calculation 
on human RP2-ARL3 crystal 
structure (PDB ID: 3BH7) 
(mean ΔΔG in kcal/mol) 
C67Y 12.81  18.75  
C86Y 15.27  20.02 
T87I -0.73 -0.97 
P95L 9.25 7.74 
C105W 25.68 21.32 
C108G 2.35 2.18 
C108Y 15.73 11.03 
R118H 0.54 2.63 
R118L -0.72 0.60 
R118G 2.98 5.67 
R118C 1.10 2.76 
E138G 0.97 2.77 
S140F 22.05 24.32 
L188P 2.55 2.34 
R211H 0.38 0.61 
R211L -0.27 0.30 
L253R 8.74 7.23 
L253P 11.03 10.90 





Figure 3.1. Background information on OSTF1 and its identification as a 
binding partner of RP2.  
A) Schematic representation of the main protein domains of OSTF1. The 214-residue 
protein consists of a proline-rich region at the N-terminus (Pro), an SH3 domain, 4 
ankyrin repeats and a cluster of acidic amino acids at the C-terminus. B) OSTF1 was 
confirmed as a binding partner of RP2 by reciprocal GST pulldown assays from 
bovine retinal extracts. Recombinant GST-OSTF1 can pulldown endogenous RP2 
and recombinant GST-RP2 can pulldown endogenous OSTF1. GST-only pulldowns 
served as negative control. (data generated by Dr Toby Hurd) C) GST-OSTF1 
pulldown assays from HEK293 cells transfected with V5-tagged wild-type human 
RP2 and pathogenic forms of human RP2 with missense mutations. The R211L 
mutation abolishes the interaction between RP2 and OSTF1 (unpublished data 
generated by Dr Toby Hurd). 
 
3.2 Results 
3.2.1 OSTF1 binds a strictly conserved area on RP2 spanning both the 
N-terminal and C-terminal domains 
Intrigued by the preliminary finding that the R211L pathogenic mutation on RP2 
abolishes the interaction with OSTF1, I aimed to map the interaction interface and 
test the hypothesis that this interaction is independent of ARL3 binding. Identifying 
more contact sites in addition to R211 has a double purpose. Firstly, it will determine 
if the OSTF1 and ARL3 binding interfaces overlap on the RP2 surface. Secondly, 
finding more residues that are important for the RP2-OSTF1 interaction will help to 
predict the effect of pathogenic mutations, both existing ones and others that will be 
found in the future.  
In order to identify more residues, I followed a PCR-based site-directed mutagenesis 
approach to mutate individual residues on RP2 and then test for the ability of the 
mutated protein to interact with OSTF1 (Figure 3.2). The different forms of RP2-
coding sequence were inserted in a mammalian expression vector which added a V5-
tag to the C-terminus of the protein and were subsequently transiently expressed in 
HEK293T cells. This cell line was chosen for its high transfection efficiency. The 
lysates of the transfected cells were then used for pulldown experiments using 
recombinant GST-OSTF1 as bait. The particular residues to be mutated were chosen 
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on the basis of advice by Dr Dinesh Soares. His analysis took the following 
characteristics into account:1) the position of the residues in relation to R211 2) the 
conservation status among vertebrates 3) the electrostatic properties and 
hydrophobicity of the residues and 4) the possibility of post translational 
modifications. The mutations generated aimed to abolish the charge, the 
hydrophobicity or the phosphorylation potential of the original residues. Taking into 
account the electrostatic properties and hydrophobicity of the different residues is 
important because these factors often mediate molecular recognition by determining 
the relative orientation of molecules in a complex as well as the binding specificity 
and affinity. As a result, highly charged and/or exposed hydrophobic residues often 
participate in protein-protein interactions (Honig and Nicholls 1995).  
In addition, structural analyses and biophysical calculations were conducted (Dr 
Dinesh Soares) to ensure that the resulting substitutions were not predicted to affect 
the overall structural stability of the protein, an unwanted side-effect which would 
lead to poor expression or absence of expression of the mutated protein. Indeed, all 
the RP2 mutants in my experiment were expressed at the same level as the wild-type 
protein (inputs in Figure 3.2A), confirming that the computational predictions were 
correct. As an additional control, I conducted pulldowns using recombinant GST-
ARL3 Q71L, the ARL3 mutant that stably interacts with RP2 (Veltel et al. 2008), as 
bait. All the mutations I generated co-precipitated with ARL3 Q71L as efficiently as 
the wild-type protein, confirming that the mutant RP2 proteins were correctly folded 
and that any defect observed was specific to the interaction with OSTF1.  
Using this approach, I previously tested mutations in 7 RP2 residues and identified 
Y245 as essential for the RP2-OSTF1 interaction to occur (Rodanthi Lyraki, MSc 
thesis). During my PhD, I confirmed the previous results and examined 6 more 
residues. This led to the identification of 2 more residues that affect the interaction 
when mutated, namely D255 and K160. Figure 3.2 shows only experiments 
conducted during my PhD. The D255 to A mutation, which abolishes the negative 
charge, is prohibitive for the RP2-OSTF1 interaction. Mutating K160 to A which 
eliminates the positive charge, only mildly affects the interaction. However, 
reversing the charge via a K160 to E mutation eliminates the interaction completely, 
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leading me to conclude that K160 has an essential role in the binding interface. 
Moreover, another substitution which affects the RP2-OSTF1 interaction by 
eliminating the positive charge of the residue is K252A, although its effect is to 
reduce rather than abolish the interaction (Figure 3.2 C).   
It is interesting that four out of the five RP2 residues so far identified as belonging to 
the OSTF1 binding interface are highly charged and in particular mostly positively 
charged (K252, R211, K160), whereas the surface of RP2 is predominantly 
negatively charged (Kuhnel et al. 2006). This observation might reveal that possible 
oppositely charged interactions are important for the RP2-OSTF1 binding. 
Identifying the OSTF1 residues that participate in the interaction will be useful to 
prove if this is the case. In addition, Y245 which has also been identified as 
participating in the RP2-OSTF1 interaction belongs to an exposed hydrophobic 
cluster which lies within a noticeable surface cavity [analysis by Dr Dinesh Soares 
based on the RP2 crystal structure solved by (Kuhnel et al. 2006)]. These 
characteristics make it a good candidate for participating in a protein-protein 
interaction.  
The residues identified as essential mediators of the RP2-OSTF1 interaction belong 
to a strictly conserved (among vertebrates) “patch” on RP2 which spans both the N-
terminal and C-terminal domains of the protein and is distinct from the interaction 
interface with ARL3. It is suggested that this “patch” forms the OSTF1 binding 
interface. The remarkable conservation status of all three residues (Figure 3.2B and 
Appendix figure 1) suggests that the RP2-OSTF1 interaction occurs in all vertebrates 
and carries out an important function. Furthermore, my results suggest that OSTF1 
probably does not antagonise ARL3 for binding to RP2 and that, in theory, a trimeric 
complex can be formed between the three proteins. Co-precipitation experiments will 
need to be conducted in the future to prove whether this complex is actually formed 
in vivo. Finally, this experiment provides one of the first pieces of evidence for a 
functional role of the NDK-like domain of RP2.  
In the future, the binding interface of other interaction partners can be mapped on 
RP2 using the same approach. Previously identified RP2 binding partners include the 
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Gβ1 subunit of transducin (Schwarz et al. 2012), Importin β2 (Hurd et al. 2011) and 
Polycystin 2 (Hurd et al. 2010). It should be noted, however, that the site-directed 
mutagenesis approach that I followed is meaningful only when applied to direct 
interactions. OSTF1 was known from the beginning to be a direct interaction partner 
of RP2 because it was identified via a yeast two-hybrid screen (work conducted by 
Dr Toby Hurd). Moreover, the RP2-ARL3 interaction is well studied and the crystal 
structure of the structure has been solved, showing direct binding of the two proteins 
(Kuhnel et al. 2006). On the contrary, the other interaction partners of RP2 have been 
identified using pull-down and co-IP approaches, which do not ensure that two 
proteins that are found together in a complex directly bind to each other. As a 
conclusion, direct binding to RP2 should be shown first before research proceeds to 




Figure 3.2 . Mapping the interaction interface between RP2 and OSTF1 on a 
conserved patch on RP2.  
A) Critical residues on RP2 surface were mutated by site-directed mutagenesis and 
the resulting constructs were transiently transfected in HEK293T cells. V5 tagged 
wild-type (WT) and mutant RP2 proteins were compared for their ability to co-
precipitate with GST-OSTF1 in pulldown assays. Pulldown assays using GST-ARL3 
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Q71L as bait were also conducted as controls for the correct folding of the mutant 
proteins. Both lysates before pulldown (inputs) and pulldown samples were 
subjected to SDS-PAGE and western blot using anti-V5 antibody. Staining with 
Ponceau shows the GST-tagged recombinant proteins that were used as baits. Using 
this method, four residues were identified as parts of the interaction interface with 
OSTF1 because mutating them completely abolished the RP2-OSTF1 interaction but 
not the RP2-ARL3 Q71L interaction (Y245, K160, K252 and D255). (B) Crystal 
structure of RP2 in complex with ARL3 (PDB ID: 3BH7) where the conservation 
status among vertebrates of residues on the surface of RP2 is shown in colour code 
(with dark purple being strictly conserved). Yellow colour represents those residues 
whose conservation status was assigned with low confidence. Arrows point to the 
four residues that have been identified to participate in the interaction interface with 
OSTF1, which are all strictly conserved. It is suggested that RP2 interacts with 
OSTF1 via the strictly conserved “patch” on the side of the protein that is shown 
here, which is distinct from the interaction interface with ARL3. Sequence 
conservation analysis was conducted by Dr Dinesh Soares using the ConSurf 
software. (C) The K252A mutation on RP2 reduces the interaction with OSTF1 but 
does not have the same effect on the interaction with ARL3. Relative quantification 
of the amount of WT and K252A RP2 co-precipitating with recombinant OSTF1 and 
ARL3 Q71L (mean +/- S.E.M for densitometry measurements from n=3 separate 
immunoblots normalised to the inputs). Two-tailed one-sample t-test was used to 
assess the significance of the observed differences between WT RP2 (value set to 
100) compared to K252A RP2 pulldowns. P-value for OSTF1 pulldowns: 0.0162. P-
value for ARL3 pulldowns: 0.0444. 
 
3.2.2 Investigation of RP2 tyrosine phosphorylation and the potential 
role of OSTF1 
Protein phosphorylation is the most widespread type of post-translational 
modification used in signal transduction (Ubersax and Ferrell 2007). Several 
phosphorylated residues on mouse and human RP2 have been experimentally 
identified by large-scale phosphoproteomic studies (Figure 3.6A), but these 
modifications have not been verified or characterised to date and their function 
remains elusive (Sharma et al. 2014, Moritz et al. , Bershteyn et al. 2010, Kettenbach 
et al. , Humphrey et al. 2013, Wang et al. 2011, Stuart et al. 2015). Tyrosine 
phosphorylation is expected to be particularly important for the function of RP2, 
since previous work in our group has shown that phospho-mimic mutations of Y27 
and Y245 disrupt binding of RP2 to its interaction partners ARL3 and OSTF1, 
respectively (Rodanthi Lyraki, MSc thesis). In order to characterise the role of 
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tyrosine phosphorylation of RP2, it is important to identify the responsible kinase. 
Interestingly, the newly identified interaction partner of RP2, OSTF1, is known to 
interact with the ubiquitous tyrosine kinase c-SRC and has been suggested to act as 
an adaptor for c-SRC’s functions (Szymkiewicz et al. 2004). Based on this, I 
hypothesised that c-SRC is responsible for tyrosine phosphorylation of RP2 and that 
OSTF1 mediates this phosphorylation as a “scaffold” molecule, a mechanism for 
bringing the kinase and the substrate into the same complex that has been described 
before as an important way to enhance phosphorylation specificity (Ubersax and 
Ferrell 2007). In addition, I hypothesised that tyrosine phosphorylation influences 
binding of RP2 to its interaction partners and thus indirectly regulates the GTPase 
activity of RP2. In Chapter 3.2.2, I will describe the methods I used to verify my 
hypotheses in vitro. I will show that c-SRC is, indeed, a candidate kinase for 
phosphorylating RP2 on Y27, but other kinases are responsible for the low-level 
tyrosine phosphorylation of RP2 that is observed in HEK293T cells.  
 
3.2.2.1 c-SRC potentially phosphorylates RP2 on Y27 
Firstly, I tested the ability of recombinant human c-SRC-GST to phosphorylate 
recombinant human RP2-His in an in vitro kinase assay. As a readout, I analysed the 
assay mix by western blot using anti-phosphorylated tyrosine antibody and observed 
the presence of a phosphorylated band at the same molecular weight as His-tagged 
RP2. This initial experiment shows that it is possible for RP2 to be directly 
phosphorylated by c-SRC (Figure 3.3).   
Subsequently, I wanted to test if it is possible to induce tyrosine phosphorylation on 
RP2 by overexpressing c-SRC in cell culture. Because the phosphorylation of 
endogenous RP2 proved impossible to detect by western blot, I detected 
phosphorylation of transiently expressed V5-tagged RP2 from HEK293T cells after 
affinity purification by anti-V5 immunoprecipitation (IP). This cell line was chosen 
because of its robust transfection efficiency which allowed me to reproducibly detect 
such a low-level modification. Simultaneous co-expression of c-SRC-GFP induced 
tyrosine phosphorylation of a band at the same molecular weight as RP2-V5 which 
was not observed with co-expression of GFP alone (Figure 3.4). This result suggests 
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that RP2 phosphorylation by c-SRC can occur not only during a kinase assay but also 
in the cell environment. The experiment could be ameliorated by the addition of a 
sample transfected with SRC-GFP alone. In the absence of this negative control, 
there is still a possibility that the observed phosphorylated band does not correspond 
to RP2-V5 but another protein of similar molecular weight that is strongly 
phosphorylated by SRC-GFP. If the phosphorylated band indeed corresponds to 
RP2-V5, then I would expect it to be absent in the sample of cells transfected with 
SRC-GFP alone.   
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Figure 3.3. RP2 is phosphorylated by c-SRC in vitro.  
Kinase assay was performed in vitro using recombinant human RP2 with a C-
terminal His-tag and increasing quantities of GST-tagged recombinant human c-SRC 
kinase. The assay mix was subjected to SDS-PAGE and western blot analysis using 
anti-phosphorylated tyrosine antibody to detect phosphorylation of the substrate. No 
phosphorylation is observed in the negative controls, when the assay mix does not 
contain any kinase (-SRC) or the phosphate donor (-ATP). The blotted membrane 
was subsequently stripped and re-probed with anti-His antibody to confirm the 
presence of RP2-His at the same molecular weight as the phosphorylated band, and 




Figure 3.4. Overexpression of c-SRC results in tyrosine phosphorylation of RP2 
in HEK293T cells.  
The phosphorylation status of exogenous human RP2 with a C-terminal V5-tag was 
examined in HEK293T cells that were transiently transfected with empty pcDNA 
destination vector, RP2-V5 alone, RP2-V5 and GFP, or RP2-V5 and human c-SRC-
GFP. To detect phosphorylation, RP2-V5 was immunoprecipitated from the cells’ 
lysates using anti-V5 antibody conjugated agarose beads. The immunoprecipitates 
(IPs) as well as the lysates before IP (inputs) were subjected to SDS-PAGE and 
western blotting using anti-phosphorylated tyrosine antibody. This approach shows 
that overexpression of c-SRC induces phosphorylation of RP2 that can be detected 
even when endogenous phosphorylation is undetectable. Subsequent re-probing with 
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anti-V5 and anti-GFP antibodies confirms correct expression of the constructs. Red 
arrows point to the RP2 bands. Annotations next to the non-specific bands as well as 
the two different GFP bands have been added to help the reader.   
 
In order to confirm that the phosphorylated band corresponds to RP2-V5 and to 
identify the phosphorylated residues, IP samples from the overexpression experiment 
were subjected to tandem mass spectrometry (MS/MS) analysis in the IGMM MS 
facility by Dr Andy Finch and Dr Jimi Wills-Bukowski. Protein complexes were 
immunoprecipitated with RP2-V5 from cell lysates transfected with empty vector 
(negative control), RP2-V5/GFP and RP2-V5/SRC-GFP and subsequently subjected 
to in-solution tryptic digest followed by LC-MS/MS. The experiment was conducted 
in three independent biological replicates. The resulting analysis showed a phosphate 
on RP2 Y27, as well as the adjacent S28, in the c-SRC overexpression sample only 
(Figure 3.5A). In addition to identifying post-translational modifications, this 
experiment provided information about the proteins that co-precipitate with RP2-V5 
which I will present in Chapter 4. Both Y27 and S28 have been identified before as 
phosphorylation sites during large-scale phosphoproteomic studies of cancer cell 
lines (Sharma et al. 2014, Moritz et al. , Stuart et al. 2015). Y27, which is more 
relevant to my study of tyrosine phosphorylation, is located on a highly flexible 
(disordered) region that was not visible on the crystal structure (Veltel et al. 2008) 
and it is therefore assumed to be surface exposed and a good candidate for 
phosphorylation. The N-terminal 25-30 residues of RP2 are essential for the 
interaction with ARL3, and Y27 in particular is engaged in hydrophilic interactions 
with Q156 and D168 of the small GTPase (Veltel et al. 2008). Not surprisingly, Y27 
is strictly conserved among vertebrates according to conservation analysis of diverse 
RP2 orthologues (conducted by Dr Dinesh Soares, Figure 3.5B). The identification 
of this particular tyrosine as a site of phosphorylation by c-SRC is further evidence 
that phosphorylation is a critical mechanism of functional regulation of RP2. It is 
also worth commenting on the phosphorylation of S28 which was also identified in 
the MS analysis to occur after SRC overexpression. The relationship between c-SRC 
activity and phosphorylation of S28 is not known, but it might be a case of 
“priming”; in other words, previous phosphorylation of RP2 by another kinase might 
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be required for the ultimate phosphorylation at Y27 (Ubersax and Ferrell 2007) or 
vice versa. Whether this is true will require separate investigation.  
Because overexpressing c-SRC can lead to off-target phosphorylation of substrates 
and might not reflect the endogenous activity of the kinase, I chose to examine 
phosphorylation of RP2-V5 by endogenous kinases. In order to confirm if Y27 is a 
phosphorylation site on RP2, I compared the phosphorylation status of WT RP2-V5 
and the non-phosphorylatable mutant Y27F in HEK293T cells. Since the Y27F 
mutant is expressed at the same levels as the WT protein (Figure 3.5C, inputs), the 
overall stability of the protein does not seem to be affected by the mutation. In figure 
3.5C, a tyrosine phosphorylated band can be seen corresponding to the molecular 
weight of RP2-V5 in both the WT- and Y27F-transfected cells. This result suggests 
that Y27 is not a site of endogenous phosphorylation in HEK293T cells, or that other 
phosphorylation sites also exist on the protein that mask any reduction in Y27 
phosphorylation. Figure 3.6B contains a list of residues on RP2 that are 
computationally predicted to be phosphorylated by SRC-family kinases using the 
GPS 3.0 prediction software operating on a medium threshold value of 9% FPR 
(false positive rate) for each kinase (Xue et al. 2008, Xue et al. 2011). Among them, 
Y27, Y198 and Y40 are strong candidates as they are both computationally predicted 
and experimentally identified as sites of phosphorylation in human cells 
(PhosphoSite Plus database). All candidate tyrosine residues are surface exposed and 
thus appropriate candidates for phosphorylation (Figure 3.6C).   
Incomplete coverage of the protein during the MS/MS analysis is one of the reasons 
that other tyrosine phosphorylation sites were not identified on RP2. As shown in 
Appendix figure 2, predicted phosphorylation sites such as Y198 and Y245 (Figure 
3.6A) are not contained in any of the six unique RP2 peptides identified in the 
MS/MS experiment. Phosphorylation of Y245, for example, would be particularly 
interesting to study both because this peptide has been identified before as important 
for the RP2-OSTF1 interaction (Figure 3.2A) but also because its phosphorylation 
has been detected before in a large-scale study of tyrosine phosphorylation in gastric 
carcinoma cells (Moritz et al. 2010). The sequence coverage of RP2 can be improved 
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in the future by combining the use of trypsin with alternative proteases during the 
digestion step of the MS workflow.    
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Figure 3.5. Y27 is a potential phosphorylation site on RP2, but is not the only 
site of endogenous phosphorylation in HEK293T cells.  
A) Affinity purification of RP2-V5 from HEK293T cells followed by tandem mass 
spectrometry (MS/MS) was conducted in order to identify sites of tyrosine 
phosphorylation when the protein is co-expressed with c-SRC-GFP. Extracted ion 
chromatograms from one repeat of the experiment show the identification of Y27 as 
a phosphorylation site only in the RP2-V5/SRC-GFP transfected HEK293T cells but 
not in the RP2-V5/GFP transfected cells or the empty vector negative control. B) 
Section of multiple sequence alignment of vertebrate RP2 orthologues, 
encompassing the Y27 residue. The conservation status of each residue is shown in 
colour code (red= strictly conserved, yellow= largely conserved/conservatively 
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substituted, white=non-conserved). Y27 is strictly conserved among vertebrates. 
(analysis conducted by Dr Dinesh Soares) C) RP2 WT-V5 and RP2 Y27F-V5 were 
immunoprecipitated from lysates of cells transfected with the respective constructs 
using anti-V5 antibody conjugated agarose beads. Cells transfected with an empty 
destination vector were used as negative control. The IPs as well as the lysates before 
IP (inputs) were subjected to SDS-PAGE and western blotting using anti-
phosphorylated tyrosine antibody. The WT and Y27F proteins are equally 
phosphorylated, suggesting that Y27 is not a site of endogenous phosphorylation in 
HEK293T cells or that other phosphorylated tyrosines mask any reduction in Y27 
phosphorylation. Subsequent re-probing with an anti-V5 antibody confirms the 
presence of an RP2-V5 band at the same molecular weight as the phosphorylated 
















Figure 3.6.  Tyrosine residues on RP2 that are good candidates for 
phosphorylation.  
A) List of phosphorylated residues on human RP2 that have been identified by large-
scale phosphoproteomics (Source: Phosphosite Plus database). Asterisks denote the 
corresponding human residues, when the phosphorylation site has originally been 
identified in mouse. Both Y27 and S28, the residues which were identified by mass 
spectrometry to be phosphorylated after c-SRC overexpression, are in the list of 
known phosphorylation sites on RP2. B) List of RP2 tyrosine residues which are 
predicted to be sites of phosphorylation by SRC-family kinases. Predictions were 
generated by the GPS 3.0 software using medium threshold (=9% False positive rate) 
(Xue et al. 2011). A “score” value is given to each prediction that should be 
compared to an individual “cut-off” value to get an idea of the strength of the 
prediction. Score values were given to the prediction that a site is phosphorylated by 
SRC-family kinases in general but also by individual kinases. C) Surface 
representation of RP2 3D structure cartoons (PDB ID: 2BX6) showing the position 
of RP2 tyrosine residues which were either identified experimentally by large-scale 
studies (Y40, Y198, Y245) or computationally predicted as possible sites of c-SRC 
mediated phosphorylation (Y341). Arrows point to the relevant tyrosine residues 
which are marked in pink colour. Surface exposed residues are shown in blue, while 
buried residues are white. Y27 is not visible because it belongs to an intrinsically 
disordered region which was not solved in the crystal structure (Kuhnel et al. 2006).  
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3.2.2.2 Overexpression of c-SRC does not markedly affect binding of 
RP2 to its interaction partners 
The identification of Y27, an important residue for the interaction with the small 
GTPase ARL3, as a potential phosphorylation site on RP2 further supports the 
hypothesis that this modification plays a role in the regulation of protein-protein 
interactions between RP2 and its binding partners. To examine this hypothesis, I 
conducted pulldowns using recombinant GST-OSTF1 and GST-ARL3 Q71L as bait 
and RP2-V5 transiently expressed in HEK293T cells as prey. I used the ability of c-
SRC overexpression to induce RP2 tyrosine phosphorylation and compared the 
amount of RP2-V5 that co-precipitated with the GST-tagged proteins between three 
different conditions, namely co-expression of GFP alone (using an inactive SRC 
mutant would be a better negative control than GFP alone), WT c-SRC-GFP or the 
constitutively active mutant of c-SRC, 527F. As shown in Figure 3.7A, 
overexpression of 527F c-SRC mildly enhances binding of RP2-V5 to its interaction 
partners, but this effect is not statistically significant for any of the pulldowns (Figure 
3.7B). Taking into account the small sample size and the small observed differences, 
it appears that if RP2 phosphorylation affects binding to its interaction partners, this 
must be a very mild effect. However, a mild effect can still have an important 
biological function, especially when it comes to finely tuning the regulation of a 
GTPase. In order to confirm this finding by enhancing endogenous RP2 
phosphorylation, the pulldown assays must be repeated after pre-treatment of the 
cells with tyrosine phosphatase inhibitors versus mock-treated cells. It must be noted 
that, while this method is indicative of a crude-qualitative effect of phosphorylation 
on the interactions of RP2, it is not quantitative because it does not provide 
information on what fraction of total RP2 is phosphorylated in vivo. If the 
stoichiometry of RP2 phosphorylation is low, this might explain why a bigger effect 




Figure 3.7. Overexpression of c-SRC mildly stabilises the binding of RP2 to 
ARL3.  
A) To determine if tyrosine phosphorylation of RP2 affects binding to its interaction 
partners, recombinant GST-OSTF1 and GST-ARL3 Q71L were used as baits to 
pulldown RP2-V5 from HEK293Tcells transiently co-transfected with RP2-V5/GFP, 
RP2-V5/c-SRC-GFP, or RP2-V5/c-SRC 527F-GFP (the constitutively active mutant 
of c-SRC). SDS-PAGE and western blotting analysis with anti-V5 antibody was used 
to approximate the amount of RP2-V5 found in the cell lysates (inputs) and bound to 
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the bait proteins. Ponceau staining was used to visualise the GST-tagged protein 
bands. B) Relative quantification of the RP2-V5 abundance between pulldown 
samples (mean +/- S.E.M n=3 densitometry measurements on 3 separate 
immunoblots normalised to the inputs). Two-tailed one-sample t-test was used to 
assess the significance of the observed differences between c-SRC-transfected 
samples compared to the RP2-V5/GFP sample, whose value was set to 100. P-values 
for GST-OSTF1 pulldowns: RP2-V5/GFP compared to RP2-V5/ c-SRC-GFP: 
0.3611, RP2-V5/GFP compared to RP2-V5/ c-SRC 527F-GFP: 0.1092. P-values for 
GST-ARL3 Q71L pulldowns: RP2-V5/GFP compared to RP2-V5/ c-SRC-GFP: 
0.5836, RP2-V5/GFP compared to RP2-V5/ c-SRC 527F-GFP: 0.2239. 
 
3.2.2.3 Total tyrosine phosphorylation of RP2 is not due to OSTF1-
mediated phosphorylation by c-SRC  
The next point of my hypothesis that I wanted to test is whether OSTF1 acts as an 
adaptor for bringing RP2 and its kinase to the same complex and if, therefore, it is 
necessary for RP2 phosphorylation to occur. For this purpose, I decided to test if the 
RP2 mutants that I previously identified as deficient in interacting with OSTF1 
(Y245A, Y245E) can still be tyrosine phosphorylated. In Figure 3.8, a tyrosine 
phosphorylated band can be seen corresponding to the molecular weight of RP2-V5 
in IPs from both the WT and the Y245A/E-transfected cells. In conclusion, 
interaction with OSTF1 is not an essential prerequisite for the endogenous tyrosine 




Figure 3.8. Binding to OSTF1 is not essential for the endogenous 
phosphorylation of RP2 in HEK293T cells.  
In order to test the hypothesis that OSTF1 acts as an adaptor protein which facilitates 
the phosphorylation of RP2 by c-SRC, I examined the phosphorylation status of RP2 
Y245A- and Y245E-V5 mutants, which do not interact with OSTF1, as shown in 
Chapter 3.2.1. RP2 WT, Y245A and Y245E-V5 were immunoprecipitated from 
lysates of cells transfected with the respective constructs using anti-V5 antibody 
conjugated agarose beads. Cells transfected with an empty destination vector were 
used as negative control. The IPs were subjected to SDS-PAGE and western blotting 
using anti-phosphorylated tyrosine antibody. An anti-mouse IgG (kappa light chain) 
HRP-conjugated secondary antibody was used for the visualisation of the 
phosphorylated bands. The WT and Y245A, E RP2 proteins are equally 
phosphorylated, leading to the conclusion that interaction with OSTF1 is not 
essential for phosphorylation of RP2 to occur in HEK293T cells. Subsequent re-
probing with an anti-V5 antibody confirms the presence of an RP2-V5 band at the 
same molecular weight as the phosphorylated band in the transfected lysates. 
 
Finally, I wanted to examine if endogenous c-SRC activity is linked to tyrosine 
phosphorylation of RP2 that is observed in HEK293T cells. To achieve this, I treated 
HEK293T cells with the novel small molecule inhibitor of c-SRC, eCF506 (Fraser et 
al. 2016). This compound is known to inhibit c-SRC and its related kinase YES and, 
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to a lesser extent, FYN at subnanomolar levels in vitro and displays exceptional 
specificity (3 orders of magnitude) against c-Abl. Inhibition of c-SRC kinase activity 
was confirmed by western blot against phospho-Y416 SRC, the residue where c-SRC 
is autophosphorylated upon activation. HEK293T cells were transfected with RP2-
V5 or empty vector and treated for 1 hr before lysis with DMSO, 100 and 200 nM of 
the inhibitor (higher concentrations caused complete detachment of the cells from the 
substrate). 100 and 200 nM treatment caused Y416 phosphorylation on SRC to drop 
50% and ~100%, respectively. However, treatment did not have any effect on RP2 
tyrosine phosphorylation (Figure 3.9). This experiment suggests that SRC is not the 




Figure 3.9. Phosphorylation of RP2-V5 in HEK293Tcells is not dependent on 
endogenous c-SRC activity.  
In order to determine if c-SRC is indeed responsible for phosphorylating RP2 
endogenously, the phosphorylation status of RP2-V5 was tested in HEK293Tcells 
that were treated with DMSO only or the novel small molecule inhibitor of c-SRC, 
eCF506. To detect phosphorylation, RP2-V5 was immunoprecipitated from the 
transiently transfected cells’ lysates using anti-V5 antibody conjugated agarose 
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beads. The IPs as well as the lysates before IP (inputs) were subjected to SDS-PAGE 
and western blotting using anti-phosphorylated tyrosine antibody. Cells transfected 
with an empty destination vector were used as negative control (NC). This approach 
shows that phosphorylation of RP2-V5 is not reduced when the cells are treated with 
the c-SRC inhibitor. Subsequent re-probing with an anti-V5 antibody confirms the 
presence of a band corresponding to RP2-V5 at the same molecular weight as the 
phosphorylated band. The inputs were also probed with an antibody against Y416-
phosphorylated c-SRC to show that the kinase activity is indeed affected by the 
inhibitor (Y416 is a site for activating auto-phosphorylation of the kinase).  
 
3.2.3 RPE1 cells lacking RP2 expression are less motile 
Two studies have previously identified OSTF1 as an important regulator of cell 
motility in cancer cell lines. According to Tanimura and colleagues (Tanimura et al. 
2011), OSTF1 exerts a negative effect on cell motility which is counteracted by 
phosphorylation by p90 ribosomal S6 kinase (RSK1) under command of the ERK1/2 
signalling pathway downstream of Ras. Indeed, overexpression of OSTF1 in HeLa 
cells where the ERK pathway is not constitutively active attenuates cell motility, 
while knockdown of OSTF1 by RNAi has the opposite effect. This role of OSTF1 is 
attributed to its direct interaction with MYO1E, a long-tail type I Myosin, whose 
intracellular localisation is regulated by OSTF1 in an ERK pathway-dependent 
manner. In particular, OSTF1 functions as a “cytoplasmic anchor” for MYO1E and 
thus prevents it from localising to sites of actin nucleation in lamellipodia, which is 
essential for their proper formation and for cell motility to occur (Tanimura et al. 
2016).  
The emergence of these studies led me to examine if the RP2-OSTF1 complex also 
has a role in cell motility regulation. To achieve this, I performed migration assays 
on hTERT-RPE1 clonal cell lines that were engineered to be genomic RP2 null by 
Dr Toby Hurd using the CRISPR/ Cas9 method (Table 3.2). Initially, I characterised 
the cell lines as shown in Figure 3.10. Two lines (G, I) were selected for analysis 
because they were proved to completely lack expression of RP2 both by western blot 
and real-time qPCR using β-actin as the loading control and reference gene 
accordingly. qPCR experiments were performed by Cora Harrison under my 
supervision as part of her Honours thesis. The levels of endogenous ARL3 GTPase, 
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the most well known interaction partner of RP2, were unchanged in the RP2 null 
cells. In order to examine if they cell lines grow normally, I generated growth curves 
by counting the number of cells in 6-well plates at different time-points. This 
experiment showed that the G line grows slower than the parental WT cells. 
However, because this defect was not observed in the I line, it is not considered a 
specific phenotype caused by the absence of RP2, but rather a product of clonal 
















Table 3.2. Deleterious mutations in the RP2 gene found in the RPE1 clones that 
are used in this study.  
G, I clones are both homozygous for 2-bp deletions, as identified by Sanger 
sequencing of a PCR product encompassing the targeted sequence of RP2 exon 2.  
The deletions are predicted to result in premature stop codons and nonsense mediated 







G 2 bp deletion CCACTCAACCCATCATTGAGTCTTCCTCAAATATCAA
A--TGGATGTTTTCAATG 
F145Wfs8x 






Figure 3.10. G and I CRISPR clones lack RP2 expression but this is not 
responsible for the growth defect observed in clone G.  
A, B) Lack of RP2 expression was confirmed in the hTERT-RPE1 clones that I use 
in this study by western blotting and real-time qPCR. A) Lysates from wild-type, G 
and I clones were subjected to SDS-PAGE and western blotting using anti-RP2, anti-
ARL3 and anti-β actin (loading control) antibodies. B) mRNA was extracted from 
WT parental, G and I RPE1 cells and was used to generate cDNA to serve as 
template for real-time qPCR. RP2 transcript levels (normalised to ACTB1 transcript 
levels) are greatly reduced in cells from the G and I clones that are homozygous for 
2-bp deletions in the RP2 gene, compared to WT cells. This reduction implies that 
nonsense mediated decay of the transcripts is taking place (error bars correspond to 
S.E.M. from 3 biological repeats of the real-time qPCR experiment, p<0.0001 for 
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WT vs I and p=0.0009 for WT vs G according to one-sample two-tailed t- test2). 
Au=arbitrary units. qPCR experiments were conducted by Cora Harrison under my 
supervision as part of her Neuroscience Honours thesis C) Growth rate of parental 
WT, G and I RPE1 cells was estimated in culture by counting the number of cells at 
different time points (error bars correspond to SEM from 3 technical repeats).  
 
In order to examine the role of RP2 in cell motility regulation, I compared the 
motility of WT parental RPE1 cells to the RP2 null RPE1 lines G and I in a random 
migration assay and a wound healing assay. The random migration assay involves 
recording the movement of individual sparsely plated cells that are not contact-
inhibited, in response to local gradients of growth factors contained in the serum-
supplemented growth medium. As shown in Figure 3.11A, RP2 null cells cover 
smaller distance compared to WT cells over the same time frame. The difference 
seems more pronounced when quantifying the absolute migration distance (defined 
as the distance between starting and ending point), implying that RP2 null cells are 
defective in directional migration compared to the WT cells. In addition, while the 
WT RPE1 cells appear to form well-defined lamellipodia, cells that lack RP2 are 
rounder in shape. On the other hand, the wound healing assay is performed on cells 
that form a confluent monolayer and are therefore contact-inhibited. Inducing a 
scratch wound on the monolayer activates the cells that are on the edges and causes 
them to move towards the centre of the wound in order to populate it. As shown in 
Figure 3.11B, cells that lack RP2 expression cover smaller area in the wound 
compared to WT cells at the same time-points. Taken together, these assays suggest 
that RP2 is also involved in the regulation of cell motility like its binding partner, 
OSTF1. Both the RP2 null cell lines are defective in cell migration compared to the 
WT cells, but they also display remarkably different behaviour between them, which 
can be attributed again to the effect of clonal variations like for example the presence 
of modifiers of the phenotype. Clonal variation is a potential problem because each 
RP2 null cell line was grown from a single cell with a specific deleterious mutation. 
While examining two different lines (G, I) partially circumvents this problem, the 
                                               
2 Mean reduction of transcript levels between WT and mutant lines: 91.5% and 94% 
for G and I lines respectively, with 95% confidence intervals: 103.6% to 79.4% and 
97.8% to 90.3% for G and I lines respectively.  
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experiment would benefit from the use of better control lines. For example, clonal 
cell lines that have undergone the CRISPR procedure but display RP2 expression at 
WT levels, either because they have retained the WT RP2 sequence or because they 
encompass silent mutations, could be used for comparison in the place of the parental 
WT cell line.  
It must also be noted that RP2 seems to have an opposite role to OSTF1 in the 
regulation of cell motility; it can be suggested, therefore, that RP2 is a positive 
regulator of cell motility. More studies are needed to characterise the phenotype and 
pinpoint exactly what the role of RP2 is in the process.  
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Figure 3.11. RP2 knockout leads to migration defects in RPE1 cells.  
A) Parental WT RPE1 and two clones (G,I) of RP2 null RPE1 cells were sparsely 
plated and random migration of individual cells was analysed over a 24-hr period. 
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Top panels show representative tracks followed by individual cells (during a 9-hr 
period) as coloured lines. Cells lacking RP2 tend to move in circles rather than 
towards a specific direction and cover less distance than WT cells. The graph on the 
left shows distance covered by individual cells over a 9 hr period in µm (mean +/- 
SEM for 40 cells from 4 technical repeats. P= 0.0006 for G vs WT, P<0.0001 for I vs 
WT as calculated by two-tailed t-test and two-tailed t-test with Welch’s correction, 
respectively3). The graph on the right shows absolute distance (distance between 
starting and ending point) covered by individual cells over a 9 hr period in µm (mean 
+/- SEM for 40 cells from 4 technical repeats. P<0.0001 for G vs WT and I vs WT as 
calculated by Mann-Whitney test). B) Parental WT RPE1 and two clones (G, I) of 
RP2 null RPE1 cells were subjected to a wound healing assay. Images on the left 
show the wound across three different time-points. Yellow represents the wound area 
and purple is the area covered by migrating cells. The graph on the right represents 
the wound surface that was covered by migrating cells 10 hrs after the scratch was 
introduced (mean +/- SEM for 6 technical repeats. P=0.0103 for I vs WT, p<0.0001 
for G vs WT as calculated by two-tailed t-tests4).  
 
3.3 Discussion 
3.3.1 Mapping the OSTF1 interaction interface on RP2: conclusions 
In this chapter, I characterised the recently identified protein-protein interaction 
between RP2 and OSTF1. By mapping the interaction interface between the two 
proteins on a patch of RP2 that is strictly conserved among vertebrates, I showed that 
OSTF1 is a specific interaction partner of RP2 whose function may underlie the 
etiology of retinal degeneration caused by mutations in the RP2 gene. Therefore, 
studying the role of the complex is important and could provide the scientific 
community with novel ways of therapeutic intervention for Retinitis pigmentosa type 
2. For example, it is worth noting that peptoid inhibitors were recently designed 
which display high affinity for the SH3 domain of human OSTF1 (Han et al. 2016), 
                                               
3 Mean difference in distance covered by WT vs mutant cells: 96.6 µm and 175.6 µm 
for G and I lines, respectively, with 95% confidence intervals: 148.6 to 44.5 µm and 
219.1 to 132.0 µm for G and I lines, respectively.  
4 Mean difference in percentage of wound area covered by WT vs mutant cells: 
21.3% and 6.5 % for G and I lines, respectively, with 95% confidence intervals: 




the domain which mediates the interaction with c-SRC and SMN (Szymkiewicz et al. 
2004, Kurihara et al. 2001). In the future, mapping of the RP2 binding interface on 
OSTF1 will provide a complete structural profile of the interaction and will help 
investigate if the SH3 domain is important. Importantly, the present study is one of 
the first to suggest a function for the C-terminal domain of RP2, namely to provide a 
binding interface for the interaction with OSTF1. The other such study was by (Yoon 
et al. 2006), who suggested that RP2 has exonuclease activity via its C-terminus.  
 
3.3.2. RP2 tyrosine phosphorylation analysis: conclusions 
To identify the function of the RP2-OSTF1 interaction, I formed two hypotheses 
based on previous evidence about the protein complexes that OSTF1 participates in. 
Initially, I investigated if OSTF1 is an adaptor for the c-SRC mediated tyrosine 
phosphorylation of RP2. In particular, I hypothesised that OSTF1, which has been 
suggested before to be an adaptor for SRC’s functions, might act as a “scaffold” for 
the phosphorylation of RP2. Binding of OSTF1 to the SH3 domain could activate the 
kinase by inducing phosphorylation of Y416 and lifting of the activation loop 
(Ubersax and Ferrell 2007). I used in vitro methods (kinase assay) and MS analysis 
to support the suggestion that c-SRC directly phosphorylates RP2 at Y27. Because 
this tyrosine residue directly participates in the interaction between RP2 and ARL3, 
one of the ramifications of this finding is the possibility that phosphorylation serves 
to regulate the protein-protein interactions of RP2. However, site-specific 
mutagenesis and western blotting showed that the non-phosphorylatable Y27F 
mutation does not alter total tyrosine phosphorylation levels on RP2 in HEK293T 
cells. This suggests that there are other phosphorylatable tyrosine residues on RP2 
which might mask Y27 phosphorylation. To confirm Y27 phosphorylation, the 
specificity of detection can be enhanced by the development of a phospho-specific 
antibody against phosphorylated Y27, instead of the generic anti-phosphotyrosine 
antibody. Finally, a different method, such as two-dimensional phosphopeptide 
mapping (Nagahara 2016), could be used to investigate if there are other 
phosphorylated tyrosines on RP2.  
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Despite the initial findings, further analysis of endogenous RP2 phosphorylation 
after treatment of HEK293T cells with a highly specific SRC inhibitor shows that c-
SRC may not be the endogenous tyrosine kinase that phosphorylates RP2. The 
responsible kinase could be identified in the future by screening a library of known 
tyrosine kinase inhibitors for any effect on RP2 phosphorylation. However, the 
hypothesis that c-SRC phosphorylates RP2 in vivo should not be entirely rejected 
based on the present study, but should be investigated further using different 
experimental methods. First of all, c-SRC may be only partly responsible for the total 
tyrosine phosphorylation of RP2 and other kinases might be involved which could 
have masked any reduction in total tyrosine phosphorylation after treatment with c-
SRC inhibitors. For this reason, the development of a phospho-specific antibody is 
again the way forward. Secondly, I had to rely on HEK293T that display very high 
transfection efficiency, as the low level of RP2 tyrosine phosphorylation meant that I 
did not manage to detect it in a cell line that is more physiologically relevant to the 
retina (such as RPE1 cells or 661W mouse cone retinoblastoma cells). Therefore, it 
is possible that I failed to detect c-SRC-mediated phosphorylation of RP2 because it 
is tissue- and cell line- specific. After all, c-SRC is known to participate in various 
retinal-specific processes: it has been reported to co-localise with rhodopsin at the 
cell body and the outer segment of photoreceptors and is linked to phosphorylation 
of phototransduction proteins (Ghalayini et al. 2002, Berta et al. 2011); c-SRC 
activity has also been associated with health and pathogenesis of the RPE (Rohrer et 
al. 2014, Law et al. 2009). Moreover, phosphorylation of RP2 by c-SRC might occur 
in a cilia-dependent manner. Ectopic c-SRC activity during G1 inhibits ciliogenesis, 
possibly via local regulation of actin polymerisation (Bershteyn et al. 2010). Finally, 
it is possible that RP2 phosphorylation by c-SRC is found downstream of specific 
signalling pathways and might need to be stimulated. In a recent large-scale study of 
the human phosphoproteome, tyrosine phosphorylation was found at exceptionally 
low stoichiometric levels in the absence of specific signalling events (Sharma et al. 
2014). As a conclusion, it might be necessary to use a different cell line and 
stimulate c-SRC activity in order to detect c-SRC-dependent endogenous 
phosphorylation of RP2.  
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3.3.3 A potential role for RP2 in cell motility regulation 
In the last part of the chapter, I find that RP2 might play a role in cell motility 
regulation, similarly to its interaction partner OSTF1. In particular, it seems that RP2 
is a positive regulator of cell motility, while the opposite is true for OSTF1. Future 
work will characterise this phenomenon in more detail and must focus on the exact 
molecular pathways that regulate the role of RP2 in cell motility. Because OSTF1 
exerts its negative effect on cell motility via its interaction with MYO1E, which 
OSTF1 prevents from associating with F-actin at sites of actin nucleation (Tanimura 
et al. 2016), future experiments could begin by investigating if RP2 also associates 
with MYO1E or if it competes with MYO1E for binding to OSTF1, which would 
explain the positive effect it has on cell migration. Site-directed mutagenesis and 
deletion approaches can be used for the identification of the exact domains on 
OSTF1 that interact with RP2. This approach could help investigate if they overlap 
with MYO1E’s binding sites. Another interesting area of study that I would like to 
investigate in the future is the role of ARL3 in cell motility regulation. It is already 
known that knockdown of ARL3 reduces cell motility in HeLa cells and this is 
associated with STAT3-mediated signalling (Togi et al. 2016). Moreover,  (Wright et 
al. 2016) have linked overexpression of constitutively active ARL3 (Q71L mutant) 
with defective migration of rod photoreceptors to the ONL during early post-natal 
development.  
A point that is important to elucidate in future experiments is the relationship 
between cell motility and retinal degeneration. For my experiments, I used 
immortalised human retinal pigment epithelial cells (hTERT-RPE1), which are 
behaving as migratory cells in cell culture. The RPE are known to have a strong 
interdependence with the photoreceptors and other layers of the retina. Many forms 
of RP arise from RPE genes such as RPE65 or MERTK which affect the visual cycle 
and OS phagocytosis, respectively. Moreover, progressive degeneration of RPE cells 
play a central role in the development of age-related macular degeneration (Nowak 
2006). However, it is important to stress that RPE should not behave as migratory 
cells in vivo. In fact, cell transformation of the RPE, a phenomenon when they regain 
their proliferative and migratory capacity, leads to loss of contact with the 
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photoreceptors and the adjacent RPE, retinal detachment and proliferative 
retinopathies such as proliferative vitreoretinopathy (PVR) (Ruiz-Loredo and Lopez-
Colome 2012).  
On the other hand, a dynamically regulated acto-myosin cytoskeleton is a 
prerequisite for many of the function of the RPE in vivo (Ruiz-Loredo and Lopez-
Colome 2012). Several myosin classes are expressed in the RPE, including I, II, III, 
V, VI, VII, IX and X. Some of them are associated with important RPE functions, 
such as phagocytosis (Myosin II, Myosin Va, Myosin VIIa which is mutated in 
Usher syndrome (Kevany and Palczewski 2010)), vesicular trafficking (Myosin VI) 
(Kitamoto et al. 2005) and melanosome aggregation (Myosin II) (Barsoum and King-
Smith 2007). The function of class I Myosins in the RPE and the retina in general is 
unknown and should be a focus of future studies.  
To find out if the RP2-OSTF1 complex has a role in retinal biology, it is important to 
investigate if the two proteins are co-expressed in the retina. Data from our group 
concerning expression analysis in mouse tissues based on β-gal staining suggest that 
OSTF1 is expressed in the RPE but not the photoreceptor layer in mice (Vermeren et 
al. 2017). Preliminary expression analysis by western blotting in various mouse 
tissues of the central nervous system (Appendix figure 3) suggests that OSTF1 and 
RP2 are both expressed in the RPE. This finding is preliminary and requires further 
corroboration by more detailed experiments that will examine OSTF1 expression in 
the retina, such as in situ hybridisation and immunostaining for the endogenous 
protein on retinal sections. Based on the data that is available so far, I hypothesise 
that OSTF1 is a negative regulator of cell motility processes in the RPE. OSTF1-
mediated regulation of cytoskeletal processes might serve to prevent RPE migration, 
an unwanted effect of cell transformation that is related to retinal detachment and  
other diseases, as mentioned above (Ruiz-Loredo and Lopez-Colome 2012). 
Alternatively, the regulatory activity of OSTF1 might be required for other motility-
related RPE functions, such as the extension of motile processes into the 
photoreceptor OS layer, or their phagocytic activity. These possibilities are discussed 
further in the next paragraph.  
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Therefore, it is suggested here that, while previous research on X-linked RP has 
focused almost entirely on the photoreceptors, future research should carefully 
examine any potential involvement of the RPE in the pathogenesis of RP type 2. An 
RPE-related process that requires extensive cytoskeletal reorganisation that could be 
reflected in the cell motility defect that I observed in vitro is the daily phagocytosis 
of shed photoreceptor OS. In order to assess if the loss of RP2 function leads to 
phagocytosis defects, I suggest that purified RPE cells from animal models of RP 
type 2 should be used in future experiments including phagocytosis assays of OS.  
Furthermore, another interesting aspect of cell motility in the retina are the apical 
microvilli that the RPE cells project into the interphotoreceptor matrix. These 
projections, which interact with the OS tips, are reported to be motile (Bonilha 2014) 
and to contain a filamentous actin core as well as several types of myosins and other 
actin-associated proteins (Gu et al. 2012). Because the RPE microvilli are thought to 
mediate key processes such as visual pigment transport and regeneration, transport of 
nutrients to the photoreceptors and removal of waste (Bonilha 2014), it would be 
interesting to study them in relation to RP type 2.  
In order to determine whether the death of photoreceptors in X-linked RP is due to 
intrinsic (cell-autonomous) defects or is caused by a dysfunction of neighbouring 
cells such as the RPE, the mosaic analysis method can be used which relies on the 
use of zebrafish as in vivo model. According to this method, zebrafish with chimeric 
retinae can be generated via the transplantation of dextran-labelled blastomeres from 
a donor to a host embryo (WT donor to mutant host or the opposite). It has been 
shown that a fraction of donor blastomeres will then contribute to the retinal 
neuroepithelium (Tsujikawa and Malicki 2004a, Pujic and Malicki 2001, Goldsmith, 
Baier and Harris 2003). It can thus be examined whether mutant photoreceptors 
surrounded by WT RPE can be rescued from degeneration, or, conversely, whether 
WT photoreceptors degenerate when their environment is composed of mutant RPE. 
Chapter 5 of the present thesis is dedicated to the generation and characterisation of 
rp2 null zebrafish lines generated using the CRISPR/Cas9 method, which would 
provide ideal platforms to apply the mosaic analysis method. 
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3.3.4 A potential role for RP2 in cell death 
If it is proved that the death of photoreceptors in RP type 2 is not a secondary effect 
of defects in other cell types, the hypothesis can be formed that RP2 mutations 
directly affect cell death pathways. In Figure 3.10C, it was shown that the growth 
rate of the G RP2 null line is slower than the WT parental cells. Although this 
observation might not be due to loss of RP2 function but simply represent a result of 
clonal variation, it must be investigated in the future if RP2 mutations lead to 
increased cell death. This can be tested directly on retinal sections of RP2 knockout 
animal models by TUNEL assay or acridine orange staining, showing DNA 
fragmentation and apoptotic cells, respectively. In addition, immunostaining for cell 
death markers, either apoptosis-specific or encompassing different cell death 
pathways (e.g. cleaved Caspase 3 or Annexin V) (Galluzzi et al. 2009) can be used 
on the RP2 null RPE cell lines that I have described.  
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Chapter 4: Characterisation of the interaction 
between RP2 and DNA PKcs and implications for 
DNA damage repair in the retina 
4.1 Introduction 
One of the prominent methods for discovering novel biological roles for a protein is 
the identification of novel interaction partners. In chapter 3, I referred to the LC/MS-
MS analysis we conducted aiming to identify phosphorylation sites on 
immunoprecipitated V5-tagged RP2. Apart from this original purpose, my 
experiment had the additional benefit of providing information about the interactome 
of RP2 when transiently expressed in HEK293T cells. In the present chapter, I will 
present the proteomic analysis of the MS results from three independent biological 
replicates. Among the proteins that were significantly enriched in the RP2-V5 IPs 
compared to the negative controls, there is an enzyme which plays a central role in 
numerous processes important for neuronal maintenance in general and retinal 
viability in particular: the catalytic subunit of the DNA damage repair (DDR) 
enzyme, DNA-dependent protein kinase (DNA PKcs, product of the PRKDC gene). 
 
4.1.1 The importance of DDR mechanisms for retinal development and 
viability 
DDR mechanisms are core components of all cells’ survival strategies. As shown in 
Table 4.1, different molecular pathways are employed to repair different types of 
DNA lesions. Among them, DNA double-stranded breaks (DSBs) are the most 
severe insults to DNA. They can be caused by ionising radiation (IR), chemical 
agents, oxidative stress or during DNA replication. Importantly, “programmed 
DSBs” are also introduced in eukaryotic organisms during physiological processes 
such as meiosis and development of the immune system. DSBs affect chromatin 
structure and will lead to cell death or trigger genomic instability and cancer if left 
unrepaired (Jackson and Bartek 2009). Moreover, selective generation of DSBs has 
been observed during neural development, and is linked to the early phase of 
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programmed cell death that occurs physiologically in the developing nervous system 
(Boya and de la Rosa 2005). For example, correct function of the DSB repair 
machinery and DNA PKcs is essential for the survival of young neurons in the 
developing mouse retina. It is worth noting that DNA PKcs has a specific role in this 
process which is not shared with other kinases of the same family that also 
participate in DSB repair, such as ataxia telangiectasia mutated (ATM) kinase 
(Baleriola, Suarez and de la Rosa 2010).  
The mature retinal photoreceptors and the retinal pigment epithelium (RPE) have 
extremely stringent requirements for efficient DNA repair mechanisms due to their 
susceptibility to oxidative stress, which is not only damaging DNA and other 
biomolecules, but is also the main mediator of light-induced photoreceptor death 
(Cortina et al. 2003, Gordon et al. 2016, Gordon et al. 2002). One of the reasons for 
this vulnerability is the extremely high lipid content of the photoreceptor outer 
segment (OS) compared to other tissues. In particular, polyunsaturated fatty acids 
(PUFAs) are readily oxidised to highly reactive compounds that initiate free radical 
chain reactions. In addition, reactive oxygen and nitrogen species (RONs) are 
produced by the activation of photosensitising molecules and by-products of the 
visual cycle (Wright et al. 2010). Therefore, it is not surprising that Retinitis 
pigmentosa (RP) is one of the clinical features of DNA damage-related conditions 
Cockayne syndrome and xeroderma pigmentosum, which stem from impaired repair 
of UV-induced DNA damage and oxidative lesions, mostly due to defects in 
enzymes of the nucleotide excision repair (NER) pathway (Ramkumar et al. 2011, 
Brooks et al. 2013, Gorgels et al. 2007).  
The link between retinal degeneration and defective DNA damage repair has not 
been extensively studied. However, reports have accumulated recently that link 
retinal degeneration and ciliopathies in general to DDR protein components. For 
example, mutations in the gene encoding for the centrosomal protein Cep164 have 
been identified in patients with retinal degeneration and other Nephronophthisis 
(NPHP)-related ciliopathies (Chaki et al. 2012); Cep164 co-localises with DDR 
proteins in nuclear foci upon UV irradiation and interacts with ATM and ATM- and 
Rad3-related (ATR) kinases, which are key DDR signalling mediators, and XPA 
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which is a core component of the NER pathway (Sivasubramaniam et al. 2008, Pan 
and Lee 2009). SDCCGA8 is another protein that was recently linked to NPHP and 
retinal degeneration in patients suffering from syndromes of the Bardet-Biedl 
spectrum (Otto et al. 2010). Renal degeneration in the Sdccga8 gene trap mouse 
model is underlined by increased DDR signalling activity and hyperactivation of 
γH2AX, a chromatin marker of DNA damage; the protein itself has been related to 
replication stress and cell cycle progression through the S-phase (Airik et al. 2014). 
Furthermore, (Valdes-Sanchez et al. 2013) report the existence of severe retinal 
degeneration in a mouse model of Seckel syndrome harboring a humanized 
pathogenic mutation in the gene encoding for ATR kinase, a DNA damage sensor 
protein which is activated by replication stress. Nevertheless, the authors of the study 
suggest that the retinal phenotype is not due to DNA damage defects but a result of a 
non-canonical function of the kinase at the photoreceptor connecting cilium (CC). 
Furthermore, it was recently found that retinal degeneration in the rd10 mouse model 
is underlined by abnormal localization of Sirt1, an MRN DNA damage sensor 
protein with neuroprotective function, from the nucleus to the cytoplasm (Jaliffa et 
al. 2009). Finally, mutations in the topoisomerase I-binding RS protein (TOPORS), 
an E3 ubiquitin ligase, have recently been linked to autosomal dominant RP 
(Chakarova et al. 2007). TOPORS is not only a nuclear protein which participates in 
DNA damage signalling but also a component of the photoreceptor CC (Chakarova 
et al. 2011). Collectively, the studies mentioned above all point to a relationship 
between DDR proteins and retinal viability. Therefore, I hypothesised that RP type 2 
might also be associated with defective DDR signalling and I aimed to characterise 
the potential novel interaction between RP2 and DNA PKcs further.  
 
4.1.2 DNA PKcs is a multi-functional kinase 
The catalytic subunit of DNA PK is a widely expressed (Proteomics DB, 
http://www.proteomicsdb.org/) large (469,089 Da) Ser/Thr kinase. It belongs to the 
phosphatidyl inositol 3 kinase-like family of protein kinases (PIKK) and it shares 
amino acid and protein architecture similarities, as well as overlapping functions, 
with the other members of the PIKK family and DDR proteins ATM and ATR. The 
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DNA PK holoenzyme refers to the catalytic subunit in complex with the Ku 70/80 
heterodimer. Ku has the property of binding to DNA ends with high affinity and in a 
sequence-independent manner. One of its main functions is to recruit DNA PKcs to 
DSBs and stimulate its kinase activity (Jette and Lees-Miller 2015).  
The main protein domains of DNA PKcs are: an N-terminal region composed of 
HEAT (Huntingtin, Elongation factor 3, regulatory subunit A of PP2A, TOR1) 
repeats and other α-helical regions, and a C-terminal region containing the kinase 
domain as well as FAT (FRAP, ATM, TRRAP) and FAT-C domains, required to 
stabilize the kinase domain. The HEAT repeats region forms the “arms” that 
surround a central cavity, a formation that is thought to accommodate DNA (Jette 
and Lees-Miller 2015, Sibanda, Chirgadze and Blundell 2010) (Figure 4.1A). These 
crude structural characteristics already give a clue about the main functions that this 
DNA-binding holoenzyme has been associated with. Its most well-studied role has 
been in the repair of DSBs via the non-homologous end joining pathway (NHEJ). 
This pathway is employed not only for the repair of random exogenously-induced 
DSBs, but also for the physiological processes of V(D)J recombination and class-
switch recombination which are essential for the development and maturation of 
lymphocytes and immunoglobulin rearrangement (Malu et al. 2012). It is therefore 
not surprising that radiosensitivity (due to defects in repairing IR-induced DSBs) and 
severe combined immunodeficiency (SCID) are prominent characteristics among 
patients with DNA PKcs deficiencies (Mathieu et al. 2015, Woodbine et al. 2013, 
van der Burg et al. 2009), similar to deficiencies in other NHEJ proteins (Woodbine, 
Gennery and Jeggo 2014).  Figure 4.1B shows an overview of the role of DNA PK in 
NHEJ (Davis and Chen 2013). The Ku heterodimer is the first complex to bind to 
free DNA ends and act as a scaffold to recruit the other NHEJ components, including 
scaffold proteins and enzymes required to process DNA ends and catalyse re-
ligation: DNA PKcs, XRCC4, DNA ligase IV, XLF, APLF, the DNA polymerases µ, 
λ and WRN helicase, among others. In this first stage of NHEJ, the cooperative 
action of Ku and DNA PKcs is required to stabilize the DSB complex and protect the 
free DNA ends from unspecific processing. Most of the NHEJ component proteins 
have also been suggested to be substrates of DNA PKcs-mediated phosphorylation: 
PNKP, Artemis endonuclease, XRCC4, DNA Ligase IV, XLF, WRN, Ku70/80 and 
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DNA PKcs itself. The cooperative action of the enzymes mentioned above is 
required for processing DNA ends to make them ligatable and filling any gaps. One 
notable role for DNA PKcs which has been studied extensively and has pathological 
importance is the activation of Artemis, which is necessary for its endonucleolytic 
activity (Ma et al. 2005, van der Burg et al. 2009). Finally, the last step is ligation of 
the broken DNA ends by DNA ligase IV. Finally, the NHEJ complex is released; in 
the case of DNA PKcs, dissociation from DNA is facilitated by a conformational 
change induced by autophosphorylation at the so-called ABCDE cluster (T2609, 
S2612, T2620, S2624, T2638 and T2647) (Jette and Lees-Miller 2015).  
DNA PKcs has a dual role in DSB repair, because it is also implicated in 
phosphorylating histone H2AX, a central event in sensing and signalling the 
presence of a DSB in the context of chromatin. Nevertheless, DNA PKcs is not the 
only kinase capable of doing so, and its specific role in the process is still debated 
(Kinner et al. 2008).  
Although its role in NHEJ is the most well documented, DNA PKcs has been shown 
to participate in other pathways of repairing DNA lesions. These can be seen in 
Table 4.1, which summarises known pathways of DDR and highlights which ones 
have been linked to the function of DNA PKcs. For example, DNA PKcs co-
precipitates in a complex with most essential components of the base excision repair 
(BER) pathway from HeLa cells, independently of DNA damage (Parlanti et al. 
2007). BER is responsible for resolving most single-stranded DNA lesions induced 
by oxidative damage. Another study has found that absence of DNA PKcs from cells 
reduces their viability and DNA repair capacity after H2O2 treatment. Interestingly, 
cells deficient in other NHEJ components do not display this vulnerability to H2O2, 
strongly arguing for an NHEJ-independent role of DNA PKcs in the cellular defense 
against oxidative stress (Li et al. 2014). In addition, (An et al. 2011) have argued that 
DNA PKcs depletion causes over-sensitivity to UV irradiation and defective 
transcription-coupled nucleotide excision repair (tcNER), the pathway that 
preferentially repairs DNA lesions caused by UV irradiation in the transcribed strand 
of a transcriptionally active gene. Finally, far from being an exclusive NHEJ factor, 
it seems that DNA PKcs actively regulates the choice of DSB repair pathway (NHEJ 
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or HR) in cooperation with ATM (Shrivastav, De Haro and Nickoloff 2008). Reports 
have contradicted each other regarding the exact effect DNA PK exerts on pathway 
choice and it seems more possible that this depends on its phosphorylation status and 
which exact residue is phosphorylated (Neal et al. 2011, Serrano et al. 2013).  
Among the multitude of processes that have been linked to DNA PKcs activity, there 
are also basic cellular functions such as mitosis and transcription. During mitosis, 
DNA PKcs is phosphorylated at multiple sites and localizes to centrosomes, mitotic 
spindle and the midbody (Douglas et al. 2014), while it mediates phosphorylation of 
checkpoint kinase 2 (Chk2) and γH2AX in a mitosis-dependent manner (Tu et al. 
2013). Lack of DNA PKcs causes multiple mitotic defects (Lee et al. 2011). 
Interestingly, these phenomena are independent of Ku and DNA damage (Douglas et 
al. 2014). Furthermore, DNA PKcs plays a major role in telomere protection (Le et 
al. 2013). This prolific kinase has even been implicated in transcriptional activation 
of lipogenic genes in response to feeding/insulin (Kong et al. 2011).  
Apart from its nuclear roles, reports have emerged recently that DNA PKcs 
participates in a number of cytoplasmic pathways, including EGFR signaling 
(Dittmann et al. 2008) and Golgi cohesion (Farber-Katz et al. 2014). Therefore, a 
more pivotal role is emerging for DNA PKcs not only in the cross-talk between 
different repair pathways and cell survival, but also in relaying DNA damage signals 
outside the nucleus and orchestrating the general cellular response, in addition to 
several other, non-DNA damage related, functions. It is not by chance that decreased 
activity and/or expression of DNA PK has been associated with diseases outside the 
typical spectrum of NHEJ deficiencies, in particular with cancer susceptibility 
(Goodwin and Knudsen 2014), neurodegeneration (Woodbine et al. 2013) and 
Alzheimer’s (Kanungo 2016).  
In the present chapter, I characterise the potential interaction between RP2 and DNA 
PKcs and provide the basis for further studies that will prove if photoreceptor 
survival can be added to the long list of physiological pathways that DNA PKcs has 
been associated with. I will provide evidence that DNA PKcs co-precipitates with 
exogenous and endogenous RP2 from HEK293T and RPE1 cells, and that this 
interaction is abolished by a pathogenic missense RP2 mutation which affects 
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palmitoylation of the protein. I will characterize the interaction further by showing 
where the proteins co-localise within RPE1 cells, and suggest that RP2 is a potential 
substrate for DNA PKcs-mediated phosphorylation at a non- S/T-Q site in vitro. 
Finally, I will provide evidence that cells lacking RP2 expression do not display 
compromised DSB repair after IR, and will suggest that the newly identified RP2-
DNA PKcs complex is likely associated with a non-canonical function of the kinase 




Figure 4.1. Protein structure of DNA PKcs and schematic overview of NHEJ.  
A)  Cartoon showing the main protein domains of DNA PKcs. The N-terminal 
HEAT repeats form the DNA-containing structure. The FAT and FATC domains are 
required for the stability of the kinase domain (Jette and Lees-Miller 2015). B) The 
basic steps of NHEJ are shown here. DNA PKcs has a central role which includes 
stabilising the DSB complex, protecting free DNA ends, and phosphorylating other 
protein components of the complex [reproduced from (Davis and Chen 2013)].  
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Table 4.1. A role has been identified for DNA PKcs in most DNA repair 
pathways 
Adaptation of the table from (Jackson and Bartek 2009), where the main pathways 
for the repair of DNA lesions in higher eukaryotes are listed. The original table has 
been complemented with newer information and the pathways where DNA PKcs has 
been shown to be involved are summarised.  
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4.2.1 RP2 co-precipitates with DNA PKcs from HEK293T cells 
The catalytic subunit of the DNA-dependent protein kinase (DNA PKcs) was among 
the top proteins that co-precipitated with V5-tagged RP2 from HEK293T cells in our 
experiment of MS/MS analysis following affinity purification of V5-tagged RP2 
from HEK293T cells. Figure 4.2A shows the analysis of MS hits presented as a 
volcano plot with the y-axis representing significance and x-axis representing 
enrichment. Quantitative analysis of proteins (fold change) was calculated by the 
label-free quantitation feature of the MaxQuant software which was used to analyse 
the MS datasets. This analysis resulted in 58 proteins that were enriched (p>0.1) in 
the RP2-V5 IPs compared to the negative controls (V5 IPs from empty vector-
transfected cells). RP2 itself is, as expected, by far the most enriched protein in the 
IPs of RP2-V5 –transfected compared to empty vector-transfected cells. Among the 
proteins that co-precipitate with RP2 with high statistical significance is OSTF1, a 
recently identified interaction partner of RP2 which is referred to in detail in Chapter 
3, and Transportin-1 (Importin β2) which has been identified before as an interaction 
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partner of RP2 that mediates its targeting to cilia (Hurd et al. 2011).  The 
identification of known interaction partners in complex with RP2 is important 
because it confirms the validity of the experiment. Another interesting hit among the 
potential interaction partners of RP2 is the PIKK-family kinase mTOR; since the 
involvement of mTOR-mediated pathways in retinal neuroprotection has been shown 
before (Faghiri and Bazan 2010), this is an interesting result that can be followed-up 
in the future. 
For the reasons described in the introduction, this study has focused on the 
characterisation of the potential interaction between RP2 and DNA-repair enzyme 
DNA PKcs. Initially, I confirmed the interaction by IP and western blotting in 
HEK293T cells under mild lysis conditions. I showed that endogenous DNA PKcs 
co-precipitates with exogenous, tagged RP2 and this is independent of the nature of 
the tag, as it occurs both with V5- and FLAG- tagged RP2 (Figure 4.2B). 
Subsequently, I wanted to show the interaction between the endogenous proteins. To 
this end, I immunoprecipitated DNA PKcs and confirmed that a fraction of the total 
RP2 co-precipitates with the anti-DNA PKcs antibody, but not with another antibody 
of the same class that is produced in the same species (“control IP”- Figure 4.2C). In 
addition, I was interested in testing if DNA PKcs co-precipitates with ARL3, the 
most well-characterised interaction partner of RP2. To achieve this, I made hTERT-
RPE1 cells that were retrovirally transduced to express FLAG-tagged ARL3 Q71L, 
the constitutively active mutant, after induction by doxycycline. ARL3 Q71L was 
used in this particular experiment because it stably binds RP2, contrary to the wild-
type protein which only transiently interacts with the GAP (Veltel et al. 2008). 
FLAG IPs from ARL3 Q71L cells, but not cells transduced with an empty vector, 
were enriched in endogenous RP2 compared to the inputs. However, DNA PKcs is 
not present in the complex (Figure 4.2D). This result is a first indication that RP2, 
ARL3 and DNA PKcs may not form a stable trimeric complex. It is possible that the 
RP2-DNA PKcs interaction takes part in a pathway that is separate to the regulation 
of ARL3. If the RP2-DNA PKcs is a direct interaction, it is also possible that ARL3 
and DNA PKcs antagonise each other for binding to RP2. This hypothesis must be 
tested in the future using a structure-based approach which will determine if the 
same RP2 domains participate in ARL3 and DNA PKcs binding. 
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Figure 4.2. RP2 interacts with DNA PKcs.  
A) Volcano plot of MS/MS data comparing anti-V5 immunoprecipitates (IPs) from 
RP2-V5 -transfected HEK293T cells vs empty vector-transfected (negative control). 
Each datapoint in the graph represents a unique protein ranked and plotted on the x-
axis according to fold enrichment (log2 transformed) in the RP2-V5-transfected cells 
(+ve x axis) over the negative control (-ve x axis). On the y-axis, proteins were 
ranked according to significance represented as –log10 p value calculated by 
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unpaired two-tailed t-tests (n=3 independent biological repeats of the IP experiment 
and MS runs). Points representing the bait protein (RP2) and top-ranked proteins that 
immunoprecipitated with it, including DNA PKcs which was chosen for further 
analysis, are shown in red. B) V5- or FLAG- tagged RP2 was immunoprecipitated 
from HEK293T cells, transiently transfected with empty vector or tagged RP2-
containing vector, using agarose beads-conjugated anti-V5 or anti-FLAG antibody, 
respectively. The IPs as well as the lysates before IP (inputs) were subjected to SDS-
PAGE and western blotting using anti-DNA PKcs antibody. Subsequent re-probing 
with anti-V5 and anti-FLAG antibodies confirms correct expression of the 
constructs. The red arrow indicates the RP2-FLAG band, while the asterisk indicates 
the light chain of the antibody used for IP. C) Endogenous RP2 was co-
immunoprecipitated with endogenous DNA PKcs from HEK293T cells’ lysates 
using a mouse monoclonal anti-DNA PKcs antibody. An anti-V5 mouse monoclonal 
antibody was used for IP as negative control. The IPs and the inputs were subjected 
to SDS-PAGE and western blotting using anti-DNA PKcs and anti-RP2 antibodies. 
The red arrow indicates the RP2 band and the asterisk indicates the heavy chain of 
the antibody used for IP. D) Anti-FLAG IP was conducted in lysates from RPE1 
cells that stably express constitutively active ARL3 Q71L-FLAG after doxycycline 
induction, as well as cells retrovirally transduced with an empty vector as negative 
control. The IPs and the inputs were subjected to SDS-PAGE and western blotting 
using anti-DNA PKcs, anti-RP2 and anti-FLAG antibodies.  
 
4.2.2 Plasma membrane localisation of RP2 might be important for its 
interaction with DNA PKcs 
After confirming that DNA PKcs is in a complex with RP2, I wanted to characterise 
the interaction further and assess the importance of the complex in RP. For this 
purpose, I tested several missense RP2 mutations initially identified in RP patients 
for any potential effect on the interaction with DNA PKcs (Figure 4.3A). The 
mutations that I chose to examine are not predicted [for R118H, R211L this fact is 
also experimentally proved by us and others (Veltel et al. 2008)] to destabilise the 
overall structure and folding of the protein based on biophysical calculations 
conducted by Dr Dinesh Soares [see Chapter 3, Table 3.1 and (Liu et al. 2017a)]. As 
a consequence, I did not expect the expression levels of the mutant proteins to be 
altered compared to the wild-type. R118H, one of the first RP2 mutations identified 
in RP patients (Schwahn et al. 1998), is known to severely affect the RP2-ARL3 
binding (Kuhnel et al. 2006). R211L (Pelletier et al. 2007) disrupts the RP2-OSTF1 
binding, as was shown recently by our group (Chapter 3, Figure 3.1). T87I is a non-
destabilising missense pathogenic mutation (Jayasundera et al. 2010) with no known 
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effect on the function of RP2; therefore, the mechanism by which this mutation 
causes retinal degeneration is yet unknown.  
Finally, my experiment included the N-terminal pathogenic mutations G2A 
(Neidhardt et al. 2008) and C3S (Jayasundera et al. 2010), which alter the sites of 
dual acylation on RP2, namely myristoylation at G2 and palmitoylation at C3. 
Attachment of myristate increases the hydrophobicity of the protein and is sufficient 
to exclude GFP from the nucleus and associate it with intracellular membranes 
(McCabe and Berthiaume 1999), but it is not sufficient to stably anchor the modified 
protein to the plasma membrane. This typically requires a second signal, for example 
a polybasic domain (as in c-SRC) or a second fatty acid, for example palmitate 
(Aicart-Ramos, Valero and Rodriguez-Crespo 2011, Resh 2016). This is the case for 
RP2, as dual acylation of the N-terminus is required for targeting and anchoring RP2 
to the plasma membrane (Chapple et al. 2002, Chapple et al. 2000). For this reason, 
the G2A and C3S mutants do not display the characteristic plasma membrane 
localisation of the wild-type protein; Instead, G2A RP2 is localised throughout the 
cytoplasm in a diffuse pattern and abnormally accumulates to the nucleus, while C3S 
RP2 is trapped in intracellular membranes (Chapple et al. 2000).  
After transiently expressing V5-tagged RP2 in its wild-type and mutant forms in 
HEK293T cells, western blotting for the V5 tag confirms that all proteins are equally 
expressed (Figure 4.3A, inputs). Subsequent anti-V5 immunoprecipitation and 
western blotting for endogenous DNA PKcs shows that none of the R118H, R211L, 
T87I and G2A mutations affect the RP2-DNA PKcs interaction. On the contrary, 
RP2 C3S has completely lost the ability to interact with DNA PKcs (Figure 4.3A, V5 
IPs), as was consistently shown in three independent repeats of the experiment. 
Importantly, this finding supports the suggestion that the RP2-DNA PKcs interaction 
is authentic and not a product of non-specific binding. Because C3 is a 
palmitoylation site, there are two possible explanations about the effect of the C3S 
mutation on the interaction. Firstly, that the residue is structurally important for the 
interaction to occur. Secondly, that the interaction is lost due to lack of co-
localisation and not because of a structural defect. However, the second hypothesis  
fails to  explain why the C3S mutation abolishes the RP2-DNA PKcs interaction but 
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the G2A mutant fully co-precipitates with DNA PKcs despite the fact that it does not 
localise to the membrane either. One possible explanation for this phenomenon could 
be that abnormal accumulation of RP2 in the nuclear compartment leads to ectopic 
binding to DNA PKcs, which makes up in the IP assays for the loss of membrane 
interaction.  
Therefore, a hypothesis can be formed that RP2 and DNA PKcs interact at the 
plasma membrane. In order to test this hypothesis, it is necessary to examine where 
the two proteins co-localise in the cell. To achieve this, I switched to hTERT-RPE1 
cells which are more physiologically relevant than HEK293T cells for studying the 
cell biology of the retina and conducted immunofluorescence experiments. Using 
this method, I showed that although DNA PKcs is predominantly localised to the 
nucleus, a pool of the protein can also be observed in a punctate pattern along the 
periphery of the cell, where it co-localises with exogenous RP2-V5 (Figure 4.3B). 
Although DNA PKcs is predominantly referred to as a nuclear protein in the 
literature, lipid raft localisation has been shown before using biochemical methods 




Figure 4.3. Membrane localisation of RP2 might be important for the interaction 
with DNA PKcs.  
A) Several missense pathogenic mutations on RP2 which do not affect the expression 
levels of the protein were tested for their effect on the interaction with DNA PKcs. 
HEK293T cells were transiently transfected with V5-tagged WT and mutant forms 
of RP2, lysed and subjected to anti-V5 IP. The IPs as well as the lysates before IP 
(inputs) were subjected to SDS-PAGE and western blot using an anti-DNA PKcs 
antibody. Subsequent re-probing with an anti-V5 antibody confirms correct 
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expression of the constructs. C3S RP2, which has lost the palmitoyl anchor to the 
plasma membrane, does not interact with DNA PKcs. B) Immunofluorescence 
staining of fixed RPE1 cells using anti-DNA PKcs and anti-V5 antibodies shows a 
pool of DNA PKcs at the periphery of the cell in addition to the main nuclear 
localisation, and suggests that DNA PKcs co-localises with RP2-V5 at the plasma 
membrane. The part of the image denoted by a white box is magnified on the right.  
 
Because of the possibility that the staining observed at the periphery of the cell is due 
to non-specific binding of the anti-DNA PKcs antibody, I aimed to confirm this 
finding using a biochemical method. To show that DNA PKcs is not exclusively 
nuclear but can also localise to the membrane compartment of the cell, I conducted 
subcellular fractionations on wild-type and genomic RP2 null hTERT- RPE1 cells, 
followed by western blotting using antibodies against the endogenous proteins. The 
RP2 null cell lines have deleterious mutations in the RP2 gene that were introduced 
by the CRISPR/Cas9 method and are described in more detail in Chapter 3 (Figure 
3.10). At first, I utilised a detergent-based commercial subcellular fractionation kit to 
generate a cytoplasmic fraction, a fraction for the plasma membrane and organelles, 
and a nuclear /cytoskeletal fraction, which is further disrupted by sonication (Figure 
4.4). This approach showed that DNA PKcs, as well as its regulatory subunit Ku80, 
is present not only in the nuclear/cytoskeletal fraction but also in the 
membrane/organelle fraction. In addition, DNA PKcs is present in the cytoplasm 
although presumably in smaller quantities. As expected based on the literature, 
endogenous RP2 is more abundant in the membrane compartment; however, I show 
here for the first time that it is also present in the cytoplasm and the 
nuclear/cytoskeletal compartment. Moreover, I observed that DNA PKcs is absent 
(clone I) or reduced (clone G) from the nuclear compartment of RP2 null cells 
compared to the wild-type RPE1, as observed in three independent repeats of the 
experiment. Because of the significant potential ramifications of this observation, I 
wanted to confirm it by using a different fractionation method. To this end, I 
repeated the crude subcellular fractionations using home-made buffers based on 
(Holden and Horton 2009). This protocol exploits the property of digitonin to bind to 
the plasma membrane and form pores on its surface to extract cytosolic proteins 
without permeabilising intracellular membranes. Subsequently, membrane 
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complexes are solubilised using NP40. Finally, the nuclear membrane and nuclear-
residing proteins are extracted using RIPA buffer (Figure 4.5). RIPA/NP40 insoluble 
proteins are then pelleted down by centrifugation and are not extracted with this 
method.  This approach confirmed the cytoplasmic, membrane and nuclear 
localisation of DNA PKcs, as well as the membrane and nuclear localisation of RP2 
(Figure 4.5). However, it did not confirm that nuclear DNA PKcs levels are reduced 
when RP2 is absent. Therefore, this is considered an artefact of the first method and 
may not be a real phenotype. It is possible that the sonication step of the first 
protocol is responsible for introducing some degree of unspecific variability among 
the samples. There is also a possibility that the reduced amount of DNA PKcs in the 
last fraction in Figure 4.4 is an effect linked to the insoluble protein fraction which is 
not extracted using the second method. Finally, it is worth commenting on the fact 
that GAPDH, a widely used cytosolic marker, is present both in the cytosolic and 
membrane fractions in both experiments (Figures 4.4,4.5). Although this observation 
might mean that cytosolic proteins were not completely extracted during the first 
fractionation step, recent studies have identified GAPDH as a membrane localised 
protein (Ghosh et al. 2010). Therefore, it is possible that GAPDH is not an 
appropriate cytosol-only marker for RPE1 cells.  
Lastly, other fractionation methods could be used to confirm my results and also to 
resolve the question of DNA PKcs localisation in RP2 null cells. One common 
method to obtain pure preparations of different subcellular organelles is density-
gradient centrifugation, based on the separation of organelles according to their size 
and density via ultracentrifugation through a density gradient of a medium such as 
sucrose (Lee, Tan and Chung 2010). Although more time-consuming, this method 
has higher resolution power than detergent-based fractionation and could help 
determine the specific organelles where RP2 and DNA PKcs co-localise, rather than 
generally isolating the membrane- associated fraction of the cells.   
In conclusion, I conducted immunofluorescence and subcellular fractionation 
experiments and showed that DNA PKcs and RP2 co-localise at the membrane and 
nuclear compartments of RPE1 cells. In theory, both these cellular compartments are 
potential sites of interaction. Because abolition of the plasma membrane localisation 
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of RP2 via the C3S mutation is prohibiting for the interaction, the hypothesis that 




Figure 4.4. RP2 and DNA PKcs co-localise at the nuclear and the membrane 
compartments of RPE1 cells: fractionation method 1.  
Parental WT and two clones (G,I) of RP2 null hTERT-RPE1 cells, generated by the 
CRISPR-Cas9 method, were subjected to subcellular fractionation using the Cell 
Signalling fractionation kit. Cell lysates (WCL) and the different fractions- 
cytoplasmic (CF), membranes and organelles (MOF) and cytoskeleton and nucleus 
(CyNF)- were subjected to SDS-PAGE and western blotting using antibodies against 
endogenous DNA PKcs, RP2 and one the regulatory subunits of DNA PK, Ku80. 
H2B, GAPDH and Integrin β1 blotting were used as markers for the nuclear, 
cytoplasmic-membrane fractions, membrane-cytoskeletal fractions, respectively.   
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Figure 4.5. RP2 and DNA PKcs co-localise at the nuclear and the membrane 
compartments of RPE1 cells: fractionation method 2.  
Parental WT and two clones (G,I) of RP2 null hTERT-RPE1 cells, generated by the 
CRISPR-Cas9 method, were subjected to subcellular fractionation using a crude 
fractionation method which included the stepwise use of digitonin, NP40 and RIPA 
buffer to solubilise cytoplasmic (CF), membrane (MF) and nuclear proteins (NF) 
respectively. (A) Diagram summarising the experimental steps of the fractionation 
protocol. (B) Subcellular fractions were subjected to SDS-PAGE and western 
blotting using antibodies against endogenous DNA PKcs and RP2. H2B, GAPDH 
and Integrin β1 blotting were used as markers for the nuclear, cytoplasmic-
membrane and membrane fractions, respectively. 
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4.2.3 RP2 is a novel substrate of DNA PKcs in vitro 
DNA PKcs is a prolific kinase with many of its substrates belonging to the NHEJ 
complex. The highly purified catalytic subunit has weak kinase activity on its own, 
which can be stimulated 5-10 fold in the presence of double-stranded DNA and the 
Ku heterodimer. Inactivation of its kinase activity results in radiosensitivity and 
defects in DSB repair, highlighting the importance of DNA PKcs-mediated 
phosphorylation of substrates for NHEJ to occur normally (Kurimasa et al. 1999). 
Apart from phosphorylating other proteins, DNA PKcs itself undergoes 
autophosphorylation, which can exert important effects on the protein such as 
inducing conformational changes which lead to the dissociation from the DNA 
damage sites (reviewed in (Jette and Lees-Miller 2015).  
Apart from phosphorylating substrates in the nucleus, DNA PK is known to 
phosphorylate numerous cytoplasmic targets, including Hsp90 (Quanz et al. 2012), 
the NFkB inhibitor IkB-β (Bottero et al. 2001) and Akt kinase (Li et al. 2013b). 
Activation of DNA PK by small DNA molecules mimicking DSBs leads to 
phosphorylation of the intermediate filament protein Vimentin, and it is suggested 
that this phosphorylation regulates cell migration and adhesion (Kotula et al. 2013). 
Another recent study showed evidence for the phosphorylation of GOLPH3, a 
protein that participates in the application of tensile forces to the Golgi, by DNA PK. 
This event ultimately leads to a dramatic reorganization of the Golgi upon DNA 
damage which appears to be crucial for cell survival (Farber-Katz et al. 2014). Thus, 
evidence is accumulating that DNA PK is responsible for transmitting signals via its 
kinase activity that ultimately lead to a cytoplasmic response to DNA damage.  
DNA PKcs is shown to have the highest selectivity for its consensus motif S/T-Q. 
However, a study involving screening of peptide libraries suggested that its substrate 
requirements are modestly flexible with respect to the critical +1 position. For 
example, there exists an additional tendency to prefer a hydrophobic residue, for 
example a Y, nearby the targeted S/T (O'Neill et al. 2000). Since then, multiple other 
DNA PKcs phosphorylation sites have been found on potential substrates that do not 
conform to the S/T-Q consensus (Jette and Lees-Miller 2015).  
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Due to the close links between the kinase activity of DNA PKcs and its numerous 
functions, I was interested in testing whether the novel interaction between RP2 and 
DNA PKcs is linked to a kinase-substrate relationship. Interestingly, the RP2 amino 
acid sequence encompasses a classic DNA PKcs consensus phosphorylation motif 
around T133 (LCCATQPIIE). T133 is a good candidate for phosphorylation because 
it is surface exposed on the unbound RP2 (Figure 4.6A). Moreover, it is strictly 
conserved among vertebrates, suggesting an important role in the protein’s core 
functions. In addition, the T133 residue is located very close to the ARL3-GDP 
interface on the RP2-ARL3 complex (Figure 4.6A). Neighbouring residues A132 and 
Q134 are both involved in hydrophilic interactions with ARL3 residues (Veltel et al. 
2008), while the R118 and E138 residues which are critical for the catalytic activity 
of RP2 towards ARL3 and sites of missense pathogenic mutations (Kuhnel et al. 
2006) are also found in close proximity to T133. Because of the position of this 
residue, I hypothesised that the addition of a phosphate group, possibly as a result of 
the RP2-DNA PKcs interaction, could affect binding to ARL3 and, as a result, serve 
as a way to regulate the catalytic activity of RP2. To test this hypothesis, I generated 
the V5-tagged phospho-mimic (T133E) and phospho-dead (T133A) mutants of RP2 
and used them to transiently transfect HEK293T cells. Both these mutations were not 
predicted to destabilise the secondary structure of the protein (stability calculations 
by Dr Dinesh Soares, unpublished) and were indeed expressed at the wild-type 
levels, as the inputs show in Figure 4.6B. Subsequently, I conducted pulldown assays 
using recombinant GST-ARL3 Q71L (the constitutively active mutant which stably 
associates with RP2) as bait, testing for its ability to associate to the V5-tagged 
proteins. Lysates expressing R118H RP2 were also included in the pulldown assays 
as a negative control, since it has been shown before that this mutation abrogates the 
RP2-ARL3 interaction (Kuhnel et al. 2006). The amount of RP2-V5 that associated 
with ARL3 was approximated by western blot and densitometry measurements of the 
V5 band intensity normalised to the total GST-tagged protein band intensity in the 
sample for 3 independent repeats of the experiment. This approach revealed that the 
phospho-mimic T>E mutation reduces the RP2-ARL3 binding efficiency, although 
its effect is not as pronounced as the one exerted by the R118H mutation which 
completely abolishes the interaction (Figure 4.6B). On the contrary, the phospho-
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dead T>A mutation does not influence the binding of the two proteins. To ensure that 
the observed changes are not due to an effect of the mutations on the overall folding 
of the protein, pulldown assays were conducted using GST-OSTF1 as bait, because 
the mutations mentioned above are found away from the RP2-OSTF1 interaction 
interface. Indeed, I found that the mutant proteins bind to OSTF1 as efficiently as the 
wild-type RP2. Overall, this experiment suggests that T133 is important for the RP2-
ARL3 interaction, and that the hypothetical addition of a negative charge at this 
position, similarly to the addition of a phosphate group, would downregulate the 
RP2-ARL3 interaction.  
Subsequently, I aimed to test if RP2 is indeed phosphorylated at the DNA PKcs 
consensus motif under conditions of DNA PKcs activation in a retinal cell line. To 
this end, I transiently expressed V5-tagged human RP2 or empty vector (as negative 
control) in hTERT-RPE1 cells. The transfected cells were treated with different 
doses of IR (2, 5 and 10 Gy of X-rays) or etoposide (50 µM for 4 hrs), a 
topoisomerase II inhibitor, to induce DNA damage and, as a result, activation of 
DNA PKcs. DMSO- treated cells were also included in the experiment as a vehicle-
only control. To detect any potential phosphorylation of RP2-V5, I 
immunoprecipitated RP2-V5 and conducted western blot with an antibody against 
the phosphorylated S/T-Q motif. As shown in the inputs lanes in Figure 4.6C, the 
antibody detects novel phosphorylated bands in the etoposide- and X-ray-treated 
inputs compared to the untreated ones. Because the phosphorylation of S/T-Q motifs 
is a general marker of DNA damage and response of the PIKK family kinases, this 
confirms that my treatments were effective in inducing DNA damage response in the 
cells. However, no S/T-Q phosphorylation was detected in the IP samples, despite 
RP2-V5 being efficiently expressed and immunoprecipitated, as shown by the anti-
V5 loading control blot (Figure 4.6C). This result suggests that RP2 is not detectably 
phosphorylated in an S/T-Q consensus motif after treatment of the cells with DSB-
inducing agents.  
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Figure 4.6. Threonine phosphorylation of RP2 at the DNA PK consensus motif 
might disrupt binding to ARL3, but could not be detected after DDR induction. 
A) Surface representation of human RP2 crystal structure (PDB ID: 2BX6) where 
T133, which corresponds to the DNA PK consensus motif (S/T-Q), is highlighted in 
red. The other two highlighted residues correspond to R118 and E138, which are 
both critical for the catalytic activity of the protein towards ARL3. B) Recombinant 
GST-ARL3 Q71L was used as bait in pulldown assays from HEK293T cells 
transiently transfected with different forms of RP2-V5. GST-OSTF1 pulldowns are 
used to control for the mutant proteins’ correct folding. SDS-PAGE and western 
 131 
blotting analysis with anti-V5 antibody was used to approximate the amount of RP2-
V5 found in the cell lysates (inputs) and bound to the bait proteins. Ponceau staining 
was used to visualise the GST-tagged protein bands. Band densitometry 
measurements were used as a relative quantification of the RP2-V5 abundance 
between pulldown samples (mean +/- S.E.M n=3 densitometry measurements on 3 
separate immunoblots normalised to GST-tagged ARL3 Q71L bands). Two-tailed 
one-sample t-test was used to assess the significance of the observed differences 
between the mutant RP2 bands’ intensities compared to that of the WT protein 
whose value was set arbitrarily to 1. As expected, the interaction between RP2 
R118H and ARL3 Q71L is almost completely abolished (p=0.0013), while the 
phospho-mimic T133E mutation also affects the interaction (p=0.0420)5. The 
phospho-dead T133A mutation does not significantly affect the RP2-ARL3 
interaction. C) RP2-V5 was immunoprecipitated from RPE1 cells transfected with 
the corresponding construct or empty vector and treated with 2,5 and 10 Gy X-rays 
(right) or 50 µM etoposide for 4 hrs (left) to induce DNA double stranded breaks. 
DMSO-treated cells were also used as a vehicle-only control. IPs and lysates before 
IP (inputs) were subjected to SDS-PAGE and western blotting using an anti-pS/T-Q 
antibody as well as anti-V5 antibody to confirm correct expression of the constructs. 
However, no band corresponding to RP2 phosphorylation was observed. Red arrows 
point to bands that become S/T-Q phosphorylated after treatment with etoposide and 
X-rays.     
 
Since I could not detect S/T-Q phosphorylation of RP2 after DNA damage, I 
hypothesised that this modification could occur under an entirely different context, 
possibly related to a non-canonical function of DNA PKcs that is independent of its 
role as a DNA damage signal-relaying kinase. To investigate the possibility of RP2 
phosphorylation with a different approach, I conducted a kinase assay using 
commercially available DNA PK, purified from HeLa cells’ nuclei, and recombinant 
His-tagged human RP2. Subsequently, I analysed the assay mix by western blot 
using the anti-phosphorylated S/T-Q motif antibody. As shown in Figure 4.7A, 
multiple phosphorylated bands can be observed in the kinase assay mix as opposed 
to the negative controls (no ATP and no DNA PK), which most likely correspond to 
autophosphorylation of the DNA PK catalytic subunit and the regulatory Ku 
subunits, as inferred by the molecular weight. As expected, overall S/T-Q 
phosphorylation in the mix is stimulated multiple fold by the addition of double-
stranded DNA, which activates the activity of the catalytic subunit. However, the 
                                               
5 Mean reduction in densitometry measurements for WT vs mutant RP2: 88.5% and 
59.9% for R118H and T133E, respectively, with 95% confidence intervals: 102.4% 
to 74.6% and 114.4% to 53.7% for R118H and T133E, respectively.  
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study of RP2 phosphorylation using this method is impeded by the presence of a 
phosphorylated band at the expected molecular weight for RP2-His, even in the “no 
RP2” negative control (marked by a red arrow in Figure 4.7A). Since the kinase I 
used in this assay is not recombinant but purified from human cells, the band 
possibly corresponds to another protein that co-purifies with the DNA PK complex. 
In order to circumvent this problem, the kinase assay mix was analysed by LC-
MS/MS in the IGMM Mass Spectrometry facility by Dr Jimi Wills-Bukowski and Dr 
Alex von Kriegsheim. This analysis revealed a modified RP2 peptide corresponding 
to phosphorylation at positions 213/214 (because of their proximity it was not 
possible to distinguish which of the two residues was phosphorylated) (Figure 4.7B). 
Intensity values, corresponding to the summed up extracted ion current of all isotopic 
clusters associated with the identified sequence (used here to loosely estimate 
quantification), show that the phosphorylated version of the corresponding RP2 
peptide was only detected in the kinase assay sample. At the same time, the 
unmodified peptide could be detected in all samples, including the negative controls 
(without ATP or without DNA PK). In addition, the identification of several sites of 
DNA PKcs autophosphorylation, which can only be detected in the full kinase assay 
and not the negative controls, provides further confirmation that the kinase used in 
the assay was active and the experiment was valid. All the identified 
autophosphorylation sites have been previously reported by other groups (Ma et al. 
2005, Douglas et al. 2002, Chen et al. 2007). 
It is important to note that the sequence context of the identified modified residues 
S213, T214 does not conform to the classical S/T-Q motif that is preferentially 
phosphorylated by DNA PK. However, it has already been mentioned that only a 
fraction of the many DNA PK substrates is phosphorylated at this canonical motif. In 
fact, a similar phosphorylation site where the targeted residue is followed by E as the 
critical +1 position has been identified before on human Artemis (Ma et al. 2005). 
On the contrary, my experiment did not detect phosphorylation on T133 which is the 
site of the canonical motif. Before the possibility of DNA PK-mediated 
phosphorylation at this site is excluded, the experiment should be repeated and 
another method should be tried, such as TiO2 enrichment of phosphopeptides. The 
absence of phosphorylation at this site could explain why I did not detect any RP2 
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phosphorylation after the induction of DSBs in RPE1 cells, since the method I used 
was only appropriate for detecting phosphorylation at an S/T-Q site (Figure 4.6C).  
My studies have led to the emergence of S213/T214 as novel potential sites of DNA 
PK-mediated phosphorylation on human RP2. T214 and S213 appear mostly 
conserved among diverse classes of vertebrates, according to multiple sequence 
alignment of RP2 vertebrate orthologues conducted by Dr Dinesh Soares. T214 is 
strictly conserved among amniota and the coelacanth, but it is replaced with A in 
ray-finned fish and the frog. On the contrary, S213 is strictly conserved among 
vertebrates. T211 on mouse RP2, which is homologous to T214 on the human 
protein, was found to be phosphorylated specifically under neurite growth conditions 
in a large-scale study of the neurite phosphoproteome (Wang et al. 2011) (See 
Chapter 3: Figure 3.6A). It is also worth mentioning that S213 and T214 are both 
surface exposed and therefore assumed good candidates for phosphorylation. In 
order to further confirm this result, the experiment should be repeated including 
treatments with DNA PK-specific small molecule inhibitors. This will ensure that 
DNA PK, and not some other kinase present in the purified complex, is the 
responsible kinase for phosphorylating RP2 in the kinase assay. Further, the next step 
for this study is naturally the development of phospho-specific antibodies for 
phosphorylated S213/T214 on RP2. The development of these antibodies will 
provide the final confirmation that these RP2 residues are authentic phosphorylation 
sites and will open the way for a multitude of new experiments discussed at the end 





Figure 4.7. RP2 is a potential substrate for DNA PKcs-mediated 
phosphorylation in vitro.  
A) Recombinant human RP2-His and purified commercial DNA PK were mixed in 
an in vitro kinase assay. The assay mix was analysed by western blotting using an 
anti-His antibody for recombinant RP2 and anti-phospho S/T-Q motif antibody, 
which is the preferred consensus motif for phosphorylation by DNA PK, as a 
phosphorylation marker.  The more intensely phosphorylated bands marked with red 
arrows likely correspond to the catalytic subunit and the regulatory subunits Ku70 
and Ku80, based on the molecular weight. B) Table summarising key findings of the 
LC-MS/MS analysis of the kinase assay. It shows the modified RP2 and DNA PKcs 
peptides identified (phosphorylated residues marked in red) and the summed up 
extracted ion current of all isotopic clusters associated with the identified sequences 
as Intensity values. C) Surface representation cartoon of the RP2-ARL3 complex 3D 
structure (PDB ID: 3BH7), where the newly identified potential phosphorylation 
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sites on RP2 are marked in red (S213, T214). These adjacent residues are found in 
close proximity to residues R211, D255 and Y245 (also in red) which are critical for 
the RP2-OSTF1 interaction to occur, as shown in Chapter 3. D) Section of the 
multiple sequence alignment of vertebrate RP2 orthologues, encompassing residues 
S213 and T214. The conservation status of each residue is shown in colour code 
(red=strictly conserved, yellow= largely conserved/ conservatively substituted, 
white=non-conserved). S213 is strictly conserved among vertebrates, while T214 is 
only largely conserved (analysis conducted by Dr Dinesh Soares).  
 
4.2.4 RP2 null cells respond normally to DNA damage with respect to 
Η2ΑΧ activation 
A fundamental question concerning the RP2-DNA PKcs binding is the function of 
this interaction. The most well characterized role of DNA PK is in the repair of DNA 
DSBs, primarily by NHEJ but also by HR, as previously discussed. Therefore, it is 
imperative to start investigating any potential role of RP2 in the same pathways, 
especially since the slightest defect in DNA damage repair could be fatal for the 
neural retina. The photoreceptor’s function is characterized by extremely high 
metabolic rates and constant threat by DSB-inducing DNA damaging agents, 
including reactive oxygen species and UV irradiation. To achieve this, I compared 
the response of RP2 null hTERT-RPE1 cells that were previously generated in our 
group using the CRISPR-Cas9 method (Dr Toby Hurd) (characterization of these cell 
lines in Chapter 3: Figure 3.10) to the parental wild-type line after DNA DSB 
induction by low-dose IR (2 Gy X-rays). As a readout, I chose the formation and 
disappearance pattern of γΗ2ΑΧ foci, which is generally considered a consistent and 
quantitative marker for DNA DSBs (Kinner et al. 2008). The H2AX variant of 
histone H2A is readily phosphorylated at S139 at the vicinity of DNA DSBs to 
generate γH2AX. All three major kinases of the PIKK family (ATM, DNA PKcs and 
ATR) have the potential to phosphorylate H2AX; there is evidence for overlapping 
functions of the three kinases and it is still not clear which one is chiefly responsible 
for the initial H2AX phosphorylation (Kinner et al. 2008). After repair, γH2AX foci 
are removed from chromatin and phosphatase PP2A is largely responsible for the de-
phosphorylation in mammalian cells (Chowdhury et al. 2005). Notably, cells with 
compromised DNA PKcs activity display abnormally retained γΗ2ΑΧ levels 
because of the persistence of unrepaired DNA breaks (Zhao et al. 2006, Koike et al. 
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2008, Woodbine et al. 2013). Figure 4.8A shows the emergence of the characteristic 
γΗ2ΑΧ foci in the nuclei of sub-confluent, IR-treated cells at 1 hr after treatment, 
which gradually disappear at later time-points as the DNA breaks undergo repair. 
Quantification of the number of γΗ2ΑΧ foci per nucleus (Figure 4.8B) shows that 
there is no obvious defect that is consistent among both the RP2 null lines in the 
γΗ2ΑΧ activation-deactivation pattern, while any differences that are not observed 
in both the RP2 null clones are considered as clonal variation and not a result of the 
absence of RP2 function.  
In order to further investigate any potential involvement of the RP2-DNA PK 
complex in DNA damage signalling or repair, I examined if their interaction is 
upregulated after DNA damage. To this end, I immunoprecipitated transiently 
expressed V5-tagged RP2 from DMSO (vehicle-only control) or etoposide-treated 
hTERT-RPE1 cells. Subsequently, I conducted western blot using an antibody 
against endogenous DNA PKcs. As shown in Figure 4.8C, the amount of DNA PKcs 
that co-precipitates with RP2 is not affected by DNA damage. In addition, I 
examined if the expression of endogenous RP2 is regulated in response to DNA 
damage in RPE1 cells. Figure 4.8D shows that the levels of endogenous RP2 remain 
unchanged 1 hr after treatment of hTERT-RPE1 cells with IR (This time-point was 
chosen because I have observed maximum γΗ2ΑΧ activation at 1 hr). Therefore, 
these experiments provide evidence that RP2 does not have an essential function in 
the DNA DSB signalling and repair machinery after IR and DSB-inducing drugs, but 
rather point towards a non-canonical function of the DNA PK complexes in cell 
biology.  
However, it is important to note that my γΗ2ΑΧ activation experiment is by no 
means conclusive about the role of RP2 in DSB response. Importantly, this 
experiment was planned to examine the cells’ response to DNA damage rather than 
survival, hence the repair of DNA breaks and the observed resumed proliferation and 
cell growth confirm that the 2 Gy dose that I used is sub-lethal. Assessing survival of 
the cells after DNA damage would be better approximated by other methods, such as 
cleaved caspase-3 staining (a marker of potentially increased apoptosis in the RP2 
null lines), and clonogenic survival assays after higher doses of X-rays. Further, it 
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should be noted that the cells were sub-confluent at the time of treatment. Therefore, 
DSB repair in my experiment could theoretically occur via both NHEJ and HR 
pathways. While this experiment is useful to give an overview of DSB repair in 
general, it could also be necessary to repeat this experiment by using fully confluent 
(synchronous) cells that can only repair their DSBs by NHEJ, in order to separate the 




Figure 4.8. RP2 knockout does not result in defects in H2AX activation and 
repair of double stranded breaks induced by X-rays.  
A) Parental WT and two clones of RP2 null hTERT-RPE1 cells were subjected to X-
ray treatment (2 Gy) and γH2AX immunofluorescence staining was conducted at 
different time-points after treatment. Red= γH2AX, blue=DAPI. B) Quantification of 
γH2AX foci in the nuclei of untreated and X-ray treated cells shows no differences in 
the activation and deactivation pattern of γH2AX among the different cell lines that 
can be attributed to absence of RP2 (mean +/- SEM for 3 technical repeats, n=50 
cells each repeat). C) In order to test if the DNA PKcs-RP2 interaction is regulated in 
response to DNA damage, RP2-V5 was immunoprecipitated from hTERT-RPE1 
cells’ lysates expressing the corresponding construct after treatment with 50 µM 
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etoposide for 4 hrs or DMSO as negative control. The IPs and the inputs were 
analysed by SDS-PAGE and western blot using anti-DNA PKcs and anti-V5 
antibodies. D) To test if the expression of endogenous RP2 is regulated in response 
to DNA damage, lysates from hTERT-RPE1 cells were analysed 1 hr after treatment 




4.3.1 Characterisation of the RP2-DNA PKcs interaction 
In this chapter, I demonstrated that the catalytic subunit of the DNA-dependent 
protein kinase (DNA PKcs) was among the proteins that qualified as potential 
interaction partners of RP2 in the LC-MS/MS analysis after affinity purification of 
RP2-V5 from HEK293T cells. Subsequently, I confirmed by western blotting that 
DNA PKcs efficiently co-precipitates with transiently expressed RP2 from 
HEK293T and hTERT-RPE1 cells and, reciprocally, that RP2 co-precipitates with 
endogenous DNA PKcs from HEK293T cells. Further, I also showed that the 
missense pathogenic RP2 mutation C3S renders the protein unable to interact with 
DNA PKcs. This result is important because it provides a useful negative control to 
support my hypothesis that the interaction is authentic and specific. In order to test if 
this interaction is important for retinal biology, it is necessary to show if it occurs in 
the retina. This could be achieved by endogenous co-IP of the two proteins from 
bovine retinal extracts.  
To form a hypothesis about the potential function of the RP2-DNA PKcs complex, I 
investigated where the proteins co-localise within the cell. I conducted biochemical 
fractionations of hTERT-RPE1 cells and showed that both DNA PKcs and RP2 can 
be detected in all three generated fractions (cytoplasmic fractions, membranes and 
nucleus). Although DNA PKcs is predominantly known as a nuclear protein whereas 
RP2 is known to be plasma-membrane bound, my results generally agree with the 
existing bibliography, as alternative localisations have been reported for both 
proteins. DNA PKcs has been shown to be involved in active shuttling between the 
cytoplasm and the nucleus (Huston et al. 2008) and to undergo microtubule-mediated 
trafficking (Poruchynsky et al. 2015). In addition, biochemical methods have been 
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used to show that DNA PKcs is a component of lipid rafts, where it mediates 
phosphorylation of many substrates following irradiation (Lucero et al. 2003). On the 
other hand, this is the first time a nuclear localisation for RP2 is reported, except for 
one study which claimed RP2 translocates to the nucleus in response to DNA 
damage (Yoon et al. 2006). Recently, the involvement of its best studied interaction 
partner ARL3 in STAT3 activation has hinted for a transcriptional role for the two 
proteins (Togi et al. 2016). Interestingly, the presence in my mass spectrometry data 
of multiple nuclear transport receptors (Transportin 1, Exportin 7, Exportin 5, 
Importin 4) might suggest active nuclear transport and export for RP2 (Appendix 
Table 1). 
To pinpoint exactly where the RP2-DNA PKcs interaction occurs, fluorescence 
resonance energy transfer (FRET) or proximity ligation assay (PLA) could be used, 
both in vitro and on retinal sections. I hypothesise that the proteins interact at the 
plasma membrane, because C3S RP2, which has lost the ability to localise to the 
plasma membrane but instead accumulates in intracellular structures, does not 
interact with DNA PKcs. Based on this, it can also be suggested that the complex is 
not part of the canonical functions of DNA PKcs in the nucleus; instead, it might 
serve to relay DNA damage signalling to the plasma membrane. Both G2 and C3, the 
sites of lipid modifications on RP2 which are responsible for membrane targeting, 
are strictly conserved residues among vertebrates, suggesting membrane targeting is 
crucial for the function of RP2 in vertebrates (Chapple et al. 2002).  It should be 
noted that both myristoylation and palmitoylation of RP2 are also necessary for its 
targeting to cilia (Hurd et al. 2010), and G2A or C3S mutants do not interact with 
Importin β2 (Hurd et al. 2011). Given the centrosomal localisation of DNA PKcs that 
has been observed during mitosis (Douglas et al. 2014), a potential co-localisation of 
the two proteins at the basal body should be investigated in the future. 
In addition, I showed that the interaction between the two proteins potentially results 
in S/T phosphorylation of RP2 by DNA PKcs at S213/T214. My study further 
highlights the flexibility of DNA PKcs-mediated phosphorylation regarding targeted 
motifs. The development of a phospho-specific antibody for this site will make it 
possible to investigate if phosphorylation is induced after DNA damage and, 
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importantly, where this phosphorylation occurs in the cells or in retinal sections; 
these experiments will be highly informative about the function of the interaction. 
Interestingly, a large-scale study of the neurite phosphoproteome in mice recently 
identified this site on RP2 as phosphorylated under neurite growth conditions (Wang 
et al. 2011). Given the importance of DNA PKcs in mouse retinal development, but 
also the extensive neurodevelopmental and neurodegenerative defects of a patient 
with very little residual DNA PKcs activity (Woodbine et al. 2013), it will be 
interesting to investigate a function for the complex in neuronal development. 
 
4.3.2 Potential roles of the RP2-DNA PKcs complex 
Because its function in NHEJ is the most well-described role for DNA PKcs, it is 
natural to begin the search for a common role of DNA PKcs and RP2 from DSB 
repair pathways. My studies have shown that hTERT-RPE1 cells that lack RP2 
expression completely can still efficiently repair DSBs caused by a low dose of IR. 
On the same note, RP2 expression does not appear to be induced by IR. Further, I 
showed that the RP2-DNA PKcs is independent of DNA damage and is not affected 
by treatment with etoposide, a DSB-causing chemotherapeutic drug. Taken together, 
these results suggest that the RP2-DNA PKcs complex is not involved in DSB repair. 
Nevertheless, it should not be excluded that it participates in another pathway of 
repairing different kinds of DNA lesions, which are perhaps more physiologically 
relevant to the retina, such as the BER pathway for repairing DNA oxidative damage 
or the NER pathway for repairing UV-induced lesions. It is intriguing that (Yoon et 
al. 2006) described RP2 as having DNA-binding and 3’ to 5’ exonuclease activity in 
vitro, and suggested it participates in the BER pathway. For these reasons, one of the 
key future experiments should be to examine the response of RP2 null cells to H2O2 
treatment and UV irradiation, for example by performing clonogenic assays (to 
assess survival) or alkaline electrophoresis-comet assay (to assess DNA damage 
repair).  
Finally, according to the existing bibliography, it is tempting to link the RP2-DNA 
PKcs to Golgi cohesion. As already mentioned above, DNA PKcs was recently 
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shown to be critical for Golgi shape reorganisation as a response to DNA damage, 
via phosphorylation of GOLPH3 (Farber-Katz et al. 2014). Cells that have reduced 
RP2 levels due to shRNA-mediated knockdown, as well as reprogrammed fibroblasts 
from an RP2 patient, have been reported to have markedly dispersed Golgi (Evans et 
al. 2010, Schwarz et al. 2015). Does this mean that the DNA PK/GOLHP3 pathway 
is hyperactive in cells that lack RP2 activity? One way to answer this question is by 
examining phosphorylation levels of GOLPH3 in cells lacking RP2 compared to 
wild-type cells, under normal or DDR conditions.  
 
4.3.3 Conclusions and future directions 
In conclusion, I have shown that RP2 binds to DNA PKcs in HEK293T and RPE1 
cells, and proposed that this interaction is likely taking place at the plasma membrane 
and is characterised by a kinase-substrate relationship. I suggest that the RP2-DNA 
complex might be functioning at the plasma membrane, possibly in a non-canonical 
DNA PKcs pathway that is independent of DSB induction. Since more experiments 
are necessary to elucidate this, it is still possible that the complex is part of the DDR 
response, more likely in a DDR pathway other than DSB repair. In any case, I 
assume that the DNA PKcs-RP2 complex participates in a neuronal-specific or even 
photoreceptor-specific pathway, given the absence of any clinical features associated 
with DNA PK dysfunction in RP patients. Although DNA PKcs is present in the 
retina at protein level (Proteomic DB, http://www.proteomicsdb.org), it would be 
interesting to investigate specifically which retinal cell types express this protein. 
Interestingly, the only reported case of almost complete lack of DNA PKcs activity 
presented with marked neurological abnormalities, including post-natal neuronal 
atrophy, sensorineural hearing loss and marked visual impairment (Woodbine et al. 
2013). This has already led scientist to suggest the existence of important roles for 
DNA PKcs in neuronal maintenance that are not shared by other NHEJ components. 
To answer these questions, it will be important to bypass the restrictions of in vitro 
work and cell culture by using animal models. For this purpose, the next chapter will 
focus on the generation of a vertebrate RP2 null model of RP type 2. 
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Chapter 5: Generation of a zebrafish model for the 
genetic loss-of-function of rp2 and examination of its 
effect on retinal lamination 
5.1 Introduction 
5.1.1 The use of zebrafish in retinal research 
In order to better understand the biological processes described in the previous 
chapters, namely the function of the RP2-OSTF1 interaction and the potential role of 
RP2 in DNA damage repair pathways, studies must be conducted in a whole 
organism context. Therefore, animal models for RP type 2 are needed. Two mouse 
models of Rp2 knockout have been generated (Li et al. 2013a, Zhang et al. 2015) 
which both model the late-onset, slowly progressive retinal degeneration observed in 
patients with RP2 mutations. However, there are disadvantages of mouse models 
when studying visual disorders. For example, mice have a rod-dominant retina, with 
cones accounting for only 3% of total photoreceptor number (Goldsmith and Harris 
2003). This could potentially constitute a drawback in RP2 research, given that the 
clinical image of patients with RP2 mutations is characterised by high involvement 
of cone degeneration from early stages (Jayasundera et al. 2010), contrary to typical 
RP where cone loss is only secondary to the primary death of rod photoreceptors.  
Zebrafish (Danio rerio) embryos have several characteristics that make them good 
models for biological research. They are a genetically tractable model system and 
combine ease of embryological manipulation with optical clarity during 
embryogenesis, offering the ability to examine the onset and course of a pathological 
process in real time in vivo. Importantly, they offer the possibility of whole-animal, 
high-throughput screenings for small molecule chemical modifiers of disease 
pathogenesis and severity, which is especially useful in pharmacology and the 
identification of new therapies (Lieschke and Currie 2007, Kitambi et al. 2009). For 
these reasons, zebrafish have been widely used not only as a model for studying 
vertebrate development, but also to study the mechanisms of visual disorders, due to 
the similarities between their retinal structure and lamination with that of the human 
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retina, and the fact that they possess a cone-dense retina (Goldsmith and Harris 
2003). However, one major difference that sets zebrafish and human physiology 
apart is their unique ability to regenerate tissues and organs including the fin, heart, 
and retina. In mature zebrafish, new retinal neurons, including photoreceptors, are 
continuously generated from a population of mitotic progenitor cells at the retinal 
periphery, as well as a population of rod progenitor cells in the central retina 
(Marcus, Delaney and Easter 1999). In addition, the regeneration of photoreceptors 
can be stimulated in response to injury (for example, mechanical damage, chemical 
toxicity, phototoxicity and inherited retinal degeneration) and it has been shown that 
the mechanisms that mediate regeneration in response to rod or cone degeneration 
are distinct and involve increased proliferation progenitor cells in the outer nuclear 
layer (ONL) or the inner nuclear layer (INL), respectively (Morris et al. 2008, 
Brockerhoff and Fadool 2011).  
Despite the regeneration capacity, mutations in plenty of genes have been identified 
to cause retinal degeneration in zebrafish adults or embryos and they participate in 
the same pathways that are important for retinal integrity in humans (Brockerhoff 
and Fadool 2011, Tsujikawa and Malicki 2004a). One prominent example is ciliary 
transport. For instance, zebrafish larvae with null mutations in ift122, encoding a 
component of the IFT-A complex, and kif3a, encoding a kinesin II family member, 
exhibit photoreceptor degeneration characterised by disorganised or absent outer 
segment (OS) discs and opsin mislocalisation (Raghupathy et al. 2016, Boubakri et 
al. 2016). In another study, kif3α mutant zebrafish embryos also display absence of 
connecting cilia and mislocalisation of basal bodies away from the apical surface of 
the photoreceptor inner segments (Pooranachandran and Malicki 2016).  Another 
example is phototransduction; a mutation in the cone-specific pde6c gene leads to 
rapid degeneration of cone photoreceptors in larvae (Stearns et al. 2007). Finally, as 
an example of an adult zebrafish model for retinal disease, heterozygous carriers of 
sonic hedgehog (shh) null alleles, display cone loss and abnormal morphology 
(Stenkamp et al. 2008).    
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5.1.2 Zebrafish Rp2 
In the zebrafish, there is only one copy of the rp2 gene on chromosome 6 which 
encodes a protein of 376 residues, sharing 65% sequence similarity with human RP2 
and the same protein domains (Figure 5.1) (Shu et al. 2011). The expression of rp2 
mRNA and protein in the embryo has been studied extensively. Different studies 
agree that rp2 expression can be detected at the time of fertilisation (0 hours post 
fertilisation-hpf) and persists through hatching and larval stages (5 days post 
fertilisation-dpf) (Hurd et al. 2010, Shu et al. 2011, Desvignes et al. 2015). 
Interestingly, because rp2 mRNA is detected during all stages of oogenesis and in 
the unfertilised egg, it is considered a maternally inherited mRNA suggesting an 
important role in the embryo’s early development (Desvignes et al. 2015). In adult 
zebrafish, rp2 appears widely expressed in many tissues including the eyes and the 
brain, like human RP2 (Shu et al. 2011). In the adult retina, Rp2 is detected by 
immunofluorescence at the outer plexiform layer (OPL), ONL, inner segment (IS), 
OS and appears to be mainly plasma membrane localised (Liu et al. 2015). 
The function of Rp2 in zebrafish embryos has been examined by knockdown 
approaches. Knockdown of both zygotic and maternal rp2 by translation-blocking 
morpholinos causes multiple developmental defects many of which are reminiscent 
of ciliary gene mutants (Omori et al. 2008, Raghupathy et al. 2016), including body 
curvature, hydrocephalus, pericardial effusion, heart looping inversion (a left-right 
symmetry defect) and cysts in the pronephric duct (Hurd et al. 2010). More relevant 
to my subject of study are the ocular phenotypic manifestations of the morphants: by 
72 hpf, these embryos display microphthalmia (small eyes) and abnormal retina, well 
documented by histology showing disorganised lamination and increased cell death 
in the retina (Hurd et al. 2010, Shu et al. 2011, Desvignes et al. 2015). However, 
knockdown on zygotic rp2 only by splicing-blocking morpholinos causes much 
milder effects (Desvignes et al. 2015). Taken together, these studies argue for an 
essential role of maternally inherited rp2 mRNA in the early development of 
zebrafish embryos as well as in retinal maintenance. Several of these defects (body 
curvature, small eyes, heart looping defects) can be at least partially rescued by 
zebrafish or human RP2 mRNA (Shu et al. 2011). However, this phenotypic rescue 
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is incomplete and often quite weak (Shu et al. 2011, Hurd et al. 2010), while several 
of the reported phenotypes are common non-specific effects of morpholino 
injections. For these reasons, the phenotypes resulting from rp2 knockdown must be 
interpreted cautiously and it is necessary to confirm them in rp2 mutant embryos.  
Based on the similarity between zebrafish and human RP2, highlighted by the 
discovery that human RP2 mRNA can rescue defects in zebrafish morphants of rp2 
knockdown, and the evidence that they participate in the same pathways, I aimed to 
generate an rp2 knockout zebrafish model, using the recently emerged CRISPR/Cas9 
technology (Hwang et al. 2013). If the knockdown phenotypes that are easy to score 
by simple macroscopic observation, like the body curvature, could be recapitulated 
in the knockout model, this would provide an excellent platform to screen for small 
molecules that counteract rp2 loss and open the way for new therapies. In this 
chapter, I describe the generation of zebrafish lines with three different deleterious 
mutations early in rp2 exon 2 and I provide evidence that they probably lead to null 
alleles. Interestingly, none of these lines display any fertility defects or embryonic 
morphological defects. At least two of the lines with frameshifting mutations present 
with mild retinal degeneration characterised by shortening of the OS at 9 months.  
 
5.2 Results 
5.2.1 Generation of rp2 null zebrafish lines via the CRISPR/Cas9 method 
In order to generate a genetic knockout zebrafish model for RP type 2, I used the 
CRISPR/Cas9 method for genome editing, the gold standard in reverse genetics in 
recent years for a wide variety of biological models including the zebrafish (Liu et al. 
2017b). I tried to target rp2 gene with three different guide RNA sequences (gRNA) 
all targeting the beginning of exon 2 which is homologous to exon 2 of the human 
RP2 gene and encodes the GAP catalytic domain of RP2 (Figure 5.1). Exon 2 is a 
mutational hotspot in the human protein since it contains about half of reported 
pathogenic mutations (Jayasundera et al. 2010). gRNA oligonucleotides and the 
mRNA encoding for nCas9 endonuclease (a modified version of Cas9 endonuclease 
that is codon-optimised especially for genome targeting in zebrafish (Jao et al. 
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2013)) were in vitro transcribed, and a mix of those two components was injected 
into 1-cell stage AB zebrafish embryos. Genomic DNA was extracted from 10-20 
pooled injected embryos at 3 dpf and was used to estimate the efficiency of rp2 
targeting using a PCR-based genotyping strategy (see Chapter 2 for genotyping 
primer sequences). Because of the potential existence of multiple different mutations 
in these embryos, the PCR products were cloned into pGEM vectors and used to 
transform competent E. coli cells. While no insertions/deletions were found in the 
targeted sequence after genotyping ~40 individual transformed colonies for gRNA 2 
and 3, gRNA 1 proved very efficient, with mutations found in ~60% of colonies 
sequenced. Although the existence of two different targeting sites was desirable, as it 
would permit me to eliminate any potential off-target effects by outcrossing fish with 
different target sites, I had to continue with one targeting site only.  
Embryos injected with gRNA 1 and Cas9 were grown to ~3 months of age when 
they could be genotyped individually to identify founders (F0). Because all potential 
founder fish carrying rp2 mutations were female, they were crossed with male AB 
fish and their progeny were screened for mutations. Two of the females were found 
to transmit rp2 mutations through the germline and were named founder 4 and 
founder 7. All progeny from F0 x AB crosses were grown to ~3 months and 
genotyped. Among the progeny, three types of deleterious mutations were found 
heterozygously: a 4 bp deletion (del4) and a 8 bp deletion (del8) among the progeny 
of founder 4, and a 1 bp insertion (ins1) among the progeny of founder 7. 
Heterozygous fish (F1) carrying the same rp2 mutation were crossed (F1 x F1) and 
their progeny genotyped when they reached ~3 months. Among their progeny (F2), 
WT, heterozygous and homozygous rp2 mutants were found in numbers that 
approximated Mendelian inheritance (Figure 5.2A shows Sanger sequencing of 
homozygous mutant fish). Knockdown of rp2 by morpholino injections has been 
reported to lead to obvious developmental phenotypes such as curved tail, 
hydrocephalus, small eyes and heart looping, that do not require histological 
observation or crossing to a reporter line to detect (Hurd et al. 2010, Shu et al. 2011). 
Interestingly, the rp2 mutants did not exhibit any embryonic phenotypes or lethality, 
reached adulthood and were fertile (data not shown). Because of this, I was able to 
maintain and breed rp2 mutant lines in homozygosity. This showed that genetic 
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inactivation of rp2 does not lead to the same phenotype as embryonic knockdown 
strategies.  
All identified mutations are predicted to be frameshifting, leading to premature stop 
codons. The del8 rp2 allele is predicted to encode a truncated polypeptide containing 
a stretch of 20 incorrect amino acids, starting with a Glu to Gly substitution at 
position 73 (pGlu73Glyfs*20). The ins1 allele is also predicted to encode a truncated 
polypeptide, containing a stretch of 21 incorrect residues starting with a Val to Gly 
substitution at position 75 (pVal75Glyfs*21). On the other hand, the del4 allele is 
predicted to encode a somewhat longer truncated polypeptide with 37 incorrect 
amino acids, starting with a Thr to Trp substitution at position 74 (pThr74Trpfs*37) 
(Appendix figure 5). To investigate the severity of these mutant alleles, I examined 
the levels of rp2 transcript in 3 dpf-old pooled embryos that were either wild-type 
AB, del8 or ins1 homozygous mutants by real-time qPCR and normalised against the 
zebrafish β-actin gene actb1, a housekeeping gene used routinely in the lab which 
shows consistent levels of expression (Figure 5.2B). To test for any alternative 
transcripts that might remain unaffected by the mutations I generated, I used three 
different sets of primers encompassing different exon-exon junctions across the 
transcript (Exons 1-2 pair which encompasses the mutations and exons 3-4 and 4-5 
pairs which are found downstream of the mutations). The primer pairs in relation to 
the transcript are shown as arrows in Figure 5.1. Both del8 and ins1 mutations lead to 
a decrease in transcript levels of approximately 70% compared to the wild-type 
transcript, indicating increased mRNA degradation possibly due to nonsense-
mediated decay. The existence of one unique qPCR product in each case was 
confirmed by melting curve analysis and agarose gel analysis (Appendix figure 6A). 
Alignment of Sanger-sequenced cDNA molecules used as templates for qPCR did 
not reveal any alternative splicing events in the mutants compared to WT embryos 
(Appendix figure 6B). To test for expression at the protein level, I conducted western 
blotting in whole eye lysates from adult (7 months) F3 homozygous mutant and 
wild-type (derived from the progeny of founder 4) fish, using an anti-human RP2 
antibody previously used to detect the zebrafish protein (Shu et al. 2011) (Figure 
5.2C). I previously confirmed that this antibody can detect zebrafish Rp2-GFP when 
expressed in HEK293T cells (Appendix figure 7). Taken together, these results 
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suggest that the del8 and ins1 mutations at least are severe and lead to null alleles. 
However, it should be noted that there is an apparently non-specific band which is 
detected by the anti-RP2 antibody at a much higher molecular weight than wild-type 
RP2 protein only in the del4 and del8 mutant eyes (indicated by a red asterisk in 
Figure 5.2C). Because this band appears in two lines only and is stronger in the del4 
fish that do not display a retinal degeneration phenotype, as it will be discussed later 
in the chapter, future research should be conducted to exclude any possibility that the 
del4 and del8 lines are hypomorphic (for example, if the unspecific band corresponds 





Figure 5.1. Ensembl annotation of the rp2 gene in zebrafish and the position of 
CRISPR- induced mutations.  
An Ensembl-based annotation of Danio rerio’s rp2 gene is shown in orange colour 
where introns, exons, and untranslated regions are depicted as lines, filled boxes, and 
empty boxes, respectively. The genomic sequence targeted by gRNA1 is located 
close to the beginning of exon 2, with the PAM sequence highlighted in red. Primers 
used for real-time PCR are shown in red (pair 1), purple (pair 2) and blue (pair 3) 
arrows. Below the gene structure, an Ensembl representation of zebrafish and other 
vertebrate RP2 cDNA molecules (from NCBI RefSeq and ENA databases) aligned to 
the genome is shown in green. The alignment of the zebrafish Rp2 protein’s Ensembl 
sequence, as well as that of the human orthologous RP2 protein, to the genome, are 
shown in yellow colour. Below the zebrafish protein’s alignment, the position of the 
main domains of the protein, TBCC-like, and NDK-like, are shown in red. These are 
encoded by genomic sequences downstream of the disruptions caused by 
CRISPR/Cas9. In addition, known sequence variants in the zebrafish gene are 
included in the diagram with the explanation of their nature found below in the 
“legend” section. Finally, the Ensembl LASTz analysis uses pink colour to show 
blocks of synteny in the aligned genomic sequences of zebrafish and human genes. 




Figure 5.2. Induction of deleterious mutations in the zebrafish rp2 gene.  
A) Sanger sequencing on DNA isolated from homozygous mutant adult fish verified 
the existence of mutations in the 3 main lines that were created by targeting rp2 gene 
with gRNA1. The 8 residues that are deleted from the del8 mutant, 4 residues deleted 
 152 
from the del4 mutant (big and small box, respectively, on WT sequence) and the 
extra residue that is inserted in the ins1 mutant are enclosed in red boxes. B) rp2 
transcript levels (normalised to β1 actin transcript levels) are reduced in 3 dpf 
embryos that are homozygous for the del8 and ins1 mutations, compared to WT 
embryos. This reduction implies that nonsense-mediated decay of the transcripts is 
taking place. Levels of expression were estimated by real-time qPCR using three sets 
of primers encompassing the exon-exon junctions between exons 1 and 2, 3 and 4 
and 4 and 5 (error bars correspond to S.E.M. from 3 biological repeats of the real-
time qPCR experiment, p< 0.005 for all WT vs mutant values assessed by one-
sample t-test). Au=arbitrary units C) In order to confirm the absence of full-length 
Rp2 from the mutant lines, protein was extracted from whole adult eyes and 
subjected to SDS-PAGE and western blotting using an antibody raised against a 
human RP2 peptide. The red arrow points to the band on the predicted molecular 
weight for Rp2. The red asterisk points to apparently non-specific bands (discussed 
in further detail in the main text). The blotted membrane was subsequently stripped 
and re-probed with an anti-β1 actin antibody as a loading control.  
 
5.2.2 Characterisation of retinal structure in adult rp2 mutant fish by 
histology 
Since the rp2 mutant zebrafish did not display any externally obvious embryonic 
defects, I decided to investigate the integrity of the retinal structure in adult fish by 
histology. In several mouse models of RP (Thompson et al. 2012, Li et al. 2013a, 
Sun et al. 2016), retinal degeneration manifests as a decline in the thickness of the 
OS and the ONL, where the photoreceptor nuclei are found, due to cell death. To test 
if this is the case in my zebrafish models, I generated 7 µm-thick paraffin retinal 
sections cut orthogonally to the vertical meridian of the eye from homozygous 
mutant F2 fish and wild-type siblings and used H&E stain to visualise the different 
layers of the retina. Subsequently, I measured the thickness of the photoreceptor 
layer (PL) (combined ONL and OS), and the INL, where bipolar, horizontal and 
amacrine cells reside (Figures 5.4-5.7). Homozygous fish for the ins1 mutation were 
examined at 9 months and displayed thinning of the PL compared to their wild-type 
siblings; this defect seems to be primarily due to the thinning of the OS rather than 
the nuclear layer (Figure 5.3). The difference occurs mainly at the nasal side and the 
central retina (near the optic nerve). 
 The observation that not all parts of the retina degenerate at the same rate has been 
reported before for other zebrafish models of retinal degeneration, both during 
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development and in adulthood. For example, cones degenerate in the central one-half 
of the retina at 4 dpf in pde6c mutant zebrafish embryos; because this pattern occurs 
during development, it is explained by the fact that central photoreceptors are more 
mature than peripheral ones (Stearns et al. 2007). In the nba zebrafish mutant, rod 
and cone degeneration is observed only in the central-most regions of the retina 
during adulthood (Li and Dowling 1997). This phenomenon is probably attributed to 
the fact that the zebrafish retina continues to grow beyond larval stages via the 
continuous addition of new cells at the peripheral region of the retina called the 
“ciliary marginal zone”. As a result, the retina that was generated in the embryonic 
and larval stages is found at the centre of the retina near the optic nerve head, while 
more recently generated retina is found near the tissue periphery (Hoon et al. 2014). 
Interestingly, the remnant of the larval retina in the adult fish retains a different, less 
organised distribution pattern of cone photoreceptors compared to the rest of the 
retina (Allison et al. 2010). These differences might account for my observation that 
thinning of the PL is more pronounced at the central retina in the ins1 rp2 mutant 
zebrafish.   
The INL remains unaffected in Ins1 homozygous fish; because RP in humans and in 
animal models is known to specifically affect the photoreceptors and to spare other 
retinal cell types, the INL provides a good control to ensure that any observed 
difference is not an unspecific result of the histological processing (Figure 5.3D).  
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Figure 5.3. Ins1 homozygous fish show mild thinning of the photoreceptor layer 
compared to their wild-type siblings at 9 months.  
A) H&E staining and light microscopy of 7 µm retinal sections cut orthogonally to 
the vertical meridian of the eye. B) Ins1 mutant zebrafish display thinner 
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photoreceptor layer (PL), including both nuclei and OS, compared to their WT 
siblings at 9 months. P<0.001 according to paired two-tailed t-test6. C, D) 
Morphometric analysis showing PL thickness (C) and inner nuclear layer (INL) 
thickness (D) at different distances from the optic nerve head (point 0 on the x-axis) 
to the far peripheral retinae. Overall, although the mean thickness of the PL was 
significantly reduced in the ins1 homozygous fish compared to their wild-type 
siblings, this is not the case for the INL (P=0.1159 according to two-tailed t-test). 
Asterisks on the graph indicate significance when the thicknesses at different 
distances on the retina were compared individually and assessed by multiple t-tests 
(*: p≤0.05, **: p≤0.01). Error bars represent S.E.M for n=3 fish.  
 
9 month-old zebrafish harbouring the del8 mutation also display a decrease of the 
mean PL thickness across the whole retina, although the difference is less 
pronounced compared to the fish with the ins1 mutation (Figure 5.4A, C-left graph). 
Because retinal degeneration in the ins1 fish was more pronounced at the nasal 
retina, I carried out a closer analysis of the nasal retina of del8 fish. When taking 
measurements from the nasal side of the retina specifically, the difference in PL 
thickness between WT and del8 fish appears more pronounced (Figure 5.4B, C-right 
graph). Again, INL thickness remains identical between wild-type and mutant fish 
along the length of the retina (Figure 5.4D). However, any differences in PL 
thickness are lost when examining 12 month-old fish (Figure 5.5). At this older age, 
although the overall mean thickness of the PL in the del8 fish appears mildly reduced 
compared to their WT siblings, no specific area of the retina appears much thinner. 
Therefore, any photoreceptor loss might be replaced by retinal regeneration as the 
fish get older. More experiments will be required to clarify this question. Finally, 
retinal sections from del4 homozygous fish were examined at 7 months and no 
statistically significant differences were found in terms of PL thickness between del4 
homozygous fish and their wild-type siblings (Figure 5.6).  
  
                                               
6 Mean difference of PL thickness (WT vs Ins1 at 9 months): 4.907 µm, with 95% 
confidence interval: 7.111 to 2.703 µm. 
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Figure 5.4. Del8 homozygous fish show very mild thinning of the photoreceptor 
layer compared to their wild-type siblings at 9 months.  
A) H&E staining and light microscopy of 7 µm retinal sections cut orthogonally to 
the vertical meridian of the eye. B) Morphometric analysis showing the thickness of 
the PL at the nasal retina and at different distances from the optic nerve head (point 0 
of the x-axis). Asterisks on the graph indicate significance when the thicknesses at 
different distances on the retina were compared individually and assessed by 
multiple t-tests (*: p≤0.05, **: p≤0.01). C) Del8 mutant zebrafish display thinner 
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photoreceptor layer (PL), including both nuclei and OS, compared to their WT 
siblings at 9 months. This difference is more pronounced when assessing the nasal 
side of the retina only. P=0.039 (whole retina), p = 0.0020 (nasal retina) according to 
two-tailed Wilcoxon matched-pairs signed rank test. D) Morphometric analysis 
showing the thickness of the inner nuclear layer (INL) at different distances from the 
optic nerve head (point 0 on the x-axis) to the far peripheral retinae. Mean thickness 
of the INL is not significantly different between WT and mutant retinae (P=0.3223 
according to two-tailed Wilcoxon matched-pairs signed rank test). Error bars 





Figure 5.5. Del8 homozygous fish show only very mild thinning of the 
photoreceptor layer compared to their wild-type siblings at 12 months.  
A) H&E staining and light microscopy of 7 µm retinal sections cut orthogonally to 
the vertical meridian of the eye. B) Del8 mutant zebrafish display marginally thinner 
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photoreceptor layer (PL), including both nuclei and OS, compared to their WT 
siblings at 12 months. P=0.0309 according to two-tailed paired t-test7. C, D) 
Morphometric analysis showing the thickness of the PL (C) and the inner nuclear 
layer (INL) (D) at different distances from the optic nerve head (point 0 on the x-
axis) to the far peripheral retinae. Overall, although the mean thickness of the PL was 
marginally reduced in the del8 homozygous fish compared to their wild-type 
siblings, none specific area of the retina appeared significantly thinner when values 
for different distances from the optic nerve were compared individually and assessed 
by multiple t-tests. The mean thickness of the INL was not significantly thinner 
between the two groups (P=0.5264 according to two-tailed paired t-test) and no 
individual point displayed statistically significant difference between the INL of WT 
and mutant fish. Error bars represent S.E.M for n=3 fish.  
  
                                               
7 Mean difference of PL thickness (WT vs Del8 at 12 months): 2.501 µm, with 95% 




Figure 5.6. Del4 homozygous fish do not show thinning of the photoreceptor 
layer compared to their wild-type siblings at 7 months.  
A) H&E staining and light microscopy of 7 µm retinal sections cut orthogonally to 
the vertical meridian of the eye. B) Del4 mutant zebrafish do not display thinner 
photoreceptor layer (PL), including both nuclei and OS, compared to their WT 
siblings at 7 months. P=0.1571 according to two-tailed paired t-test. C) 
Morphometric analysis showing the thickness of the PL (C) and the inner nuclear 
layer (INL) (D) at different distances from the optic nerve head (point 0 on the x-
axis) to the far peripheral retinae. Overall, the mean thickness of the PL was not 
significantly reduced in the del4 homozygous fish compared to their wild-type 
siblings, and none specific area of the retina appeared significantly thinner when 
values or different distances from the optic nerve were compared individually and 
assessed by multiple t-tests. Error bars represent S.E.M for n=3 fish.  
 
 
5.2.3 Generation of rp2 knockout/eGFP knock-in zebrafish model   
When I started my project, it was not known yet whether rp2 knock-out would cause 
embryonic lethality in homozygosity. If the mutant adult fish had to be kept in 
heterozygosity, I had to find a way to isolate homozygous mutant embryos to use in 
the small-molecule screen. For this reason, I planned to engineer fluorescent 
reporter-encoding sequences in the zebrafish genome and in particular at the Cas9 
endonuclease target site in the rp2 gene. This approach would have a double 
purpose: 1) to easily isolate rp2 homozygous mutants based on fluorescence 
(especially if I generated two heterozygous lines encoding different fluorescent 
reporters that I could intercross) 2) to express fluorescent reporters under the control 
of rp2 promoter sequences, offering the ability to study Rp2 expression. Knock-in of 
fluorescent reporters has been achieved before by homologous recombination in 
endogenous zebrafish loci where double-stranded breaks have been induced by 
TALENs (Zu et al. 2013). On the other hand, a simpler approach has also been 
reported where large DNA cassettes were injected into sites of Cas9 targeting in 
exogenous loci in the zebrafish genome via non-homologous end joining, with three 
times higher efficiency (Auer et al. 2014). Their simple technique includes co-
injecting the embryo with a vector containing the DNA cassette downstream of a 
sequence identical to the gRNA target sequence in the genome. Since gRNA would 
guide Cas9 to cleave both the genomic site and the vector, the latter would then 
integrate into the genome as a linear DNA piece.  
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To achieve this, I generated the relevant constructs using pEntr plasmid as a 
template. Into this vector, I cloned eGFP and mKate2 coding sequences downstream 
of a “bait” sequence which is identical to the gRNA 1 target sequence in the rp2 
gene, and a P2A self-cleaving peptide sequence between them (Figure 5.7). 
Subsequently, I injected the modified vector into 1-cell stage zebrafish embryos 
together with nCas9 mRNA and gRNA1. However, co-injecting the constructs 
proved toxic for the embryos and this impeded the continuation of the project. 
However, this preliminary work can provide the basis for a future project with the 
aim to ameliorate the efficiency of the injections and produce the desired zebrafish 
lines.   
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Figure 5.7. Description of the experimental design for the generation of an rp2 
knockout/eGFP knock-in zebrafish model. 
The following components were injected into 1-cell stage zebrafish embryos: gRNA 
against the target site on rp2 exon2, WT Cas9 mRNA and a pEnter vector containing 
eGFP coding sequence downstream of a ‘bait’ sequence which is identical to the 
gRNA target sequence. Cas9 is expected to cleave both the plasmid and the genomic 




5.3.1 The discrepancy between gene editing approaches for targeting 
rp2 in zebrafish and morpholino-mediated knockdown  
Morpholino-mediated knockdown of zebrafish rp2, a method which has been the 
gold standard in zebrafish reverse genetics for years, leads to severe developmental 
defects that are easily detected, according to more than one studies (Hurd et al. 2010, 
Shu et al. 2011, Desvignes et al. 2015).  However, rp2 morphants are not a good 
platform for conducting chemical screens because of the variability of the 
phenotypes and the difficulty in controlling toxicity arising from morpholino 
injections. On the other hand, if rp2 mutants presented with developmental 
phenotypes, they would provide an ideal platform for a high-throughput small 
molecule screen to identify substances that can rescue or modify the phenotype 
caused by the loss of Rp2 function. To create a uniform population of mutant 
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embryos and to avoid the variabilities in phenotype severity and knockdown 
efficiency, which are often observed in a population of morpholino-injected 
embryos, I aimed to generate stable genetic mutations in rp2. I generated F2 fish 
homozygous for frameshifting mutations in rp2 exon 2 which are predicted to 
generate premature stop codons, namely del8, del4, and ins1. Truncation mutations, 
due to deletions or premature stop codons, are the most common type of RP2 
pathogenic mutations and lead to complete protein degradation (as in the case of the 
common p. R120X mutation) (Schwarz et al. 2015) or aggregation in insoluble 
fractions when expressed in mammalian cells (Schwahn et al. 2001). I found that the 
mutations I generated caused increased rate of mRNA degradation in 3 dpf embryos 
and absence of protein in the adult eyeballs- the tissue I focused my experiments on. 
Therefore, the rp2 mutants I generated should be good models for RP2 disease in 
humans.  
However, it soon became apparent that the homozygous mutant embryos did not 
present with any externally obvious developmental malformations. Moreover, F2 
homozygous fish could be intercrossed to produce viable embryos. Interestingly, 
while this project was ongoing, a study was published where the authors used 
TALENs to generate zebrafish that are homozygous for a 5 base-pair deletion in rp2 
exon 2 (Liu et al. 2015) (“del5”). Similarly to my observations, (Liu et al. 2015) 
report the absence of any developmental phenotype and the ability of adult 
homozygous fish to breed normally despite the complete absence of rp2 expression 
and reduced rp2 transcript levels. This latest study combined with my results put a 
question mark over the conclusions drawn by morpholino-mediated knockdown 
experiments. In fact, since the emergence of genome editing strategies in zebrafish, 
finding that the knockout embryos do not display the same phenotypes as the 
morphants is a very common occurrence. It has even been claimed that, most of the 
time, zebrafish mutants generated by targeted genome editing exhibit no obvious 
phenotype (Kok et al. 2015). These findings highlight the off-target effects 
morpholinos often produce in zebrafish embryos, even when the morphants’ 
phenotype can be rescued by co-injection with the wild-type mRNA, and the need to 
find more stringent controls for this type of experiments. However, other studies 
indicate that morpholino-mediated knockdown should not be rejected too easily as 
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different reasons might be responsible for the discrepancy in phenotypes caused by 
the two experimental approaches, like the generation of hypomorphic alleles and the 
induction of genetic compensation by knockout approaches. For example, a recent 
study found that genetic lesions lead to specific upregulation of proteins in two 
genetic knockout zebrafish lines, a phenomenon which can account for the 
phenotypical rescue and does not occur after knockdown (Rossi et al. 2015).  
That said, it still cannot be ruled out that Rp2 has a role in the zebrafish embryo’s 
early development, especially since it is a maternally inherited mRNA, even though I 
observed that progeny of homozygous mutant mothers were viable and developed 
normally. To solve this question in my mutant lines, I would first have to investigate 
rp2 expression in the ovaries of mutant female fish and in very early embryos, as 
specific alternative rp2 transcripts might be expressed in these tissues that are not 
affected by the mutations I generated. In addition, morpholino-mediated knockdown 
of rp2 to study developmental phenotypes can still be used if the morpholinos are 
titrated on rp2 null embryos to find an appropriate concentration that does not lead to 
any developmental phenotypes on this background. Another approach to 
investigating the validity of morpholinos is to examine if there is p53 mRNA 
induction after injections, as this often hints at non-specific effects (Robu et al. 
2007). However, solving this problem was not a central aim in my Ph.D. 
 
5.3.2 Comparing the phenotype of adult zebrafish rp2 mutants to other 
reported animal models of RP2 disease 
According to the other study describing targeting zebrafish rp2 by gene editing 
methods, Del5 rp2 null zebrafish display late-onset retinal degeneration (which starts 
at ~4 months and is very pronounced by ~7 months); this affects both rods and cones 
and manifests mainly as shorter and aberrant OS layers (Liu et al. 2015). This 
phenotype is comparable to Rp2 knockout mouse models, although thinning of the 
ONL due to the loss of photoreceptor nuclei, one of the main manifestations of 
retinal degeneration in the mouse models, is not observed in zebrafish. Moreover, 
degeneration in the del5 zebrafish model is characterised by slightly decreased 
 166 
protein levels and/or impaired trafficking of lipid-modified phototransduction 
proteins Grk1 (rhodopsin kinase), Gnat1 and Gnb1 (alpha and beta subunits of rod 
transducin), as well as total prenylated proteins in the retina (Liu et al. 2015). In that 
aspect, the del5 zebrafish model agrees with the gene trap mouse model (Zhang et al. 
2015) more than with the exon2 deletion mouse model (Li et al. 2013a) (the 
phenotypes of these two mouse models are described in detail in Chapter 1.3.3).  
Ins1 rp2 null zebrafish which are described here display mild late onset thinning of 
the PL at ~9 months, manifesting mainly as shorter OS, which is the same 
histological observation that was reported in the del5 zebrafish study (Liu et al. 
2015). Importantly, histopathological examination of eyes from RP patients have 
also reported the existence of poorly organised, shorter or absent OS (Ben-Arie-
Weintrob, Berson and Dryja 2005). Protein levels of phototransduction proteins were 
not assessed in my thesis, as in previous studies (Liu et al. 2015, Liu et al. 2017a). 
However, I provide here the complete histological analysis of the thickness of retinal 
layers across the whole length of the retina, which is not reported in the other study. 
My analysis reveals that thinning of the PL at the ins1 model is more pronounced at 
the central area of the nasal retina. Given the polarity of the zebrafish retina and 
because OS thickness is not consistent across the length of the tissue, I show here 
that is important to report which exact area of the retina a picture has been taken 
from.  
Ins1 zebrafish seem to display a more late-onset and milder phenotype compared to 
del5 zebrafish, as reported in the other study (Liu et al. 2015). It is not clear why this 
discrepancy occurs, but it is possible that it is a result of inconsistency in light 
exposure levels between the different fish rooms. In addition, it is surprising that the 
del4 mutant fish do not display any retinal degeneration, despite the absence of Rp2 
protein from their eye lysates (Figure 5.2C). It is possible that the age when the del4 
animals were tested (7 months) was too early for any degeneration to show. Because 
Ins1 fish originate from a different founder female (no 7) than del4 and del8 (no 4), 
another explanation could be that modifier genes are expressed in one background 
and not the other and manage to rescue the degeneration phenotype. This situation 
might reflect the extreme phenotypic variability observed among RP2 patients, even 
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within the same family. More experiments will be needed to clarify this question. For 
example, backcrossing rp2 homozygous null fish from the founder 4 background to 
fish from the founder 7 background and examining retinal lamination in the progeny 
could help clarify if modifier genes play a role in the emergence of retinal 
degeneration.  
Moreover, retinal degeneration should be confirmed in the Ins1 fish by further 
analysis, for example histological examination of a bigger animal sample and in 
older ages, assessing visual function by examining ERG or optokinetic response 
(OKR), and examining cone and rod cell death more closely by 
immunofluorescence. Finally, the localisation and expression levels of lipid-modified 
phototransduction proteins Grk1 and Pde6 in retinae from the ins1 fish should be 
examined in the future in order to verify the conclusion of the other study that Rp2 
participates in the trafficking of these proteins (Liu et al. 2015). 
Finally, it will be important to determine whether thinning of the photoreceptor layer 
is due to cell loss or defective growth of the retina. As mentioned before, cell 
proliferation continues throughout the lifetime of zebrafish in the ciliary marginal 
zone (Malicki et al. 2016). To test if cell proliferation is affected in the rp2 mutant 
retinae, 5-bromo-2-deoxyuridine (BrdU) incorporation and staining can be used, as 
well as staining for proliferating cell nuclear antigen (PCNA), a marker of 
proliferation expressed in the retinal mitotic progenitor cells (Morris et al. 2008, 
Malicki et al. 2016).  
 
5.3.3 Potential use of rp2 null embryos for studying the role of Rp2 in 
DNA damage repair 
Because of the lack of developmental phenotypes at the embryonic level, the rp2 
mutant lines are in the end not appropriate for a phenotype-based screening of small 
molecules, as it was originally designed. However, the embryos of these fish could 
provide a whole organism platform to test if the RP2-DNA PK complex plays a role 
in DNA damage repair, expanding on cell culture studies by taking advantage of the 
benefits of the zebrafish embryos as an experimental model. Zebrafish are a valid 
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model for investigating DNA repair deficiencies in humans because they have 
orthologues of genes involved in all known DNA damage pathways of mammals (Pei 
and Strauss 2013). Prkdc null zebrafish have been already generated by genome 
editing technologies. Their main characteristic is severe combined 
immunodeficiency (scid), as is the case with DNA PKcs deficiency in mice and 
human patients (Mathieu et al. 2015), characterised by the absence of functional T/B 
lymphocytes, growth delay and susceptibility to infections (Jung et al. 2016). 
Although the authors of this study did not specifically look for neuronal phenotypes 
or retinal manifestations, it appears that DNA PKcs in zebrafish has the same 
functional roles as in humans, at least in the maturation of the immune system. 
Additionally, the genes encoding for Ku70 and Ku80 zebrafish orthologues have 
been cloned and it has been found that both these proteins originate from maternally 
inherited transcripts and are strongly expressed in the embryonic brain and retina. 
For both these proteins, it was proved that knockdown results in radiosensitivity of 
the embryos (Bladen et al. 2005, Bladen et al. 2007).  
It is, therefore, apparent that zebrafish embryos possess a functional DNA PK 
holoenzyme and are appropriate for studying the consequences of RP2 loss of 
function in DNA repair. An experiment that could be readily performed is to treat the 
embryos with increasing doses of ionising radiation and perform TUNEL assay to 
assess cell death in the retina or the whole embryo. If cell death is more pronounced 
in the rp2 null embryos after radiation compared to WT embryos, it is an indication 




Chapter 6. Conclusions and future directions 
6.1 The importance of basic research for the identification of novel 
therapies for RP  
Today, no widely available treatment exists that can prevent or reverse vision loss in 
patients with inherited retinal degenerations. The disease can at best be managed or 
slowed down via the treatment of specific symptoms, nutritional supplements such as 
lutein/zeaxanthin macular pigments, avoidance of sunlight, and supportive 
equipment (Sahel et al. 2014). Research has so far focused on two different strategies 
to treat inherited retinal degenerations: 1) gene-independent therapies and 2) gene- 
and mutation-specific therapies. The first group includes therapeutic approaches 
which can apply to many different types of RP and other retinal degenerations 
because they focus on pro-survival signalling, cell restoration or preventing the 
secondary death of cones. For example, the administration of neurotrophic factors 
and other pharmacological approaches have shown efficacy in animal models, and 
some have been assessed in clinical trials with results which have been limited but 
existent nonetheless (e.g., regarding calcium channel blockers (Nakazawa et al. 
2011, Sacchetti et al. 2015)). Moreover, cell replacement therapy, i.e. the integration 
and differentiation of retinal precursor cells in the diseased retina, is a very 
promising strategy for degenerative diseases that lead in cell death and altered retinal 
morphology, and it has been successfully tried in several rodent models. The sources 
of those cells are either embryonic stem cells (ESCs) or induced pluripotent stem 
cells (iPSCs) (reviewed in (Zarbin 2016)). Recently, human ESC-derived RPE cells 
were implanted in age-related macular degeneration (AMD) and Stargardt’s disease 
patients in a clinical trial with no significant adverse effects (Schwartz et al. 2015). 
One must not overlook advances in a different field, the field of retinal prosthetics 
devices, which have acquired commercial use approval in the USA and function in 
activating the inner retinal network in the place of lost photoreceptors (Sahel et al. 
2014). 
Among the category of gene-specific prospective therapies, gene therapy is perhaps 
the most promising approach, aiming to augment or replace the improperly 
functioning genes with wild-type genes via adeno-associated or lentiviral vector 
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delivery. Clinical trials for RPE65 gene replacement in canine models and patients 
with LCA are safe and resulted in improvement of visual functions for at least three 
years (Cideciyan 2010, Sharif and Sharif 2017). Today, gene replacement clinical 
trials are ongoing in patients with Stargardt’s disease, MERTK-associated RP, 
choroideremia and AMD (Sahel et al. 2014). RP type 2 is an appropriate candidate 
for this kind of therapeutic intervention because it is a monogenic disease, it is 
caused by loss-of-function mutations, and wild-type gene delivery has already been 
tested in rodent models and showed rescue of retinal degeneration (Mookherjee et al. 
2015).  
Another promising aspect of gene therapy is the use of CRISPR/Cas9 gene editing 
techniques to correct genetic defects in the retina. Because photoreceptors are 
nondividing cells and primarily use NHEJ to correct DNA breaks such as the ones 
induced by the CRISPR system, this therapeutic development is closer to actual 
application in diseases caused by dominant negative alleles. For example, disruption 
of a dominant negative rhodopsin allele (S334Ter) by CRISPR-based knockout has 
been recently tried in vivo in a rat model and led to photoreceptor rescue (Bakondi et 
al. 2016). In cases of loss-of-function mutations, on the other hand, the potential to 
correct endogenous genes via HR-based repair of CRISPR DNA lesions using a 
donor template, while successful in cell culture, still needs a lot of study and 
improvement before it can be applied to animal models of photoreceptor 
degeneration [reviewed by (Chrenek, Nickerson and Boatright 2016)]. 
Despite the success of LCA trials in restoring visual function, a subsequent study 
showed that transgene expression failed to halt retinal degeneration in treated 
patients, possibly because a significant portion of the photoreceptors had already 
“committed” to cell death at the time of administration. This study also suggested the 
combination of different therapeutic strategies as the way to achieve treatment of 
retinal degeneration (Cideciyan et al. 2013). Furthermore, studies in mouse models 
for the loss of RPGR function, the other major gene for X-linked RP, showed that the 
overexpression of the RpgrEx1-19 isoform on the Rpgr-null background led to a more 
severe phenotype than the one caused by the loss of Rpgr alone (Wright, Hong and 
Perkins 2011). Rp2 null mouse studies also report retinal toxicity resulting from high 
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doses of the exogenous gene (Mookherjee et al. 2015). Therefore, the experience of 
gene therapy clinical trials for retinal diseases has highlighted the importance of a 
thorough knowledge of the natural history of the disease and the functions of the 
transgene product, in order to predict any potential toxic effects of overexpression in 
the retina.  
The work presented here is important because it suggests previously unknown 
functions of RP2 in the retina and can thus promote future research on the pathways 
implicated in disease and the identification of novel therapies. It can also enhance the 
safety of future clinical trials by pointing pathways in the cell that can be affected by 
the protein’s overexpression. For example, if it is proved that RP2 is indeed a 
positive regulator of cell motility by modulating the interaction between OSTF1 and 
MYO1E, as it is suggested in Chapter 3, then future research must investigate any 
potential unwanted side-effect of transgene overexpression to stimulate the migratory 
capacity of the RPE layer.  
 
6.2 Studying the RP2-OSTF1 interaction: future directions 
In Chapter 3, I showed that the C-terminus of RP2 participates in the interaction with 
OSTF1 and that this function is evolutionarily conserved in vertebrates since the 
residues identified as belonging to the interaction interface are strictly conserved in 
all the species tested. Because OSTF1 is an adaptor for c-SRC kinase (Szymkiewicz 
et al. 2004), I tested the hypothesis that c-SRC phosphorylates RP2 via the 
interaction with OSTF1. Despite showing that c-SRC can directly phosphorylate RP2 
in vitro and that overexpression of c-SRC leads to phosphorylation of RP2 at Y27, 
my experiments were inconclusive about the existence of endogenous c-SRC-
mediated RP2 phosphorylation. This pitfall points out that the use of antibodies 
against global tyrosine phosphorylation was not the best tool for answering this 
question and that phospho-specific antibodies need to be developed.   
Secondly, I examined if RP2 null cells display abnormal migratory behaviour in 
culture, following previous suggestions that OSTF1 is a negative regulator of cell 
motility (Tanimura et al. 2011, Tanimura et al. 2016), and observed reduced 
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migration capacity compared to wild-type cells. Many questions stem from this 
observation. Firstly, my results suggest that RP2 has a positive effect on cell motility. 
One interesting hypothesis that should be tested in the future is that RP2 exerts this 
effect by modulating the OSTF1-MYO1E interaction. In fact, a study from our group 
that was recently published and includes part of the work presented here in Chapter 3 
suggests that RP2 negatively regulates the OSTF1-MYO1E interaction by recruiting 
OSTF1 to the cell membrane (Lyraki et al. 2018). This hypothesis is presented 
schematically in Figure 6.1A. Another important question that follows my 
experiments is after what trigger/under what conditions the RP2-OSTF1 interaction 
occurs. It could be that RP2 has two separate functions, the regulation of ciliary 
protein transport in ciliated cells and the regulation of cell migration via the 
interaction with OSTF1 in dividing, non-ciliated cells.   
Finally, it will be interesting to examine how this effect might be translated in 
impaired cytoskeletal rearrangements in the diseased retina. Interestingly, the other 
major XLRP protein, RPGR, has been suggested before to influence actin dynamics 
by several studies. One study showed that actin turnover and interact with the 
scaffold protein Whirlin which participates in the cytoskeletal assembly in 
photoreceptors (Lyraki et al. 2016, Wright, Hong and Perkins 2012). Recently, 
RPGR was also found to mediate actin disassembly in the photoreceptor CC and, 
consequently, rhodopsin transport, via its interaction with the actin-severing protein 
Gelsolin (Megaw et al. 2017). To further understand if loss of RP2 also leads to 
defective cytoskeletal rearrangements in vivo, photoreceptors and RPE cells from 
Rp2 null mice could be subjected to cytoskeletal staining and tested for OS 
phagocytosis.  
 
6.3 A potential role of DNA damage-associated signalling in RP type 2: 
future directions 
Another outcome of the work presented here is the identification of DNA PKcs as an 
interaction partner of RP2, based on MS/MS analysis of the complexes that co-
precipitate with RP2 from HEK293T cells. One of the key functions of DNA PKcs is 
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in the NHEJ pathway for the repair of DNA DSBs. DSB repair is of particular 
importance for the viability of neurons in the central nervous system, both during 
neuronal development and in mature neurons, considering their high metabolic 
activity and post-mitotic status (Borges, Linden and Wang 2007). It is important to 
note that because neurons are non-dividing, they lack replication-dependent DNA 
repair mechanisms such as HR, and must solely depend on NHEJ for the repair of 
DSBs. These characteristics are also true for the photoreceptors, with the added 
factor of high PUFA content and constant light exposure which renders them even 
more susceptible to DNA damage, especially ROS-mediated damage. For this 
reason, future experiments should focus on elucidating if the lack of RP2 function 
leads to accumulation of unrepaired DNA damage underlying photoreceptor 
degeneration. Since my work showed that RP2 null cells repair X-ray-induced DSBs 
normally, and because of the photoreceptor’s physiology, I suggest that future 
research should focus on ROS-induced DNA lesions, rather than “clean” DSBs 
induced by radiation or topoisomerase inhibitors. On the other hand, it is important 
to note that my experimental setup did not distinguish HR from NHEJ modes of DSB 
repair, and therefore it might not have detected subtle defects in one or the other 
pathway.  
Two existing in vivo systems can be ideally used for these types of experiments. 
Firstly, levels of DNA damage accumulated physiologically pre- and during retinal 
degeneration can be compared in Rp2 null vs. WT mice. For the visualisation of 
DNA damage, antibodies can be used which detect different kinds of DNA damage, 
such as 8-hydroxyguanosine, 53BP1 and γH2AX. Secondly, the response of the 
retina when challenged with excessive amounts of DNA damage, for example after 
treatment with H2O2 or cytotoxic drugs, can be compared in rp2 null vs. WT 
zebrafish embryos. The effect on these processes of modulating DNA PKcs activity, 
for example using specific DNA PKcs inhibitors, should also be examined. 
On the other hand, it is important to note that in my MS/MS analysis, RP2 did not 
co-precipitate with other DDR proteins, such as ATM, ATR, or other NHEJ 
components (Appendix Table 1). This observation suggests that RP2 is not a part of 
classical DNA repair pathways in the nucleus, but might instead interact with DNA 
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PKcs in a non-canonical context. The idea that DNA PKcs has specific functions that 
are not shared by other NHEJ components has been suggested before. Studies have 
shown a specific requirement for DNA PKcs during neural development in general 
and retinal development in particular (Woodbine et al. 2013, Baleriola et al. 2010). 
Interestingly, my work suggested that a kinase from the DNA PK complex can 
phosphorylate RP2 in vitro at a site which has already been identified as 
phosphorylated under neurite growth conditions (Wang et al. 2011) (Figure 6.1B).  
Some of the specific functions of DNA PKcs might even take place outside the 
nuclear compartment, and my work already suggested that the protein might interact 
with RP2 in the plasma membrane (Figure 6.1B). Other studies previously suggested 
that DNA PKcs acts in relaying DNA damage signal to the cytoplasm and the 
cytoskeleton (Kotula et al. 2013, Farber-Katz et al. 2014). Therefore, it will be useful 
to study if modulation of the DNA PKcs function can affect RP2-dependent 
processes such as RP2-regulated protein trafficking. Another interesting subject of 
future study is the regulation of Golgi cohesion which has been attributed to DNA 
PKcs, especially since patient-derived RP2 null cells display abnormal Golgi 
fragmentation, according to an earlier study (Schwarz et al. 2015). Moreover, it 
should be investigated if DNA PKcs localises to primary cilia, the cilium-associated 
centrioles, or the photoreceptor CC, similarly to RP2.  
Importantly, following up the experiments presented in Chapter 5 could lead to 
clinical benefits. Because DNA PK has emerged as an attractive target for cancer 
therapy, several series of selective and potent inhibitors have been designed (Ihmaid 
et al. 2017). These could be repurposed for the treatment of RP if future research 
shows that suppressing DNA PKcs activity can modulate retinal degeneration. 
Moreover, it is important to note that antioxidant therapy might present a promising 
approach to manage XLRP in the future if further research shows that excessive 
oxidative stress-induced DNA damage underlies photoreceptor loss due to RP2 
mutations. One example of a component that has been administered in RP patients in 
clinical trials is docosahexaenoic acid (DHA), an omega-3 fatty acid with 
neuroprotective and free-radical scavenging properties through its derivative NPD1 
(Bazan 2006). DHA administration has so far shown a poor capacity to ameliorate 
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visual acuity or fundus appearance but has slowed down the rate of progression of 
visual field sensitivity (Hoffman et al. 2015). However, if future research shows that 
ROS-induced DNA damage underlies retinal degeneration specifically in patients 
with RP2 mutations, DHA administration might show better results in these cases.   
Lastly, it is essential that future research establishes if there is a relationship between 
RP2 mutations and sensitivity to cytotoxic drugs and other DNA-damaging 
components. This information will be especially important for RP patients who need 
to undergo some form of anti-tumour therapy. Some studies have reported a link 
between retinal toxicity and cytotoxic chemotherapy (Blanchet, Wellemeyer and 
Burton 1992, Tang et al. 2017).   
 
6.4 Convergence of the OSTF1- and DNA PKcs-associated pathways 
The two ways for RP2 phosphorylation discussed in this thesis, i.e. c-SRC-mediated 
and DNA PKcs-mediated, might not be separate but belong in interdependent 
pathways. It has been shown before that c-SRC is activated by ionising radiation and 
has a role in relaying DNA damage signalling from the plasma membrane to the 
nucleus, via phosphorylation of EGFR and subsequent translocation to the nucleus 
and DNA PK activation. Suppression of c-SRC activation is associated with 
radiosensitivity (Dittmann et al. 2008). In addition, c-SRC phosphorylates the Ku70 
subunit of the DNA PK holoenzyme, and this phosphorylation has a protective role 
against hyperactive apoptosis (Morii et al. 2017). The development of phospho-
specific antibodies to Y27 and S213/T214 phosphorylation will aid in examining if 
the two modes of phosphorylation participate in the same pathway. Future studies 
should examine if phosphorylation in those two separate sites is induced after DNA 
damage and if suppressing phosphorylation in one site affects the other site, and vice 
versa.  
 
6.5 rp2 null zebrafish as models of retinal degeneration 
The necessary next step is to transfer in vitro studies on RP2 function to a more 
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physiological context, such as animal models. For this purpose, Chapter 5 of the 
thesis was dedicated to the generation of a zebrafish model for RP2 type 2 using the 
CRISPR/Cas9 method. At least two (ins1, del8) of the rp2 null zebrafish lines that I 
generated present with late-onset retinal degeneration characterised by thinning of 
the OS layer, similarly to human disease where the retina is properly formed and 
starts to degenerate later in life. Another study which reports the same phenotype in 
adult zebrafish with rp2 loss-of-function mutations (Liu et al. 2015) corroborates my 
results.  
My work showed that loss of Rp2 in zebrafish does not lead to developmental 
defects and embryonic phenotypes. Nonetheless, this observation will require further 
clarification, as it is not sure why rp2 is a maternally provided transcript if it has no 
role in early development (Desvignes et al. 2015).  The data presented in my thesis 
refute previous studies using morpholino injections to knock-down rp2 expression in 
zebrafish embryos, which describe a variety of embryonic phenotypes including 
small eyes (microphthalmia) and disorganised retina, pericardial oedema, laterality 
defects, body curvature and hydrocephaly (Desvignes et al. 2015, Hurd et al. 2010, 
Shu et al. 2011). Although these studies report rescuing the phenotypes by co-
injecting the embryos with WT rp2 mRNA, the specificity of the phenotypes is 
questionable because the rescue is only partial. Many other zebrafish mutants do not 
display the phenotypes reported by morpholino-mediated knockdown, even though 
these have been partially rescued by WT mRNAs (Kok et al. 2015). One useful way 
to identify non-specific phenotypes, a common occurrence following injections with 
morpholinos, is to test if the phenotypes arise when the injections take place in 
embryos that are null for the gene in question (Rossi et al. 2015). As a conclusion, it 
seems that the generation of knockout fish lines will be essential for all zebrafish 
research from now on.  
The rp2 null zebrafish represent important assets in the research for the molecular 
mechanisms that underlie RP, as they can be used to test hypotheses arising from 
biochemical approaches and to identify the functional relevance of RP2 interactions 
described in Chapters 3 and 4 of the present thesis. For example, I suggested in 
Chapter 3 that the involvement of RPE dysfunction in RP type 2 must be carefully 
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examined, as both RP2 and OSTF1 are expressed in the RPE, and the regulation of 
cell motility is related to important RPE functions in vivo. One way to examine this 
question would be to conduct mosaic analysis in the zebrafish model. It has been 
shown before that the transplantation of donor cells to a host embryo during the 
blastomere stage will result in a chimeric retina, where at least some donor cells will 
contribute to the neuroepithelium (Goldsmith et al. 2003, Tsujikawa and Malicki 
2004a). Using the mosaic analysis approach, it could be tested if mutant 
photoreceptors survive when they are in contact with WT RPE cells, or if WT 
photoreceptors degenerate when their environment is composed of mutant RPE cells. 
This experiment will show if the photoreceptor degeneration observed in RP is a 
cell-autonomous process and will reveal the exact site where RP2 exerts its role.  
Moreover, the rp2 null zebrafish embryos could be used to test whether RP2 
mutations confer sensitivity to DNA damage, as I have proposed in Chapter 4. This 
could be achieved by comparing the viability of WT and mutant embryos, as well as 
the amount of cell death in the retina and other tissues following exposure to DNA 
damage-causing drugs or ionising radiation [an approach which has been used before 
by (Bladen et al. 2005, Bladen et al. 2007)]. As a whole-organism platform, zebrafish 
embryos are far superior to cultured cells for this type of assays. If rp2 null zebrafish 
embryos display sensitivity to DNA damage, then they can be used for a small-
molecule screen looking for chemical compounds that alleviate or rescue this 
sensitivity. Finally, it should be examined whether any link of RP2 mutations to 
increased sensitivity to DNA damage is because of increased apoptosis due to the 
inability to repair DNA damage or cell cycle arrest due to the inability to resume 
proliferation after replication stress caused by DNA damage. This possibility can be 
examined in zebrafish retinae, taking advantage of the fact that proliferating cells 
exist throughout the animals’ lifetimes in the ciliary marginal zone (Hoon et al. 
2014). The amount of cell proliferation in WT and rp2 null retinae can be compared 
via staining for cell proliferation markers such as PCNA, or BrdU incorporation 
(Morris et al. 2008). 
Finally, zebrafish genetics can be leveraged to identify potential functional 
interactions between the two different RP2 interaction partners studied in the present 
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thesis, OSTF1 and DNA PKcs. For example, RP2/OSTF1, RP2/DNA PK and 
OSTF1/DNA PK double mutants could be generated to examine if mutations in both 
genes exacerbate or rescue the phenotypes caused by mutations in one of the genes 
only. Thus, it can be determined if the proteins act in the same pathway and whether 
they act upstream or downstream of RP2.  
As a conclusion, it seems that both mouse and zebrafish can successfully model late-
onset retinal degeneration caused by RP2 mutations (Liu et al. 2015, Zhang et al. 
2015, Li et al. 2013a) and will complement each other in future research. 
 
6.6 Final remark 
By demonstrating that RP2 participates in novel complexes, my work suggests that it 
is a multifunctional protein with more than one roles in cellular biology and that it 
might not be correct to view RP type 2 as a disease of exclusively ciliary pathology. 
This finding might benefit retinal research in general, as other forms of retinal 
degeneration might share the same pathogenic mechanisms, as well as ciliopathy 
research, by adding one more piece of evidence to the emerging paradigm of ciliary 
genes participating in DNA-related processes.   
 179 
 
Figure 6.1.Schematic representation of suggested roles for the RP2-OSTF1 and 
RP2-DNA PKcs interactions. 
A) RP2 might be a positive regulator of cell motility by downregulating the OSTF1-
MYO1E interaction. According to (Tanimura et al. 2016), OSTF1 inhibits cell 
motility by acting as a cytoplasmic “anchor” for MYO1E with whom it directly 
interacts. I suggest that this is the case in the absence of RP2 (right, top panel). In the 
presence of RP2 (right, bottom panel), the RP2-OSTF1 interaction might lead to 
reduced OSTF1-MYO1E interaction (for example, via recruitment of OSTF1 to the 
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plasma membrane). This allows MYO1E to translocate to sites of actin nucleation, 
permitting lamellipodia formation and cell motility to occur.  B) RP2 might interact 
with DNA PKcs at the plasma membrane, leading to phosphorylation of RP2 at S213 
or T214. I suggest that this interaction is part of a “non-canonical” role of DNA PKcs 





Appendix figure 1. Multiple sequence alignment of RP2 vertebrate orthologues. 
Strictly-conserved positions that were identified as part of the binding interface with 




Appendix figure 2. Peptide coverage of RP2 in MS/MS analysis used to identify 
sites of tyrosine phosphorylation. 
Sequence of human RP2 protein where the unique peptides detected during the 
MS/MS analysis (Figure 3.5) are highlighted in red. Blue boxes enclose tyrosine 
residues that are either predicted to be phosphorylated by computational tools or 





Appendix figure 3. Expression pattern of RP2 and OSTF1 in the mouse central 
nervous system by western blot.  
A) Mouse neural tissues were lysed in mild (Triton-containing) lysis buffer and 
subjected to SDS-PAGE and western blot using anti-RP2 and anti-OSTF1 antibodies 
(n=1 mouse tested). Anti-β actin blot was used to ensure equal loading. RPE: retinal 
pigment epithelium, TG: trigeminal ganglion. The neural retina was crudely 
separated from the RPE during dissection. Evidence of RP2 expression at protein 
level exist in the RPE, cortex, cerebellum, thalamus, hippocampus and spine while it 
is exceptionally high in the olfactory bulb. Note that there is no detectable RP2 
signal in the neural retina, contrary to the RPE; RP2 expression in mouse 
photoreceptors has been shown before by electron microscopy and therefore it is 
assumed that it is too low to be detected by the present method (Evans et al. 2010). 
OSTF1 is present in all tissues tested except for the neural retina and it is highly 
expressed in the TG. It is therefore assumed that, regarding ocular tissues, RP2 and 
OSTF1 are co-expressed in the RPE, at least in mice. However, the trustworthiness 
of the anti-OSTF1 antibody is ambiguous as it detects two bands around the 
predicted molecular weight for OSTF1. It is assumed that the lower band (red arrow) 
is the correct one because it disappears after OSTF1 knockdown by siRNA in 
HEK293T cells (B)  
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.  
Appendix figure 4. RP2 null cells do not have altered reactive oxygen species 
(ROS) balance compared to wild-type cells in culture.  
The CellRox Green reagent (Molecular Probes) was used for oxidative stress 
detection in live hTERT-RPE1 cells, either wild-type or RP2 null (G,I clones). This 
dye emits bright green fluorescence upon oxidation by ROS. Here, fluorescence 
intensity was measured by flow cytometry. “Negative control” corresponds to 




Appendix figure 5. Multiple sequence alignment of human, zebrafish wild-type 
and zebrafish mutant RP2. 
Multiple sequence alignment of human RP2 (“Homo”), zebrafish wild-type Rp2 
(“Danio”) and the predicted truncated peptides that would theoretically be expressed 
from the mutated rp2 gene in the lines generated by CRISPR/Cas9 genome editing.  
Important residues R118, E138 and R211 (shown in red) on the human protein which 
are sites of missense pathogenic mutations and conserved on the zebrafish protein 
would be absent from these truncated peptides. R118H and E138G (in the catalytic 
core of the protein) abolish the GAP activity of RP2 and the RP2-ARL3 interaction, 





Appendix figure 6. Agarose gel and Sanger sequencing-based analysis of 
products and templates of qRT-PCR experiments conducted in order to detect 
zebrafish rp2 transcript levels. 
A) Analysis of qRT-PCR products generated using β-actin and two sets of rp2 
primers on 2% agarose gels. cDNA from WT, Del8, and Ins1 3 dpf embryos was 
used as template. “Control 1” corresponds to cDNA synthesis without polymerase, 
while “Control 2” corresponds to cDNA synthesis without RNA template. B) cDNA 
molecules synthesised from RNA isolated from WT, del8 and ins1 3 dpf embryos 
were Sanger sequenced using rp2 sequencing primers and aligned using Clustal O 




Appendix figure 7. Western blotting detection of exogenously expressed 
zebrafish Rp2-GFP by the anti-RP2 antibody used in Chapter 6. 
To test if the anti-RP2 antibody used for western blotting on zebrafish eyeballs 
(Chapter 5: Figure 5.2C) can recognise zebrafish Rp2, zebrafish Rp2-GFP and GFP 
alone (as a negative control) were transiently expressed in HEK293T cells and the 
lysates were used for western blotting using anti-RP2 and anti-GFP antibodies. Red 
arrows point to endogenous RP2, recognised by the antibody in both cell lysates, and 
exogenous zebrafish Rp2-GFP, recognised by the antibody only in the Rp2-GFP –




Appendix Table 1. List of proteins identified by MS/MS in RP2-V5 IPs.  
Ratio represents fold enrichment in RP2-V5 IPs vs. negative control (IPs from 
empty-vector transfected cells). P- value represents significance and is estimated 
using unpaired two-tailed t-tests based on three biological replicates. Only proteins 
with p<0.1 are shown. 
 
PROTEIN NAMES GENE NAMES RATIO P- VALUE 
Protein XRP2 RP2 12.9961056 0.01091767 
Signal recognition particle 
receptor subunit beta 
SRPRB 6.64169678 0.0172088 
Osteoclast-stimulating 
factor 1 
OSTF1 6.31091699 0.00037541 




PGRMC1 5.95995821 0.00622987 
Exportin-5 XPO5 5.94028863 0.02001779 
Cullin-associated NEDD8-
dissociated protein 1 
CAND1 5.73851598 0.04820888 
26S proteasome non-
ATPase regulatory subunit 
13 




SLIRP 5.19970632 0.05151275 
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 
2 
ATP2A2 5.14348908 0.06921151 
Voltage-dependent anion-
selective channel protein 2 




LRPPRC 5.02057991 0.02757329 
MICOS complex subunit 
MIC19 
CHCHD3 4.82963271 0.04965206 
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Trafficking protein particle 
complex subunit 3 
TRAPPC3 4.75336925 0.0017578 
Serine/threonine-protein 
kinase mTOR 
MTOR 4.71363582 0.01205821 
Stomatin-like protein 2, 
mitochondrial 








PGRMC2 4.64552553 0.0053892 
Transportin-1 TNPO1 4.38670885 0.0176949 
Importin-4 IPO4 4.24765752 0.06078979 
26S protease regulatory 
subunit 4 
PSMC1 4.18162594 0.0495033 
Protein unc-45 homolog A UNC45A 4.1082625 0.08899154 
Importin subunit beta-1 KPNB1 4.0303007 0.02633798 
V-type proton ATPase 
subunit H 
ATP6V1H 4.01426437 0.06693755 
Uncharacterized protein 
C19orf43 
C19orf43 3.91551744 0.00311376 
Coatomer subunit 
alpha;Xenin;Proxenin 
COPA 3.91363061 0.04869633 
Proteasome-associated 
protein ECM29 homolog 
ECM29 3.85356057 0.09807692 
Exocyst complex 
component 7 
EXOC7 3.84508421 0.06550598 






USP9X;USP9Y 3.77167126 0.0957394 
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Lamin-B receptor LBR 3.65550145 0.0958337 
Translational activator 
GCN1 
GCN1L1 3.5656167 0.06320478 
Nuclear autoantigenic 
sperm protein 
NASP 3.55868492 0.09971216 
Gem-associated protein 2 GEMIN2 3.51443752 0.08090646 
RNA-binding protein 26 RBM26 3.47584639 0.00361256 
Protein transport protein 
Sec61 subunit beta 
SEC61B 3.19949487 0.06655518 
T-complex protein 1 
subunit delta 
CCT4 3.00994036 0.05778609 
Transmembrane protein 
194A 
TMEM194A 3.00897411 0.01802931 
DNA-dependent protein 
kinase catalytic subunit 




DPM3 2.96870761 0.06986405 
MICOS complex subunit 
MIC60 
IMMT 2.96309514 0.03614755 
D-3-phosphoglycerate 
dehydrogenase 
PHGDH 2.75431643 0.05261122 
FAST kinase domain-
containing protein 5 
FASTKD5 2.72236827 0.08381522 
Proteasomal ubiquitin 
receptor ADRM1 
ADRM1 2.66563899 0.008217 
T-complex protein 1 
subunit eta 
CCT7 2.53475966 0.04880528 
Nascent polypeptide-
associated complex subunit 
alpha, muscle-specific form 
NACA 2.44676709 0.08967704 
Far upstream element-
binding protein 2 
KHSRP 1.99539916 0.09425262 




phosphatase 4 regulatory 
subunit 
3A;Serine/threonine-protein 
phosphatase 4 regulatory 
subunit 3B 
SMEK1;SMEK2 1.68458981 0.04695093 
G2/mitotic-specific cyclin-
B1 
CCNB1 1.5924915 0.0961335 
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